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Summary
Macroautophagy (autophagy hereafter) is a dynamic cellular recycling process, which is essential to
maintain cellular homeostasis and cope with metabolic stress. Central to the process are double-layered
vesicles, termed autophagosomes, which form de novo and engulf cytoplasmic target material before
fusing with lysosomes to become autolysosomes. In the autolysosomes, autophagic cargo is degraded
and released back into the cytoplasm as nutrients or metabolic precursors 1,2.
Autophagosome formation and nucleation of the isolation membrane are orchestrated by three protein
complexes, mTORC1, ULK1 and PI3KC1 3. Two distinct PI3K complexes have been reported, each con-
taining the core components Vps34, p150, Beclin1 and either Atg14L or UVRAG as a fourth subunit 4,5.
Upon autophagy induction, the Atg14L-containing PI3K complex is recruited to the endoplasmatic reti-
culum (ER). Here, the lipid kinase Vps34 generates phosphatidylinositol 3-phosphate (PI3P) leading to
nucleation of a scaffolding platform, termed omegasome, from which the autophagosome is arises 6,7.
UVRAGs exact function in autophagy remains elusive. The UVRAG-containing PI3K complex is suppos-
edly involved in autophagosome formation, but UVRAG also interacts with the HOPS complex to acti-
vate the small GTPase Rab7 and stimulate autophagosome-lysosome fusion 4,8,9. Furthermore, UVRAG
plays a role in the generation and trafficking of Atg9 vesicles, supplying membrane to the forming au-
tophagosome 10. Besides its function in autophagy, UVRAG participates in maintaining genomic stabil-
ity, retrograde Golgi-ER transport and many other vesicular trafficking or fusion processes 11,12. Since
vesicular transport pathways are naturally intertwined, this makes it even more difficult to pinpoint
UVRAGs exact role in autophagy 13.
The controversy about UVRAG’s function in autophagy highlights the need for new techniques to study
the spatiotemporal context of highly dynamic processes in vivo. Traditional techniques are mostly based
on altering the gene expression levels by knock out/down or on small molecule modulators of protein
function. However, gene silencing is a chronic and global perturbation, which takes hours to days and
often alters cellular processes altogether. Chemical inhibitors or inducers allow for fast and efficient
perturbations, but many of them lack specificity or show time- and dose-dependent side effects 14. We
thus created the knock off and on approach, which is based on chemically inducible dimerization and
facilitates rapid, specific inhibition and re-activation of autophagy in vivo. Inducible dimerization sys-
tems have become a widespread tool, since dimerization can be induced on a timescale of seconds
and with subcellular spatial resolution. The dimerization strategies differ between photoinducible and
chemically inducible systems, but the basic principle, remains the same: two proteins are artificially
brought into close proximity. Chemically induced dimerization forces proteins into high-affinity in-
teraction through addition of a small molecule, termed dimerizer. Application and dosage control of
dimerizers are simple, they can penetrate tissues inaccessible to light, the dimerization kinetics can be
rapid and some systems are even reversible 15,16,17.
The SLF’-TMP dimerizer utilized in this thesis is superior to most chemical dimerization systems
available to date 18,19. SLF’, a synthetic ligand of the FKBP12, binds with over 1000-fold selectivity to
FKBP’, the F36V mutant of FKBP12 20. Trimethoprim (TMP) is highly selective for the E.coli protein
viii
eDHFR. SLF’-TMP dimerizes FKBP’- and eDHFR-fusion proteins rapidly (t1/2 = 44 s) and is completely
bioorthogonal in eukaryotic systems. SLF’-TMP-mediated crosslinking is also rapidly reversible by out-
competing eDHFR-binding with TMP and may be applied orthogonal to rapamycin-based systems. In
the knock off and on approach, we employed the SLF’-TMP dimerization system to conditionally mis-
localize autophagic target proteins. The knock off and on strategy is based on a bait and prey principle,
in which the localization-dependent function of endogenous prey proteins is disrupted by re-routing
them to another cellular compartment. Typically, the bait protein is an exogenous FKBP’-fusion protein,
which co-localizes with an eDHFR-tagged cellular anchor upon dimerizer addition. Due to its overex-
pression, the bait protein is highly concentrated, so that mislocalization of the bait-prey complex results
in complete depletion and functional disruption of the endogenous prey protein (knock off). Correct lo-
calization and function of the prey protein is re-established upon addition of the competitor (knock on).
In this study, we modulated the autophagy process by conditionally mislocalizing PI3K complex proteins
to the plasma membrane to disrupt their function in autophagosome formation. As a proof of principle,
we successfully employed an anti-Vps34 nanobody as bait in knock off/on system, which demonstrates
the technique’s broad applicability to any protein of interest. By knock off of PI3K complex proteins,
we were able to stop the autophagy process during isolation membrane formation and re-activate it
through knock on. Using different autophagy markers, we studied the spatiotemporal aspect of PI3K
complex function and found that it participates in the early stages of isolation membrane formation,
but not in autophagosome transport or maturation. It is interesting to note that the functionality of the
complex, i.e. Vps34s kinase activity, is only maintained in presence of the core components, Beclin1
and Atg14L. Furthermore, the complexes function appears to be related to its intracellular localization,
as autophagosome formation was enhanced upon re-routing PI3K proteins to the ER. Using the knock
off/on approach, we also determined that UVRAG is essential for autophagosome formation and matu-
ration. Based on our observations, we hypothesize that UVRAG is first involved in generation, transport
and fusion of Atg9 vesicles to support autophagosome formation and later coordinates trafficking and
lysosomal fusion of the closed autophagosome.
Taken together, our results demonstrate that the knock off/on approach is very powerful new tool, es-
pecially in combination with traditional autophagy assays. Knock off/on allows to rapidly perturb and
monitor autophagosome formation and maturation in live cells, which has not been possible so far.
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Zusammenfassung
Makroautophagie (nachstehend Autophagie) ist ein zellulärer Recyclingprozess, der zur Erhaltung der
Homöostase und zur Bewältigung von Zellstress dient. Von zentraler Bedeutung sind dabei Dop-
pelmembranvesikel (Autophagosomen), die de novo entstehen und das für den Verdau bestimmte, zy-
toplasmische Zielmaterial umschließen, um dann mit Lysosomen zu Autolysosomen zu verschmelzen.
Hier wird das Zielmaterial abgebaut und in Form von Nährstoffen oder metabolischen Vorläufern
wieder ins Zytoplasma freigesetzt 1,2.
Die Bildung von Autophagosomen wird hauptsächlich von den drei Proteinkomplexen mTORC1, ULK1
und PI3K gesteuert 3. Der PI3K-Komplex liegt dabei in zwei Konfiguration vor: Er enthält immer die
Kernkomponenten Vps34, p150 und Beclin1 und als vierte Untereinheit Atg14L oder UVRAG 4,5. Sobald
Autophagie induziert wird, lokalisiert der Atg14L-PI3K-Komplex zum endoplasmatischen Retikulum
(ER) und die Lipidkinase Vps34 katalysiert die Bildung von mPhosphatidylinositol-3-phosphat (PI3P).
Dies führt zur Entstehung von formgebenden Plattformen, den Omegasomen, in denen schließlich das
Autophagosom gebildet wird 6,7.
Die Funktion von UVRAG im Autophagieprozess ist noch nicht vollständig erschlossen. Der UVRAG-
PI3K-Komplex ist wahrscheinlich an der Entstehung von Autophagosomen beteiligt, aber das Protein
interagiert auch mit dem HOPS Komplex , was zur Aktivierung der kleinen GTPase Rab7 führt und so
die Fusion von Autophagosomen und Lysosomen einleitet 4,8,9. Darüberhinaus vermittelt UVRAG die
Bildung und den Transport von Atg9-Vesikeln, welche Membranbestandteile zum entstehenden Au-
tophagosom liefern 10. UVRAG ist außerdem an der Erhaltung der genomischen Stabilität, dem Golgi-
ER-Transport und verschiedenen anderen vesikulären Transport- und Fusionsprozessen beteiligt. Dies
erschwert es zusätzlich, die genaue Funktion UVRAGs im Autophagieprozess zu definieren 13.
Die Debatte um UVRAGs Funktion unterstreicht die Notwendigkeit für neue Methoden zur Unter-
suchung hoch dynamischer Prozesse in vivo und mit höherer zeitlicher Auflösung. Herkömmliche
Methoden konzentrieren sich meist darauf, die Expression bestimmter Gene zu verändern (knock
out/down) oder bedienen sich kleiner Moleküle, um einzelne Proteine zu beeinflussen. Das chro-
nische An- oder Ausschalten von Genen kann jedoch einige Stunden oder Tage dauern und betrifft
häufig mehr als einen zellulären Prozess. Chemische Modulatoren hingegen wirken innerhalb von
Minuten, sind aber häufig unspezifisch und zeigen zeit- und dosisabhängige Nebenwirkungen 14. Wir
haben daher die knock off/on-Strategie entwickelt, welche auf induzierbarer, chemischer Dimerisierung
basiert und schnelle, spezifische Inhibition und Reaktivierung von Autophagie ermöglicht. Induzierbare
Dimerisierungssysteme sind inzwischen ein weit verbreitetes Werkzeug, da die Dimerisierung innerhalb
von Sekunden und mit subzellulärer Auflösung induziert werden kann. Die Dimerisierungsstrategien
werden in fotoinduziert und chemisch induziert unterteilt, aber das Grundprinzip bleibt dasselbe: Zwei
Proteine werden künstlich in räumliche Nähe gebracht. Chemisch induzierte Dimerisierung zwingt
Protein in eine hoch affine Bindung durch Zugabe eines kleines Moleküls, den Dimerisierer. Die An-
wendung und Dosierung von Dimerisierern ist einfach, sie können in lichtundurchdringliche Gewebe
eindringen, die Dimerisationsgeschwindigkeit ist hoch und einige Systeme sind sogar reversibel 15,16,17.
x
Der SLF’-TMP-Dimerisierer ist den meisten bekannten Dimerisierungssystemen überlegen 18,19. SLF’,
ein synthetischer Ligand von FKBP12, bindet mit über 1000-facher Spezifität an FKBP’, die F36V Mu-
tante von FKBP12, während Trimethoprim (TMP) äußerst selektiv an das E.coli Protein eDHFR bindet.
SLF’-TMP dimerisiert FKBP’- und eDHFR-Fusionsprotein innerhalb von Sekunden (t1/2 = 44 s) und ist
bioorthogonal in eukaryontischen Systemen. SLF’-TMP-basierte Dimerisierung ist zudem innerhalb
von Sekunden durch Zugabe von TMP umkehrbar und kann auch parallel zu Rapamycin-basierten Sys-
temen angewandt werden. In der knock off/on Strategie wurde dieses Dimerisierungssystem benutzt,
um Fehllokalisierung von Autophagieproteinen zu induzieren. Dabei wurde eine Bait und Prey Strate-
gie angewandt, um endogene Proteine in ein anderes zelluläres Kompartment umzuleiten und damit
ihre lokalisationsabhängige Funktion zu inhibieren. Als Bait-Protein wurde ein stark überexprimiertes
FKBP’-Fusionsprotein gewählt, das bei Zugabe von Dimerisierer an ein eDHFR-Fusionsprotein bindet,
welches als zellulärer "‘Anker"’ fungiert. Aufgrund der starken Überexprimierung ist das Bait-Protein
hochkonzentriert, sodass Fehllokalisierung des Bait-Prey-Komplexes zur totalen Depletion und damit
funktionalen Inhibierung des endogenen Zielproteins führt (knock off). Die korrekte Lokalisierung des
Zielproteins kann anschließend durch Zugabe von TMP wiederhergestellt werden (knock on).
In dieser Studie wurde der Autophagieprozess durch induzierte Fehllokalisation von Autophagiepro-
teinen zur Plasmamembran gesteuert. Dabei wurde auch ein anti-Vps34 Nanokörper als Bait-Protein
eingesetzt, was es ermöglicht, die knock off/on-Methode auf jedes zelluläre Protein anzuwenden. Durch
knock off von PI3K-Komplexproteinen, konnten wir den Autophagieprozess während der Induktions-
phase erfolgreich stoppen und reaktivieren. Unter Verwendung verschiedener Autophagiemarker
wurde die Funktionsweise des PI3K-Komplexes untersucht und es zeigte sich, dass der PI3K-Komplex
während der frühen Autophagiestadien sehr wichtig ist, aber während des Transportes und der Fusion
von Autophagosomen mit Lysosomen keine Rolle spielt. Interessanter Weise ist die Kinasaseaktivität
von Vps34 nur gegeben, wenn alle Kernkomponenten des Komplexes, d.h. Beclin1 und Atg14L, vorhan-
den sind. Darüberhinaus scheint die Funktion des Komplexes im direkten Zusammenhang mit seiner
zellulären Lokalisation zu stehen, da die Bildung von Autophagosomen zunahm, als der PI3K-Komplex
an das ER lokalisiert wurde. Unter Verwendung der knock off/on Strategie konnten wir außerdem
zeigen, dass UVRAG zur Bildung, aber auch zur Reifung von Autophagosomen benötigt wird. Basierend
auf unseren Beobachtungen nehmen wir daher an, dass UVRAG zunächst die Bildung, den Transport
und die Fusion von Atg9-Vesikeln reguliert und danach den Transport und die Fusion von autophagi-
schen Vesikeln koordiniert.
Zusammenfassend lässt sich anhand der vorliegenden Ergebnisse feststellen, dass die knock off/on-
Strategie ein sehr vielversprechendes, neues Werkzeug darstellt, insbesondere in Kombination mit tra-
ditionellen Autophagie-Assays. Knock off/on ermöglicht es die Bildung und Reifung von Autophago-
somen zu beeinflussen und gleichzeitig in lebenden Zellen zu beobachten, was bisher so nicht möglich
war.
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1 Introduction
1.1 Autophagy: An Overview
Living organisms are in constant state of cellular renovation, continuously remodeling, degrading and
re-synthesizing the components they are made of. This renovation process is tightly regulated to main-
tain cellular homeostasis and at the same time guarantee a steady supply of building blocks as well as
an efficient clearance of old or dysfunctional material. In eukaryotes, cellular components are degraded
by two major systems: the proteasome and the lysosome. Whereas the proteasome is largely respon-
sible for clearance of ubiquitinated substrates, the lysosome is supplied with proteins, organelles and
extracellular material by the endocytic or the autophagic pathway. Typically, endocytosis shuttles extra-
cellular material to the lysosome, while cytoplasmic components are delivered by autophagy 21.
The term ’autophagy’ is a conglomerate of the Greek words ’auto’ (self) and ’phagy’ (eating) and is evo-
lutionary conserved throughout all kingdoms of life. Macroautophagy (autophagy hereafter) is crucial
to maintain cellular integrity or cope with metabolic stress, which is why malfunction of autophagy has
been linked to a wide range of diseases 22,23. Central to the process, are double-layered vesicles, termed
autophagosomes, which form de novo and capture cytoplasmic target material before fusing with lyso-
somes to become autolysosomes 1. In the autolysosomes, autophagic cargo is degraded and released
back into the cytoplasm as nutrients or metabolic precursors 2.
The process is typically divided in three phases: initiation, sequestration and maturation of autophago-
somes. In mammalian cells, sequestration and maturation, i.e. formation, closure and lysosomal fusion
of the autophagosome are orchestrated by two protein complexes, ULK1 and PI3KC1, and two ubiquitin-
like conjugation systems Atg12-5-16L and LC3-PE. Overall autophagic activity is largely controlled by the
master regulator mTOR and strongly related to absence or presence of nutrients and growth factors 2,3.
Contrary to popular belief, autophagy was first described in a written report in 1860 and has suppos-
edly been known to the scientific community even longer. However, the cellular process referred to as
autophagy nowadays was discovered by Christian de Duve in 1963. Using electron microscopy, de Duve
first identified the end point of autophagy, the lysosome, in 1955 and almost a decade later he suggested
the existence of an ’autophagic’ sequestration pathway, which delivers cytoplasmic material to the lyso-
some.
In the following four decades, understanding of the autophagy pathway progressed slowly, as most
data was obtained from electron microscopy and detection of autophagosomes or lysosomes remained
challenging due to their short life time and heterogeneous morphology. A milestone in autophagy re-
search was the identification of autophagy genes in the yeast Saccharomyces cerevisiae by Nobel Lau-
reate Yoshinori Ohsumi in the early 1990s and the observation that the process could be initiated by
various modes of starvation. This finally provided a readout to monitor autophagy and gave way to a
vast number of studies cataloging the yeast autophagy genome. In 1998 Mizushima and co-workers dis-
covered the first autophagy genes in mammalian cells demonstrating that the process is conserved from
yeast to mammals and starting the long process of identifying mammalian homologs. Two years later,
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the Yoshimori lab found the mammalian homolog of the widespread yeast autophagosome marker Atg8
(LC3) thus paving the way for the development of numerous assays to monitor mammalian autophagy.
Since then, understanding of the autophagic pathway has progressed tremendously and the autophagic
machinery has been largely identified and extensively characterized 3.
1.1.1 Regulation of Autophagy
Cell homeostasis is of fundamental importance to maintain growth, function and development. To keep
an efficient balance between anabolic and catabolic processes, most cell types continiously perform au-
tophagy on a basal level and merely enhance the process upon a starvation or stress signal. Typically,
these signals originate from the extracellular space, are detected at the plasma membrane, in the cytosol
or in cellular organelles and then forwarded to the autophagic machinery. Here, mTOR is the key regu-
lator activating or inhibiting autophagy depending on the cells nutritional status 24,25.
The mTORC1 complex, comprised of the serine/threonine kinase mTOR, raptor, deptor, PRAS40 and
mLST8, positively regulates glycolysis as well as synthesis of proteins, lipids or nucleotides while it sup-
presses autophagy by inhibiting ULK1s kinase activity. The factors regulating mTORC1 are as diverse as
the output it produces: it reacts to levels of oxygen, amino acids, glucose, ATP and growth factors, but
also to signals from oncogenes, pathogens or mechanical stress (see Figure 1.1). Autophagy, on the other
hand, is mainly governed by the absence or presence of amino acids and growth factors 3.
In general, limited availability of amino acids triggers autophagy by disrupting mTORC1s activity. How-
ever, the specific regulatory mechanisms differ, depending on the individual amino acid or their com-
bination. Especially, leucine, arginine and glutamine levels appear to be pivotal for mTORC1 activity.
Amino acid sensing via mTORC1 is mediated by the GTPases RagA/B and RagC/D, which form a het-
erodimer and interact directly with raptor. The Rag GTPases are activated depending on the cellular
amino acid levels. If extracellular amino acids are available, L-glutamine is initially shuttled into the cell
by its high-affinity membrane transporter SLC1A5. The high L-glutamine levels then facilitate uptake of
other essential amino acids through the bidirectional transporter SLC7A5-SLC3A2, which uses the in-
tracellular L-glutamine as an efflux substrate 26.
In presence of high amino acid concentrations RagA/B exchanges guanosine diphosphate (GDP) for
guanosine triphosphate (GTP) and consequently assumes its active conformation, while RagC/D ex-
changes GTP for GDP and is inactivated. The nucleotide exchange is mediated by v-ATPase and a
complex termed Ragulator that resides at the lysosome. Subsequently, activated RagA/B forms a het-
erodimer with inactive RagC/D, which then binds to raptor and sequesters mTORC1 to the lysosomal
surface through interaction with the Ragulator complex 27. Here, mTORs kinase activity is dramatically
upregulated through interaction with another small GTPase, termed Rheb, which resides at lysosomes
and is a potent activator of mTORC1 28.
Rheb also appears to serve as molecular ’and-gate’ integrating growth factor signaling with nutrient
sensing. To interact with Rheb, mTORC1 needs to be recruited to lysosomes by the amino acid-sensing
Rag-Ragulator pathway. Yet, for subsequent activation of mTORC1, Rheb needs to be activated by
growth factor signaling. This mode of signal integration also explains the dominance of amino acid
sensing over growth factor signaling: in nutrient-rich conditions cell development may be stimulated,
but in starvation conditions mTORC1 is inhibited to induce autophagy and restore intracellular amino
acid levels first 26.
In contrast to amino acid-sensing, growth factor signaling communicates the nutritional status of the
whole tissue or organism to control proliferation, development and differentiation. mTORC1 is mainly
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regulated by growth factors binding to receptor tyrosine kinases or G-protein-coupled receptors (GPCR)
at the cell surface. Insulin binding to its GPCR, for instance, triggers a major mTORC1-regulating signal-
ing cascade starting from the phosphatidylinositol-3-OH kinase (PI3KC1a).
Upon growth factor binding, PI3KC1a is activated and generates increased levels of phosphatidylinosi-
tol (3,4,5)-triphosphate (PIP3) at the plasma membrane. This attracts the serine/threonine kinase PDK1,
which in turn activates the kinase Akt and thereby disrupts a protein complex termed TSC. The TSC com-
plex consists of the heterodimeric proteins TSC1/2 and exhibits a GAP activity towards Rheb to maintain
the GTPase in its inactive conformation. Upon Akt-mediated phosphorylation of TSC2, however, TSCs
complex stability and function is perturbed and GTP-bound Rheb can accumulate to stimulate mTORC1
activity. Additionally, several other serine/threonine kinases, like Erk or AMPK, also regulate mTORC1
through phosphorylation of TSC1/2 making it the most essential signaling route in response to growth
factor binding 26,27.
Another mTORC1-dependent signaling cascade regulating autophagy responds to the cellular energy
state via the energy sensor AMPK. In cells, energy generated by glycolysis or mitochondrial respiration
is typically stored by converting adenosine monophosphate (AMP) into adenosine triphosphate (ATP)
and monitored by the kinase AMPK. In low energy conditions, i.e. high levels of AMP, AMPK is acti-
vated by the kinase LKB1 and stimulates TSCs GAP activity towards Rheb. This induces accumulation
of inactive GDP-bound Rheb, which inhibits mTORC1 activity and thus activates autophagy. Apart from
AMP/ATP ratios, different stress signals, such as cytoplasmic p53 or nitric oxide (NO), have also been
observed to induce autophagy through the AMPK-TSC pathway. In addition AMPK has been reported
to directly disrupt mTORC1 by phosphorylating raptor and to enhance autophagy through direct inter-
action with ULK1 and Beclin1 26.
Apart from mTORC1-dependent pathways, autophagy may also be induced by several other signaling
cascades. It appears to be negatively regulated by inositol signaling and also responds intracellular cal-
cium or cAMP levels, for instance. Another level of regulation might be direct activation or inhibition of
the ULK1 or PI3K complexes through interaction with their numerous binding partners. One candidate
could be the binding platform Beclin1 of the PI3K complex that functionally interacts with more than 50
different proteins of which at least some of them have been linked to autophagy. However, the majority
of mTORC1-independent mechanisms and particularly the question, how they integrate with growth
factor and amino acid sensing, have not been completely understood yet and remain to be clarified in
the future 3,26.
1.1.2 Autophagosome Formation and Maturation
Formation of double-layered membrane vesicles, termed autophagosomes, is a key step of the au-
tophagic pathway and has been extensively studied, first in yeast and later in mammalian systems. The
process is coordinated by several autophagy-related ’Atg’ proteins and kinases and can be broadly di-
vided into nucleation, elongation and closure of the autophagosome. Nucleation is primarily controlled
by the ULK1 and PI3K protein complexes, while the ubiquitin-like conjugation systems Atg12-5-16L
and LC3-PE assist elongation and closure. Transport to the lysosome and fusion, i.e. maturation of
the autophagosome, are orchestrated by different motor proteins, Rab GTPases, membrane tethers
and SNAREs. However, compared to autophagosome formation the understanding of the maturation
process is still very limited 7.
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1.1.2.1 Autophagosome Nucleation
One of the earliest signaling events in autophagosome formation is translocalization of the ULK1 com-
plex to the endoplasmatic reticulum (ER), where it interacts with the PI3K complex to induce formation
of the so-called isolation membrane 29. In nutrient-rich conditions, the ULK1 complex, comprised of the
serine/threonine kinase ULK1, Atg13, Atg101 and FIP200, associates with mTORC1 and its kinase activity
is inhibited by mTOR-mediated phosphorylation of ULK1 and Atg13. In starvation or stress conditions,
mTOR is inactivated, ULK1 and Atg13 are dephosphorylated and the complex dissociates from mTORC1.
ULK1 then becomes autophosphorylated and in turn phosphorylates FIP200 and Atg13, which induces
translocalization of the complex to the autophagosome formation site. ULK1 is also phosphorylated by
AMPK and acetylated by TIP60, but it is not entirely clear how these postranslational modifications inte-
grate with each other 1,7. ULK1 also phosphorylates raptor of the mTORC1 complex, which supposedly
further activates autophagy by decreasing mTORC1 substrate affinity 3.
The activated ULK1 complex interacts with several downstream proteins like Atg16L or LC3 to initiate
and assist isolation membrane nucleation and has been observed to enhance PI3K complex activity.
Two distinct PI3K complexes have been reported, each containing the core components Vps34, p150
and Beclin1 and either Atg14L or UVRAG as a fourth subunit 4. Both PI3K complexes assemble from two
protein pairs, the Vps34-p150 heterodimer and the Beclin1-Atg14L/UVRAG heterodimer with Atg14L
and UVRAG binding mutually exclusive to Beclin1’s coiled-coil domain (CCD) 5.
Upon starvation, Beclin1 dissociates from the inhibitory protein Bcl-2 and the PI3K complex is recruited
to the ER by Atg14L. Atg14L associates with the ER membrane through its cysteine-rich N-terminal do-
main. At the ER, Beclin1 is directly and indirectly (via AMBRA) phosphorylated by ULK1 to enhance the
kinase activity of Vps34. The enzyme is additionally phosphorylated by several other kinases, like PKD
or AMPK, but their exact function has not been resolved yet. Vps34 is a class III lipid kinase and gen-
erates PI3P from phosphatidylinositol, which leads to nucleation of a PI3P-enriched platform, termed
omegasome, from the ER. PI3Ps also serve as second messengers recruiting effector proteins like WIPIs
and DFCP1 that may support elongation and closure of the isolation membrane 1,3,7.
Several positive feedback loops might additionally stimulate the process. For instance, PI3Ps have been
observed to positively interact with Atg13 in the ULK1 complex, which may increase recruitment of the
ULK1 complex to the omegasome. Similarly, Atg14L contains a C-terminal ’Atg14L (Barkor in yeast) au-
tophagosome targeting sequence’ (BATS) with a high affinity for highly curved, PI3P-rich membranes
that may further enhance translocalization of PI3K complexes to the forming autophagosome. The im-
portance of these feedback processes, however, remains to be further investigated 30.
1.1.2.2 Formation and Elongation of the Isolation Membrane
After nucleation of the isolation membrane, two ubiquitin-like conjugation systems, Atg12-5-16L and
LC3-PE, accumulate at the omegasome and promote membrane elongation. The Atg12-5-16L complex
is recruited first and then supports formation and activity of the LC3-PE system, which is essential for
elongation and closure of the autophagosomal membrane.
The Atg12-5-16L complex assembles from Atg12-5 and Atg16L, in an enzymatic process similar to
ubiquitin conjugation during which Atg12 is initially conjugated to Atg5 and then binds to Atg16L.
In the beginning, Atg12 carries an N-terminal glycin, which is cleaved by the E1-like enzyme Atg7 in
order to transfer Atg12 to the E2-like protein Atg10 and later conjugate it to Atg5. Atg12-5 then forms
a homodimeric complex with Atg16L at the isolation membrane. The Atg12-5 complex alone shows
no distinct membrane localization, but interaction with Atg16L dramatically increases its affinity for
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Figure 1.1: Regulation of autophagy induction, autophagosome formation and maturation 1,2,21,27,31. A Regula-
tion of autophagy by growth factors and cellular energy state. mTORC1 is activated through the PI3KC1/Akt/TSC
pathway and inhibits autophagy induction. B Autophagy is negatively regulated in response to amino acid influx,
which activates mTORC1 via Rag GTPases. C Autophagosome formation. The ULK1 complex translocates to the
ER and stimulates generation of PI3Ps by the PI3K complex. Increased PI3P concentrations attract WIPI and DFCP1
and promote omegasome formation. Two interdependent ubiquitin-like conjugation systems generate Atg12-5-16L
and LC3-PE complexes, which support isolation membrane elongation and closure. Atg9 vesicles may provide an-
other membrane source. D The closed autophagosome is transported to the lysosome by kinesin or dynein motors,
which bind supposedly through RILP- or FYCO1-Rab7 complexes. Lysosomal fusion is most likely orchestrated by
a combination of Rabs, HOPS and SNARE complexes and requires the UVRAG-containing PI3K complex. In the
autolysosome, the autophagic cargo is degraded and recycled.
the convex surface of the isolation membrane in presence of PI3Ps 32. Only recently, Mizushima and
co-workers proposed that interaction with FIP200 targets Atg16L to the autophagosome formation site
by reversing a self-inhibitory effect of Atg16Ls C-terminal WD-repeat domain 33.
Due to its function as E3-like enzyme during LC3-PE conjugation, localization of the Atg12-5-16L
complex also determines the site of LC3 lipidation. In mammals, the LC3 family is comprised of
seven homologs (LC3A/B/C, GABARAP and GABARAPL1/2/3) with LC3B being the most common
isoform within the autophagy process. Similar to Atg12, LC3 is initially expressed with a C-terminal
extension that is cleaved by the protease Atg4 so that LC3 can be activated by Atg7 (E1-like enzyme).
Afterwards, LC3 is transferred to the E2-like enzyme Atg3 and eventually conjugated to PE supported
by Atg12-5-16L’s E3-like activity 34. In contrast to Atg12-5-16L, which dissociates from the isolation
membrane upon closure, LC3-PE remains bound to the inner and outer autophagosomal membrane
and appears to act as a scaffold for membrane elongation. Accordingly, the complex has also been
related to the size of the forming autophagosome and appears to be involved in membrane tethering
and closure of the isolation membrane 35,36.
Consistent with these observations, a model of autophagosome biogenesis has been proposed in
which Atg12-5-16L is recruited to highly curved isolation membranes and promotes LC3 lipidation.
Accumulation of LC3-PE then induces membrane elongation resulting in a decrease of membrane
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curvature. Through interaction with LC3-PE, Atg12-5-16L remains associated to the low curvature
membrane for stabilization while it simultaneously mediates LC3 lipidation at the highly curved edges
of the isolation membrane. In another scenario, LC3-PE is enriched at highly curved membranes by
the E2-like enzyme Atg3, which has also been shown to sense membrane curvature. However, both
hypothesis have not yet been confirmed in vivo and require further clarification 2.
While the function of LC3 family members within autophagosome biogenesis is not entirely clear,
they have been shown to interact with different receptor proteins sequestering specific cargo to the
autophagosome formation site. Ubiquitinated cargo, for example, is delivered by p62/SQSTM1, NBR1,
Optineurin or NDP52 through interaction with LC3/GABARP proteins. This interaction is mostly
mediated via a LC3-interacting region (LIR) in the receptor proteins, but it remains to be elucidated
whether LIR motifs are a common feature in autophagic receptor proteins and which proteins deliver
the remaining autophagic cargo 3.
1.1.2.3 Source of the Isolation Membrane
Another yet unresolved aspect of autophagosome formation is the source of the isolation membrane.
Even though LC3-PE is assumed to mediate elongation of the isolation membrane, it is not clear whether
a given membrane source is merely elongated or if small vesicles fuse with the isolation membrane to
expand it (or a combination of both). In yeast, the transmembrane protein Atg9 catalyzes the delivery
of vesicles from the Atg9 compartment to the autophagosome formation site, which is crucial for mem-
brane expansion and closure. Here, Atg9 is recruited by the yeast counterpart of the ULK1 complex and
even integrated into the autophagosome membrane. In mammals, Atg9 shuttles between the trans-
Golgi network (TGN) and endosomes, but upon starvation it associates with forming autophagosomes.
However, while it is necessary for autophagosome formation, it is not required for isolation membrane
elongation or closure and also not incorporated in the isolation membrane 2,3,37.
The ER has long been a candidate for the membrane source in mammalian systems and recently, several
studies provided direct evidence to support this hypothesis. While other compartments like mitochon-
dria, the plasma membrane, endosomes, the Golgi or ERGIC are also potential sources, the autophagic
machinery initially assembles at the ER to create omegasomes 38,39. Recent EM-based analysis have
shown membrane continuity between the ER and the isolation membrane, which led to the proposal
of a model where the forming autophagosome is sandwiched between two ER sheets 40,41,42. However,
it has been reported that mitochondria can transfer lipids to the isolation membrane as well and that
ERGIC membranes may serve as template for in vitro lipidation of LC3 43,44. Atg9 has also been associ-
ated with the TGN and endosomes rather than the ER. Furhtermore, Atg16L can associate with plasma
membrane derived vesicles to generate autophagosomes 45. Based on these observations, it seems most
likely that different compartments contribute membrane throughout autophagosome formation 3,37.
1.1.2.4 Closure and Maturation of the Autophagosome
The last phase of autophagy is probably also the most understudied and least understood step of the
process. So far, it has been established that autophagosomes must be closed to travel to the lysosome,
where they fuse to become an autolysosome and initiate cargo degradation. How theses processes are
regulated, however, is not entirely clear yet.
Sealing of the isolation membrane to form a double-membrane vesicle marks the final step of au-
tophagosome biogenesis and seems to be controlled by various members of the LC3 and Atg4 families.
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A study in Caenorhabditis elegans demonstrated that the homologs of mammalian GABARAP and LC3
are required for closure of the isolation membrane, but could not determine their specific function 46.
Several other suggested an involvement of Atg4 or its family members, which mediate delipidation and
subsequent membrane removal of LC3 47,48,49. The FYVE-domain containing protein FYCO1 has also
been associated with the process, but again a complete picture remains elusive 2.
Once the autophagosome is sealed, it is transported from the omegasome to the endocytic system, sup-
posedly along microtubules and actin filaments. In yeast, microtubular destruction showed no effect
on autophagy, but in mammals microtubules seem to at least enhance lysosomal fusion as autophago-
somes have been observed to move along microtubular tracks 50,51,52,53,54. In neurons, autophagosomes
were observed to travel towards the cell center in a dynein motor-dependent manner and consistently
with this observation, loss of dynein has been associated with LC3-PE accumulation and perturbed
clearance of autophagic cargo 55,56. Since lysosomes localize mostly to the perinuclear region, involve-
ment of dynein motors, which move towards the plus end of microtubules, seems not surprising. How-
ever, disruption of kinesin motors, which move towards the cell periphery, resulted in autophagy dis-
ruption as well 57.
Another unresolved aspect is the transport mechanism of autophagosomes and particularly the con-
nection between the motor proteins and the autophagic vesicle. Rab7, which plays a vital role in en-
dosome trafficking, is one candidate to mediate motor recruitment as it has been observed to interact
with FYCO1, which binds to autophagosomes via PI3Ps and LC3. Overexpression of FYCO1 resulted in
redistribution of autophagosomes to the cell periphery indicating a functional connection to kinesin-
dependent transport 58,59.
Only few studies dealt with the role of actin filaments in autophagy and provided evidence that actin
may be important for the fusion process. Lee et al. reported that caractin, which regulates actin poly-
merization, is recruited to autophagosomes via HDAC6 and that loss of actin, coractin or HDAC6 pre-
vents lysosomal fusion in selective autophagy 60. Similarly, depleting cells of myosin motors perturbed
autophagosome turnover 61.
Once the autophagosome arrives at its destination, fusion with the lysosome is supposedly initiated in
a cooperative process by Rab GTPases, membrane-tethering complexes and SNAREs 62. Of the Rab GT-
Pases, Rab7 is again a potentially important regulator, since loss of Rab7 blocks fusion entirely. Rab33b,
which interacts with Atg16L, and its GAP OATL1 have also been associated with lysosomal fusion. Still,
their exact function remains to be determined 63,64. The UVRAG-containing PI3K complex may pro-
vide another connection to Rab GTPases, as UVRAG interacts with Vps16, a component of the HOPS
complex, which controls various membrane tethering and fusion processes. Interaction with UVRAG
recruits HOPS to membranes, where the GEF and HOPS subunit Vps39 further activates Rab7. The
GTPase then disrupts binding of UVRAG to its inhibitory interaction partner Rubicon, thus liberating
additional UVRAG to recruit more HOPS and enhance Rab7 activation 65,66.
Based on their function in other processes, Rab proteins are most probably also involved in the recruit-
ment of tethering factors to the autophagosome. Membrane tethers, like the HOPS complex, have been
observed to support fusion processes by bridging membranes and induce formation of SNARE com-
plexes. However, only two tethering factors, HOPS and TECPR1, have been associate with autophagy so
far and their function requires further clarification 62.
SNARE proteins are membrane anchors, which mediate vesicle fusion by bringing two membranes
into close proximity. Typically, SNARE complexes form at opposing membranes and ’zip up’ the so-
called donor and acceptor membranes by forming a bridging trans-SNARE complex. Only one com-
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plete SNARE complex consisting of syntaxin 7, syntaxin 8, Vti1b, VAMP7 and VAMP8 has been indirectly
linked to autophagosome-lysosome fusion, because it participates in endosome-lysosome fusion and
at least VAMP8 and Vti1b seem to be required during selective autophagy. Syntaxin 17 is the only SNARE
protein that appears to be directly involved in autophagy, as loss of syntaxin 17 effectively prevents au-
tophagosomal fusion, but the remaining components of the SNARE complex need to be identified 62.
Lysosomal fusion and delivery of the autophagosomal contents typically marks the terminal point of
the autophagic pathway, even though the cargo remains to be degraded and recycled back into the cyto-
plasm. Degradation of autophagic cargo, however, appears to proceed in a similar manner as recycling
of cellular material delivered by the endocytic pathway. Still, the degradation process also remains to be
further investigated to completely understand the autophagosomal maturation process.
1.1.3 Studying Self-Digestion: Autophagy Modulation
In order to understand complex processes, such as autophagy, the most common in vivo approach, be-
sides mere observation, is to inhibit or enhance the function of one or more components and study the
consequences. Traditionally, cells are depleted of a certain protein by genetic knockdown or knockout,
while protein function can be enhanced by overexpression or (re-)introduction of dominant negative
and constitutively active variants. Especially in the early days of autophagy research, genetic modulation
of the process helped to gain a broad understanding of the relationship between autophagy complexes
and to identify key regulators 3. More recently, autophagy modulation with chemical inducers or in-
hibitors has sparked great interest, as it provides a more dynamic approach to dissect the process exper-
imentally, and because autophagy has become an increasingly important therapeutic target. Dysregula-
tion of autophagy has been associated with various diseases including cancers as well as metabolic, neu-
rodegenerative and infectious conditions. In most of these pathological states, autophagy is inhibited
or downregulated. This contributes to obesity or diabetes, but also promotes accumulation of protein
aggregates leading to neurodegenerative conditions like Parkinson’s or Alzheimer’s disease. In cancers,
autophagy may be inhibited or enhanced depending on the type of cancer, so that the pharmacological
approach modulating autophagy needs to be adjusted to the given conditions 67.
In principle, genetic or chemical perturbation can be applied to any protein, but the choice of candi-
dates is often limited by availability of appropriate functional read-outs or structural information as
basis for drug design. Based on the available information, the kinases mTOR, AMPK and Vps34 are pop-
ular targets for autophagy modulation. Other targets include Beclin1 or microtubules and lysosomes.
However, the functions of mTOR, AMPK or Vps34 are not limited to autophagy and consequently, the
majority of chemical modulators lack specificity. Rapamycin, for instance, is a potent mTOR inhibitor
and effectively induces autophagy, but also globally affects glycolysis, lipid synthesis and various other
metabolic pathways 68.
Popular, but less specific inhibitors of autophagosome sequestration are 3-MA, LY294002 and wortman-
nin. These drugs target class I and III PI3Ks, which generate PIP3s and PI3Ps that serve as second mes-
sengers and are also required for autophagosome formation. Wortmannin might be the most specific of
the three, as it specifically inhibits Vps34. However, amongst other side effects, it also promotes forma-
tion of endocytic vacuoles that are easily mistaken for autophagosomes 14.
Besides sequestration inhibitors, a large number of chemical drugs were designed to disrupt micro-
tubular transport or fusion at the lysosome. Particularly for the lysosome, different strategies have been
applied to inhibit lysosomal enzymes (e.g. leupeptin, pepstatin, E-64d) or to increase the lysosomal pH
by inhibiting v-ATPases with bafilomycinA1 and concanamycinA or with weak base amines like methyl-
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or propylamine, chloroquine and Neutral Red. However, protease inhibitors like leupeptin, pepstatin
and E-64d also affect cytosolic proteases while modulators increasing the pH might target other acidi-
fied compartments as well. Consequently, autophagy inhibitors are mostly applied in combination with
other assays or inhibitors in order to identify and exclude unwanted side effects 14.
Besides rapamycin, only few autophagy inducers have been reported to date. Lithium, sodium valproate
and carbamazepine are a few examples for inducers that act independently of mTOR by decreasing
myo-inositol 1,4,5-triphosphate levels. Other inducers like valproic acid, for instance, inhibit histone
deacetylases to stimulate autophagy by yet unknown mechanisms. Much more specific are Beclin1 sim-
ulators such as the cell penetrating peptides Tat-Beclin1 or Tat-wtBH3D and Tat-dsBH3D, which disrupt
the inhibitory interaction between Beclin1 and Bcl-2. However, similar as for the autophagy inhibitors,
the specificity and variety of induces stills needs to be improved to allow for efficient autophagy induc-
tion 14.
Apart from chemical modulation, autophagy can also be regulated on a transcriptional level. Overex-
pression or post-translational activation of TFEB, for example, upregulates biogenesis of autophago-
somes and lysosomes. The same applies to the transcription factor CEBPB, which has been success-
fully activated in order to stimulate autophagy in hepatocytes 69. In another study, knockdown of the
nucleolar transcription factor RRN3/TIF-IA induced autophagy in neurons and MCF7 cells 70,71. Tran-
scriptional upregulation of Beclin1 expression might be achieved with the anti-cancer drug tamoxifen,
however, the effect has only been observed in a few cell lines and needs to be further validated 14,72.
Taken together, only few methods to specifically and dynamically modulate autophagy are currently
available. Most known autophagy inhibitors and inducers exert pleiotropic effects and can only be ap-
plied in combination with other autophagy assays. Transcriptional control of the autophagic process
provides more specific control over distinct proteins and has been successfully applied in many in-
stances, but requires a time frame of hours to days. Chemical biology tools like inducible dimerization
could provide an alternative approach to overcome these limitations, but has not been applied to study
autophagy yet.
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1.2 Inducible Dimerization
Inducible dimerization systems have become a widespread tool with an ever increasing number of bi-
ological applications. While the dimerization strategies differ between photoinducible or chemically
inducible systems, the basic principle, remains the same: two proteins are artificially brought into close
proximity. This approach can be used to induce protein interactions in a controlled manner, to manip-
ulate protein localization, to activate proteins or protein degradation or to reconstitute split proteins.
Dimerization can be induced on a timescale of seconds to minutes and with subcellular spatial reso-
lution. In contrast, genetic alteration of protein expression, requires hours to days and interferes with
cellular events globally and chronically 15,16,17. Thus inducible dimerization approaches are often supe-
rior when studying dynamic and spatiotemporally confined processes.
Dimerization systems differ according to their dimerization trigger. Chemically inducible dimerization
approaches rely on small molecules that are able to interact with two proteins or protein domains si-
multaneously. If the proteins are identical, the inducers are called homodimerizers, whereas small
molecules binding to different proteins are referred to as heterodimerizers 17. Optogenetic dimeriza-
tion systems, on the other hand, employ light-sensitive protein domains that undergo a conformational
change upon illumination and consequently induce protein interaction. Photoinducible dimerization
approaches combine the former systems by using a small molecule dimerizer, which is photocleaved or
decaged upon illumination at a specific wavelength 73. Subsequently, the different approaches and their
variations will be introduced in detail.
1.2.1 Chemically Inducible Dimerization
Chemically induced dimerization was the first approach to force proteins into high-affinity interaction
through addition of a small molecule, termed ’dimerizer’. Application and dosage control of dimerizers
are simple, they can penetrate tissues inaccessible to light, the dimerization kinetics can be rapid and
some systems are even reversible. Speed and specificity are essential for the applicability of a dimerizer,
but an ideal dimerizer should also be bioorthogonal, cell permeable and feature a high binding affinity.
Spatial control of chemically induced dimerization would be another desirable feature, but is almost
impossible to achieve 17.
1.2.1.1 Homodimerization Systems
The majority of dimerizers used today has at least partially evolved from natural products and opti-
mized to meet the requirements listed above. The first rationally designed dimerizer was developed by
Spencer et al. in 1993 and named FK1012. It was derived from the naturally occurring immunosuppres-
sant FK506, which interacts with the proteins calcineurin and FKBP12 (FK506-binding protein of size 12
kD) and paved the way for an entire family of homodimerizers 17,74. FK1012 was generated by fusing two
copies of FK506 via a flexible linker attached to the calcineurin binding site so that FK506-calcineurin
interaction would be blocked. Addition of FK1012 thus initiates homodimerization of FKBP12 and any
protein of interest fused to FKBP12. The induced dimerization process is rapid, dose-dependent and
also reversible by competitive removal of the dimerizer through addition of monomeric FK506 or cal-
cineurin inhibitors like cyclosporin-A. However, FK1012 is not bioorthogonal and interacts with the
endogenous form of FKBP12. This may be compensated by administering high concentrations of the
dimerizer, but remains problematic due to the high abundance and ubiquity of FKBP12 74. Additionally,
the chemical structure of FK1012 is rather complex (Figure 1.2), prompting many efforts to generate a
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Figure 1.2: Molecular structures of small molecule homodimerizers. A FK1012 is comprised of two copies of FK506
and homodimerizes FKBP12 74. B AP1510 consists of two synthetic FKBP12 ligands (SLFs) 75. C AP20187 is a FKBP12
dimer with high affinity for FKBP’ 20. D xCrAsH dimerizes proteins with the sequence motif CCPGCC and exhibits
fluorescence upon crosslinking 76. E Coumermycin is a bacterial product that interacts with GyrB proteins 77. F
CoDi3 is a member of the CoDi family and crosslinks SNAP-tagged proteins 78.
simplified, bioorthogonal dimerizer for FKBP12.
Holt and colleagues reported several fully synthetic dimerizers originating from AP1510, a non-cyclic,
but less affine dimerizer of FKBP12 75,79. AP1510 is a symmetric dimer of monomeric synthetic ligands
for FKBP12, which was later termed SLF (synthetic ligand of FKBP) and served as the basis for many
dimerizers to follow. Since AP1510 and its variants did not adress the specificity problem, Holt and co-
workers applied the ’bump and hole’ strategy to generate bioorthogonal dimerizers 20. In the bump and
hole approach, presented by Belshawl et al., a space-filling group (bump) is added to the ligand, while
a cavity (hole) is engineered into the ligand-binding site of the interacting protein. Consequently, only
the modified, but not the native, protein can interact with the ligand 80,81.
After screening different FKBP12 mutants and a panel of SLF analogs with bulky adducts, Holt and col-
leagues combined a F36V FKBP12 mutant (FKBP’ hereafter) with the dimerizers AP1903 and AP20187.
The resulting constructs bind to FKBP’ with an affinity of 1.8 nM and to FKBP12 with an affinity of 2.9µM,
thus exhibiting over 1000-fold selectivity for the mutated FKBP’. As the compounds differ only in their
flexible linkers and AP20187 showed better pharmacological properties, it was made commercially avail-
able and is still a widely used FKBP’ homodimimerizer 20,82,83.
Shortly after the concept of chemically induced dimerization was first introduced, another non-covalent
homodimerizer derived from the bacterial product coumermycin was presented by Farrar et al. 77.
Coumermycin acts as a natural dimerizer of the bacterial protein GyrB and is thus bioorthogonal in
eukaryotic systems, a major advantage over other available dimerization systems at the time. It is also
non-toxic and reversible through addition of the related monomeric antibiotic novobiocin 77,83. Even
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though non-covalent crosslinking of proteins has no fundamental drawbacks, direct detection of pro-
tein interaction in vivo was challenging at the time and thus several groups focused on covalent homod-
imerizers.
Johnsson and co-workers generated the CoDi homodimerization system based on the SNAP-tag, which
they presented earlier as a method for covalent protein labeling in vivo 78,84. In principle, the SNAP-tag
is a mutant of the human DNA repair protein hAGT that forms a covalent bond with the nucleobase
O6-benzylguanine (BG) and its derivatives. BG derivatives were initially conjugated to fluorescent dyes
to visualize hAGT-fusion proteins (SNAP-tagged proteins) in cells, but Lemercier et al. joined two BG
subunits via a flexible linker to generate different covalent homodimerizers. These ’CoDi’ dimerizers in-
duce interaction of SNAP-tag fusion proteins. They are bioorthogonal and dimerization can be detected
in vivo by electrophoresis or microscopy. However, the labeling reaction appears to proceed rather slow
(6 hours) and is not reversible 78,83.
The Schulz lab generated another covalent homodimerizer, termed xCrAsH, which was derived from a
protein labeling system developed by Tsien and co-workers and features faster kinetics (1 hour label-
ing), high specificity and reversibility 76,85. A major advantage of the xCrAsH system is the small size
of the dimerization domains, which consist of only twelve amino acids (4cys-tag) and should thus dis-
turb protein activity or localization to a lesser extent than bulky protein tags. Protein crosslinking is
achieved through interaction between a dimeric biarsenic derivative of carboxyfluorescein (xCrAsH)
and the unique sequence motif CCPGCC that is integrated into the protein of interest. Dimerization can
be reversed through addition of dithiols and additionally, the crosslinked proteins emit a fluorescent
signal upon dimerization, which can be used during live cell microscopy 76.
Among the inducible homodimerization systems, AP20187 and coumermycin combine probably most
of the desirable features of a chemical dimerizer (see table 1.1). However, as all of the homodimerization
systems, they also suffer from saturation effects caused by excess dimerizer. To avoid saturation effects,
careful optimization of the dimerizer concentration is required. If the dimerizer concentration is too
high, each dimerizer molecule binds only one copy of the interacting protein and thus dimerization is
limited or completely prevented. Therefore, various labs focused on generation and optimization of
heterodimerizers 83,86,87.
1.2.1.2 Heterodimerization Systems
A milestone in the development of chemical heterodimerizers was the discovery and characterization of
the bacterial antibiotic rapamycin and its analogs (rapalogs), which remain the most thoroughly studied
and widely used dimerizers to date 16,17. Rapamycin is an immunosuppressant and inhibits the kinase
TOR (target of rapamycin) of the TORC1 complex. Since dysregulation of TORC1 has been associated
with metabolic diseases, cancer or aging, rapamycin was initially studied as a clinical drug 96,97. How-
ever, as soon as the mechanism of rapamycin-mediated TOR inhibition was discovered, the macrolide
sparked interest in the field of chemical biology. In order to block enzymatic activity of TORC1, ra-
pamycin binds to FKBP12 first and the FKBP12-rapamycin complex then binds to TORs FRB domain.
Ergo, rapamycin acts as a chemical heterodimerizer of FKBP12 and FRB 17. In 1996, rapamycin-induced
heterodimerization of FKBP12/FRB-fusion proteins was demonstrated for the first time 88,89. It became
quickly apparent that the antibiotic has several other beneficial properties: rapamycin is cell permeable,
binds to both FKBP12 and FRB with a low nanonmolar affinity, dimerization occurs within minutes and
since the FRB domain interacts only with the FKBP12-rapamycin complex, but not rapamycin alone,
it can be applied at high concentrations 98.Then again, rapamycin is not bioorthogonal and causes off-
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Figure 1.3: Molecular structures of natural chemical heterodimerizers. A Rapamycin is a bacterial antibiotic and
binds to FKBP and FRB domains 88,89. B MaRap was generated by modification of rapamycins C16 position and
dimerizes FKBP with FRB* 90. C AP21967 was generated by indole substitution at C16 and dimerizes FKBP and
FRB* with improved pharmacokinetics 91. D iRap was evolved from AP21967 and crosslinks FRP* and FKBP 6-
fold faster 92. E AP21998 mediates dissociation of self-associating FKBP* complexes 93. F ABA is phytohormone
and dimerizes PP2C and PYL domains 94.G The modified phytohormone GA3-AM induces dimerization of GAI and
GID1 95.
target effects leading to cell-cycle arrest and autophagy induction, which may only be avoided by using
resistant cell lines 16. Several studies have attempted to overcome these limitations using the bump-
and-hole strategy to generate bioorthogonal rapalogs (Figure 1.3).
Liberles et al. introduced bulky substituents to rapamycins FRB-binding site and created MaRap, which
binds to the triple mutant FRB*. However, MaRap is difficult to synthesize, unstable and its pharmacoki-
netic properties needed optimization 90,99. Based on MaRap, Bayle and co-workers screened different
rapalog/FRB combinations in order to mitigate MaRaps drawbacks and identified the FRB*-binding ra-
palog AP21967. The drug exhibits optimized pharmacokinetics and stability, so that it can be applied in
vivo and was soon made commercially available 16,91. Another bumped rapalog, termed iRap, was intro-
duced by Inoue and colleagues and induces dimerization of the mutant FRB* and FKBP12 6-fold faster
than AP21967 92. Rollins et al. choose a different approach and presented a reverse dimerization system
based on the F36M FKBP12 mutant (FKBP*), which aggregates in absence of the rapalog AP21998. Here,
dimerizer addition causes dissociation of the self-associating FKBP* complex 93. Despite the many ben-
efits of rapalogs developed thus far, several limitations still remain. Synthesis is often complicated and
expensive, restricting the accessibility and moreover in vivo dimerization is effectively irreversible due
to rapamycins high affinity towards its interaction partners. Attempts have been made to address this
issue by out-competing FKBP-binding with high concentrations of FK506, but the majority was largely
ineffective on a reasonable time scale 16,17,83.
Crabtree and co-workers looked for alternative heterodimerizers and found the phytohormone abscisic
acid (ABA), which induces dimerization of PP2Cs (protein phosphatase type 2C) and PYL domains. Sim-
ilar to rapamycin, it binds initially to the pyrabactin resistance (PYR)/PYR1-like (PYL)/regulatory com-
ponent of the ABA receptor (RCAR) and the resulting complex then interacts with PP2Cs to block their
enzymatic activity. In plants, ABA signaling is fundamentally important for stress response regulation
and stimulation of development 94. ABA-based is orthogonal in mammalian systems, not cytotoxic, in-
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Figure 1.4: Molecular structures of artificial chemical heterodimerizers. A FK-CsA is a combination of cyclosporin-
A and FK506 that crosslinkes FKBP12 and cyclophilinA 100. B Dex-FK506 combines FK506 with the glucocorticoid
hormone dexamethasone to dimerize FKBP and GR 101. C Dex-Mtx is a fusion product of dexamethasone and
DHFR-binding methotrexate 102. D In Dex-TMP, dexamethasone was fused to trimethoprim to crosslink GR and
eDHFR 103. E TMP-SLF combines trimethoprim with synthetic ligand of FKBP12 to dimerize eDHFR and FKBP12 19.
F SLF’-TMP employs a SLF with higher selectivity for the mutant F36V mutant of FKBP and induces rapid dimer-
ization of FKBP’ and eDHFR 18. G HaXS combines a Halo ligand with benzylguanine (BG) to dimerize SNAP- and
Halo-tags 104. H rCD1 is a fusion of BG and a SLF and crosslinks FKBP’ with Halo-tagged proteins 105.
expensive and dimerization can be reversed by washout. On the downside, ABA-mediated dimerization
displays slower kinetics than rapamycin-based tools (see table 1.1) and has to be applied in at micro-
molar concentrations 16,94. Another inducible dimerization system utilizing plant hormones was intro-
duced by Miyamoto et al. and employs the gibberellin GA3 as a heterodimerizer. Like ABA, GA3 first
forms a complex with gibberellin-insensitive dwarf1 (GID1) prompting a conformational change, which
then facilitates interaction of GID1 and gibberellin insensitive (GAI). Initially, GA3 displayed poor cell
permeability due to its negatively charged carboxylic acid moieties. Addition of an acetoxymethyl group
(AM) to mask the carboxyl group solved the permeability problem effectively 95. In the cytoplasm, the
AM groups are hydrolyzed by esterases and GA3s reactivity is re-established. In contrast to ABA, GA3-
AM induces dimerization on a time scale of seconds, but the dissociation kinetics remain comparably
slow 16,95.
Recently, the ABA- and GA3-AM-based dimerization systems were combined with a chemical decaging
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Table 1.1: Properties of chemically inducible dimerization systems.
SYSTEM DIMERIZATION TRIGGER TIME SCALE REVERSIBILITY
FK1012s
FKBP12-FKBP12
FK1012 (AP1510, AP1903,
AP20187) addition
Dimerization: <10 minutes FK506/Cyclosporin-A
addition (t1/2 = 15 s)
Coumermycin
GyrB-GyrB
Coumermycin addition Dimerization: 30 seconds Novobiocin addition
CoDi
SNAP-SNAP
CoDi addition Dimerization: 6 hours –
xCrAsH
CCPGCC-CCPGCC
xCrAsH addition Dimerization: 1 hour Dithiol addition (5 min)
Rapamycin
FKBP12-FRB
Rapamycin addition Dimerization: t1/2 < 1 min Washout/Outcompeting
with FK506 (hours)
MaRap/AP21967
FKBP12-FRB*
MaRap/AP21967 addition Dimerization: t1/2 = 60 s Washout/Outcompeting
with FK506 (hours)
iRap
FKBP12-FRB
iRap addition Dimerization: t1/2 = 10 s Washout/Outcompeting
with FK506 (hours)
ABA
PYL-ABI
ABA addition Dimerization: 30 min Washout (hours)
GA3-AM
GID1-GAI
GA3-AM addition Dimerization: 10-60 s Washout (hours)
ABA-HP/GA-HP
PYL-ABI/GID1-GAI
H2O2 induced decaging Decaging: 5-30 min
Dimerization: 10-30 min
–
HaXS
SNAP-Halo
HaXS addition Dimerization: > 15 min –
rCD1
SNAP-FKBP
rCD1 addition Dimerization: 10-30 min FK506 addition
(t1/2=15 s)
SLF’-TMP
FKBP’-eDHFR
SLF’-TMP addition Dimerization: t1/2 = 44 s TMP addition (1-5 min),
redimerization by dimer-
izer addition
approach to achieve improved temporal control. To this end, ABA and GA3-AM were modified with a
H2O2-sensitive boronate ester moiety to mask their dimerization activity. Consequently, the modified
dimerizers, termed ABA-HP and GA-HP, only become active upon dose-dependent exposure to exoge-
nous or endogenous H2O2, which promotes chemical cleavage of the boronate group 15,106. Finally, ABA
and GA3-AM or ABA-HP and GA-HP can be used orthogonal to rapamycin-based dimerization tools so
that two signaling events can be manipulated independently within a single cell 17.
In addition to dimerizers derived from natural products, several artificial heterodimerizers haven been
reported (Figure 1.4). The first artificial, non-covalent heterodimerizer, FK-CsA, was developed in
1996 by Belshaw et al. and consists of cyclosporin-A-fused to FK506. FK-CsA crosslinks FKBP12- and
cyclophilinA-tagged proteins, but lacks biorthogonality and is thus not much superior to the homod-
imerizer FK1012 100. The same applies to Dex-FK506, which is a fusion product of FK506 and the glu-
cocorticoid hormone dexamethasone and induces proximity of FKBP12 and a glucocorticoid receptor
(GR) 101. Dexamethasone was further combined with the dihydrofolate reductase (DHFR) inhibitor
methotrexate to yield Dex-Mtx, a heterodimerizer for DHFRs and GR 102. However, Dex-Mtx causes
many off-target effects due to its interaction with endogenous DHFRs and was thus soon replaced by
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Dex-TMP. Trimethoprim (TMP) is another DHFR inhibitor, but in contrast to methotrexate it is highly
selective for E.coli DHFR (eDHFR), so that Dex-TMP is orthogonal in yeast 103.
The Cornish and Bertozzi labs joined efforts to develop a dimerizer, named TMP-SLF, which combines
trimethoprim with a synthetic ligand of FKBP12 and mediates crosslinking of FKBP12 and eDHFR, but
is not bioorthogonal 19,83. Liu et al. addressed this challenge by combining TMP with a SLF (SLF’) that
binds with over 1000-fold selectivity to FKBP’, the F36V mutant of FKBP12, and was initially applied for
FKBP’ homodimerization 20. SLF’-TMP is thus completely orthogonal in eukaryotic systems and induces
rapid dimerization of eDHFR- and FKBP’-fusion proteins. Additionally, SLF’-TMP-mediated crosslink-
ing is rapidly reversible by outcompeting eDHFR-binding with TMP and may be applied orthogonal
to rapamycin-based systems, which makes this dimerization tool superior to most available chemical
dimerizers 15,18.
The only comparable system in terms of orthogonality and reversibility was presented by Schulz and col-
leagues, who generated the synthetic rCD1 dimerizer, a fusion of benzylguanine (BG) and another SLF.
BG binds covalently to the SNAP-tag and accordingly rCD1 induces dimerization of SNAP- and FKBP’-
fusion protein 105. SNAP and Halo-tags had been employed to generate dimerizers before and Erhart et
al. even combined both tags in their HaXS heterodimerizer, however even extensive optimization could
not mitigate the slow kinetics and saturation effects 104. rCD1 displays rapid dissociation kinetics, yet
dimerization proceeds relatively slow, which presents a serious limitation for some applications.
Taken together, SLF’-TMP appears to be superior to most chemical heterodimerizers in terms of speed,
orthogonality and reversibility. It provides improved temporal control of dimerization and dissociation
of proteins, especially compared to chemical homodimerizers. Plant hormone based dimerizers, par-
ticularly GA3-AM, feature rapid dimerization kinetics and biorthogonality as well, but their dissociation
kinetics remain to be optimized.
1.2.2 Photoinducible Dimerization Systems
Photoinducible dimerization systems provide a spatiotemporal resolution that is unmatched by chemi-
cal crosslinking approaches. While the speed of chemically induced dimerization is limited to at least a
few seconds by the cellular diffusion rate, photoactivation can be performed within milliseconds or even
faster. Moreover, light-induced dimerization can be applied in a spatially defined manner on a subcel-
lular level, which is beneficial when studying spatiotemporally restricted processes. Similar to chemical
dimerizers, photodimerizers should ideally be bioorthogonal, non-cytotoxic, and react rapidly, but the
photoactivation conditions, i.e. wavelength and intensity, are also decisive factors. Exposure to ultra-
violet (UV) light can potentially cause DNA damage and other off-target effects. The same applies to
high intensity illumination over a longer period of time 83,114. Still, most photocleavable caging groups
employed to confer photosensitivity to small molecules, react to UV light irradiation, which has to be
optimized in the future.
In 2011, two rapamycin-based photosensitive dimerizers were reported: pRap and cRb. Karginov
et al. generated photocaged rapamycin (pRab) by installing a photocleavable α-methyl-6-
nitropiperonyloxycarbonyl (MeNPOC) group at the C-40 position of rapamycin. Like rapamycin, pRab
induces interaction of FRB and wild type FKBP12 even in its photocaged form, so that engineering of
a pRab-specific FKBP12 mutant, iFKBP, was necessary. Photodecaging can be performed by UV light
illumination on a time scale of 1-2 minutes (see table 1.2) and even though dimerization speed was not
reported, it should be in an order comparable to rapamycin induced dimerization 107.
Umeda and co-workers chose a different approach and modified rapamycin with a biotin-avidin com-
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Figure 1.5: Molecular structures of photocaged chemical dimerizers, photocleavage sites are indicated by dot-
ted red lines. A pRap has a photocleavable MeNPOC group at rapamycins C-40 position and crosslinks FRB- and
iFKBP-domains after decaging at 365 nm 107. B cRb features a biotin-avidin complex attached through a nitroben-
zyl linker that is cleaved at 365 nm to dimerize FRB- and FKPB-domains 108. C dRap has a N-succinimidyl carbon-
ate at rapamycins C-40 position, which is cleaved at 365 nm to induce homodimerize FKBP-domains 109. D PhAP
was developed by inserting a o-nitrobenzyl group into AP20187, which is photocleaved at 365 nm to homodimerize
FKBP’ 110. E ABA-DMNB/DEACM feature a nitrobenzyl (DMNB) or coumarin (DEACM) group at the carboxylic acid
moiety of ABA. DMNB is cleaved at 365 nm and DEACM at 405 nm to crosslink PYL- and ABI-domains 111. F pcGA3-
1-3 have a DMNPP (pcGA3-1), EANBP (pcGA3-2) or 2-(o-nitro-phenyl)propyl (pcGA3-3) that are photocleaved at
365 nm (pcGA3) or 412/800 nm (pcGA3-2/3 ) to dimerize GAI- and GID1-domains
112 . G MeNV-HaXS combines
BG with a Halo ligand and a photocleavable linker (365 nm) to induce dissociation of SNAP- and Halo-fusion pro-
teins 73 . H cTMP-Htag is comprised of a Halo ligand and NVOC-caged TMP that is photoactivated at 385-405 nm
and dimerizes Halo- and eDHFR-tagged proteins 113.
plex attached through a photocleavable nitrobenzyl linker to yield cRb. Due to the large size of the
biotin-avidin group, the dimerizer cannot cross the plasma membrane and is sequestered in the ex-
tracellular space until UV light-induced release of rapamycin. Here, dimerization is induced within a
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similar time frame as for pRap, but photodecaging can be performed within 0.5 seconds and is thus
significantly faster 108. The most recent modification of rapamycin was presented by Brown et al., who
created the UV light-sensitive dimerizer dRap by attaching a N-succinimidyl carbonate to rapamycins
C-40 position. In contrast to pRap, dRap interacts with wild type FKBP12 while the kinetics of decaging
and dimerization are similar 109. However, none of the rapamycin-based dimerizers is bioorthogonal or
reversible and whereas spatial confinement of dimerization is already very limited for pRap and dRab,
cRb can only be applied to manipulate processes at the plasma membrane 83.
Ahmed et al. developed a photocaged variant of the FKBP’ homodimerizer AP20187 by replacing the
amine linker with a photosensitive o-nitrobenzyl group. This dimerizer, termed PhAP, crosslinks FKBP’-
fusion proteins in their caged state and releases them upon UV light-induced photocleavage 110. The-
oretically, the PhAP system offers better spatiotemporal control than pRap, dRap and cRb, however,
this has not been practically demonstrated. Moreover, the required 10 minutes of photodecaging might
cause off-target effects.
In a similar approach, Zimmermann and co-workers generated a photocaged version of the Halo-SNAP
heterodimerizer HaXS by inserting a photocleavable methyl-6-nitroveratryl (MeNV) group to the core
module linking Halo and SNAP moieties. MeNV-HaXS chemically prompts dimerization of Halo- and
SNAP-tagged proteins, which can then be reversed through UV light induced photolysis of the dimer-
izer. Here, spatiotemporal control of the system was extensively demonstrated by releasing proteins
from individual vesicles, but the kinetics of dimerization and photodecaging range on a timescale of
10-15 minutes, which is comparably slow 73.
Recently, the plant hormone-based dimerization tools ABA and GA3-AM have also been modified to be-
come photoactivatable. To generate UV light-sensitive ABA-DMNB, a nitrobenzyl group (DMNB) was
attached to the carboxylic acid moiety of ABA, while addition of a coumarin group (DEACM) yielded
ABA-DEACM (Figure 1.5). The latter is photoactivatable by 405 nm light, which may be more convenient
when experiments are performed on a confocal microscope lacking a UV lamp. The principle of ABA-
DMNB/DEACM-regulated dimerization is similar to the pRap and cRb dimerization systems: crosslink-
ing of PYL- or ABI-fusion proteins is induced by photocleavage of the the DMNB and DEACM groups
from the ABA dimerizer. Here, photodecaging of the dimerizer can be triggered within a few minutes
of illumination, but dimerization is only achieved after about 15 minutes. Still, ABA-DMNB/DEACM
synthesis is simpler than generating the rapamycin variants and in theory, the system can be used or-
thogonal to other, chemically induced dimerization systems as well 15,111.
Based on GA3-AM, Schelkle et al. established three other photoactivatable tools, termed pcGA3-
1-3, that were generated by addition of different caging groups: 2-(4,5-dimethoxy-2-nitrophenyl)
propyl (DMNPP), (2-(4’-bis((2-methoxyethoxy)ethyl)amino)-4-nitro-[1,1’-biphenyl]-3-yl)propan-1-ol)
(EANBP) and pi-extended 2-(o-nitro-phenyl)propyl, respectively. Dimerization of GAI- and GID1-tagged
proteins is induced upon photoactivation of the dimerizers by one-photon decaging with 405/470 nm
light for pcGA3-1/2 or two-photon decaging of pcGA3-3 at 800 nm. Due to the red shifted absorption
spectra of pcGA3-2 and pcGA3-3, they can be applied in parallel to UV light-sensitive tools and similar
to ABA-DMNB/DEACM, pcGA3 dimerizers do not interfere with rapamycin-based chemical dimeriza-
tion systems. In contrast to most of the photoactivatable dimerizers, pcGA3-1-3 decaging is completed
within 3 seconds and protein crosslinking takes less then 3 minutes, which makes the pcGA3 dimerizers
superior to many others 112. However, imaging in the commonly used GFP-channel might cause unde-
sired decaging effects of pcGA3-2/3 dimerizers and both of the plant hormone-based systems still lack
reversibility of dimerization 15.
18
Table 1.2: Properties of photoinducible dimerization systems.
SYSTEM DIMERIZATION TRIGGER TIME SCALE REVERSIBILITY
pRap
FRB-iFKBP
Decaging at 365 nm Decaging: 1-2 min
Dimerization: not indicated
(30-60 min)
Washout/Outcompeting
with FK506 (hours)
cRb
FRB-FKBP12
Decaging at 365 nm Decaging: 0-60 s
Dimerization: 2-10 min
Washout/Outcompeting
with FK506 (hours)
dRap
FRB-FKBP12
Decaging at 365 nm Decaging: 3 min
Dimerization: not indicated
(similar to pRap)
Washout/Outcompeting
with FK506 (hours)
PhAP
FKBP’-FKBP’
Decaging at 365 nm Decaging: 10 minutes
Dimerization: 5-10 min
Washout/Outcompeting
with FK506 (hours)
MeNV-HaXS
SNAPTag-HaloTag
MeNV-HaXS addition Dimerization: 2-10 min Photocleavage of dimer-
izer at 360 nm (1-60 s)
ABA-DMNB/DEACM
PYL-ABI
Decaging at 365/405 nm Decaging: 1-4 min
Dimerization: 15 min
Washout (30 min)
pcGA3-1-3
GID-GAI
Decaging at 405/470 nm
and two photon-decaging
at 800 nm
Decaging: 2-10 s
Dimerization: 30-180 s
–
cTMP-Htag
eDHFR-HaloTag
Decaging of cTMP at 365-
405 nm
Decaging: 2 s
Dimerization: 15-240 s
TMP addition (2-10 min),
redimerization after
washing (10-30 min)
The most promising photoinducible dimerizer yet was introduced by Ballister et al., who combined
NVOC-caged TMP with an uncaged Halo ligand to yield cTMP-Htag. Whereas most of the photocaged
dimerizers diffuse throughout the whole cell after photoactivation, cTMP-Htag can be pre-localized
prior to decaging and thus provides an improved spatial resolution. The dimerizer is targeted to the
compartment of choice via Halo-tagged cellular anchors and only then activated by illumination at 385-
405 nm for 2 seconds. Crosslinking of eDHFR-fusion proteins and the pre-localized dimerizer is compa-
rably fast (15-240 s) and the dimerization is also readily reversible by addition of TMP. Additionally, the
system is completely bioorthogonal in mammalian cells and yeast, which in summary makes it the best
available photoinduced dimerization tool yet 15,113.
1.2.3 Optogenetic Dimerization Systems
Light-responsive regulatory proteins occur naturally throughout all kingdoms of life and orchestrate
processes ranging from plant development, gene expression and circadian rhythm to motion of mi-
crobes and communication of visual information. Accordingly, the photoreceptor family, comprises
proteins with distinct chromophores, spectral ranges and kinetics, which have been utilized in vari-
ous optogenetic dimerization systems. Six classes of photoreceptors have been identified: rhodopsins,
phototropins, cryptochromes, phytochromes, BLUF proteins and photoactive yellow proteins 115.
Rhodopsins were the first photoreceptors used as optogenetic tools to manipulate gene expression or
control action potentials in neurons by Shimizu-Sato et al. and Zemelman et al., respectively 116,117.
One of the first optogenetic dimerization devices was developed by Yazawa et al. 118 based on the pho-
totropin Light-Oxygen-Voltage (LOV) domain, which belongs to the PAS domain family and imparts
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blue-light sensitivity 119,120,121. Phototrophins, BULF proteins and cryptochromes are characterized
by their flavin chromophore and the distinct structure of their light-sensing domains, LOV, BLUF and
CRY 115. LOV domains are flavin mononucleotide (FMN) binding photosensors and form a covalent
bond to FMN molecules upon photoactivation, which may remain stable for seconds to days (depend-
ing on the type of LOV domain) 122.
Yazawa et al. generated an inducible dimerization system from the LOV domain containing protein
FKF1 of A. thaliana, which has been found to interact with the nuclear protein GIGANTEA (GI) in a
light-dependent manner. Illumination at 450 nm induces crosslinking of FKF1- and GI-fusion proteins
within 5 minutes, but dissociation of the complex proceeds rather slow 118. However, since the photore-
ceptors originated from plants, the system is bioorthogonal in mammalian cells and yeast, which indeed
applies to the majority of optogenetic tools.
In an attempt to optimize dissociation kinetics, several systems were designed based on the asLOV2
domain of A. sativa phototropin 1, which features the characteristic C-terminal helical extension Jα.
Photoactivation induces conformational changes in the asLOV2 domain resulting in Jα unwinding
and ultimately dissociation. Initially, Hahn and co-workers fused asLOV2-Jα to constitutively active
Rac1 in order to sterically block effector binding in the dark state thus yielding a photoactivatable GT-
Pase 123. Strickland et al. then adapted the principle and introduced tunable light-inducible dimeriza-
tion tags (TULIPs) based on interaction of asLOV2 and engineered variants of the Erbin PDZ domain
(ePDZ) 124. Although many physical properties of LOV domains had already been successfully opti-
mized 125,126,127,128, TULIPs were also among the first approaches to decrease the size of dimerization
tags. To this end, Strickland and co-workers fused a ePDZ-binding peptide epitope to the Jα of asLOV2
so that the peptide would be allosterically blocked in the dark state. Photoactivation at 450 nm exposes
the peptide and thus facilitates dimerization of the so-called LOVpep domain and the ePDZ domain,
which is rapidly reversible in the dark state 122,124. A very similar approach was developed by Lungu et
al. based on the same strategy using different peptides (ipaA and SsrA) and their respective interaction
domains (vinculin and SspB) 129.
Wang et al. developed the LightOn dimerization system employing the smallest LOV domain-containing
protein Vivid (VVD) fused to the DNA-binding domain of Gal4 and the p65 activation domain of NF-
κB 130. Due to the VVD LOV domain, this fusion protein, named GAVPO, homodimerizes upon illu-
mination at 450 nm, binds to a promoter and induces transcription of target genes 131. However, as
the initial LightOn system featured slow on/off kinetics and weak dimerization (see table 1.3), different
groups evolved the original principle and dimerization/dissociation can now be performed within sec-
onds 131,132,133.
Several other dimerization systems were generated based on the same principle as the LightOn ap-
proach: Motta-Mena et al. used an optimized version of the LOV domain-containing signaling peptide
EL222 of E. litoralis with rapid on/off kinetics 134,135,136, Ohlendorf et al. presented the Dusk/Dawn sys-
tem, which evolved from the YtvA system introduced by Möglich et al. 119,137,138 and most recently Hahn
and colleagues combined asLOV2 with the protein Zdark (Zdk) to yield LOVTRAP. Since Zdk binds selec-
tively to the dark state of asLOV2, illumination of LOVTRAP results in dissociation of the dimerization
domains thus releasing the aLOV2- or Zdk-fused target protein 139.
Besides LOV domain-based dimerization systems, many approaches engage the light-sensing domains
of cryptochromes, CRY. Photosensitivity of CRY domains is largely conferred through disordered C-
terminal extensions that unfold upon photoactivation to expose recognition sites for interaction part-
ners 115. Kennedy and co-workers combined the CRY2 domain of cryptochrome 2 from A. thaliana
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with a truncated version of its interacting protein CIB1 to yield a blue light-inducible dimerization sys-
tem. While dimerization proceeds as fast as in the LOV-based systems, dissociation kinetics are slightly
slower, but still on a time scale of minutes 122,140. Based on CRY2-CIB1 heterodimerization Konermann
et al. introduced a system termed LITEs (light-inducible transcriptional effectors), which consists of the
customizable TALE DNA-binding domain coupled to CRY2 and CIB1 bound to the transcriptional ac-
tivator VP64 141. A different approach exploited the recent finding that CRY2 domains form oligomeric
clusters independently of CIB1 interaction to generate the homodimerization system CRY2olig 142,143.
However, dissociation kinetics remain slower than observed for LOV-domain mediated dimerization
and homodimerization is mostly inferior to heterodimerization approaches.
Another kind of blue light-sensitive photoswitches are BLUF proteins, which also carry a flavin chro-
mophore, but occur predominantly in bacteria and lower eukaryotes 115. Only few optogenetic dimer-
ization approaches employ BLUF domains and the majority of them is based on photoactivated adeny-
lyl cyclases (PACs), photosensitive enzymes featuring BLUF and enzymatic domains. PACs from E.
gracilis (euPAC) and Beggiatoa (bPAC) have mostly been engineered to photocontrol cyclic adenosine
monophosphate (cAMP) levels in neuronal cells of different organisms, but also to manipulate steroid
hormone levels in D. rerio or in neuromuscular junctions of C. elegans 122,144,145,146.
All of the optogenetic dimerization systems mentioned above rely on blue light-sensitive photorecep-
tors, however, several approaches engage red light-sensitive phytochromes (PHY). Red light can pene-
trate deeper tissues and has a lower energy content than blue light, which is especially beneficial when
probing whole organisms 147. Phytochromes bind a tetrapyrrole chromophore and photoswitch be-
tween the red-sensitive (inactive) and far-red-sensitive (active) conformers Pr and Pfr, respectively. The
conformational change from Pr to Pfr is initiated by photoactivation at 650 nm, but can be reversed
upon illumination at 750 nm 148. Five different phytochromes have been identified in plants and mi-
crobes (PhyA to PhyE). They interact frequently with constitutively active transcription factors called
PIFs (phytochrome-interacting factors) 115. Of the five, PhyB from A. thaliana is the most frequently
used optogenetic tool. However, like all phytochromes it requires exogenous addition of a chromophore
such as phycocyanobilin. This is beneficial because light protection is not necessary during sample han-
dling. Still, chromophores are difficult to obtain and have a short half-life time in common cell culture
media. Therefore Müller and co-workers developed a strategy to produce phycocyanobilin from heme in
mammalian cells and thus provide sufficient chromophore levels to support phytochrome function 147.
Shimizu-Sato et al. generated a dimerization system based on PhyB-PIF3 interaction, which is photoac-
tivated within seconds of illumination at 650 nm and rapidly reversed by irradiation at 750 nm 116,149.
Even though, the on/off kinetics were already rapid, Müller and colleagues adapted the method to de-
sign a PhyB/PIF6 based dimerization system, in which dissociation is induced within milliseconds 150.
Aside from phytochromes, the fluorescent protein Dronpa from stony coral has also been engineered to
reversibly photoswitch between the blue light-sensitive active form and the violet light-sensitive inactive
form 122,151. In modified variants of Dronpa conformational conversion is induced rapidly upon illumi-
nation, which was exploited by Zhou et al. to build photosensitive ’caged’ single-chain proteins 151.
Another commonly applied optogenetic dimerization system engages the A. thaliana photoreceptor
UVR8, which contains a tryptophan-based chromophore and forms a homodimer in the dark state.
Upon UV light illumination, the dimer dissociates and the two subunits interact with the WD40 do-
mains of COP1 122,152. While crosslinking takes only seconds, the dissociation kinetics are very slow thus
limiting the applicability of UVR8-based tools. However, Chen et al. demonstrated that the slow reas-
sociation kinetics of UVR8 can also be exploited and created a photoinducible protein secretion system
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Table 1.3: Properties of optogenetic dimerization systems.
SYSTEM DIMERIZATION TRIGGER TIME SCALE REVERSIBILITY
FKF1-GI Photoactivation
at 450 nm
Dimerization: 5 min Dark state
Dissociation: hours
TULIPs
LOVpep-ePDZ
Photoactivation
at 450 nm
Dimerization: seconds Dark state
Dissociation: seconds
LightOn/Magnets
VVD-VVD
Photoactivation
at 450 nm
Dimerization: seconds Dark state
Dissociation: seconds to
days
Dusk/Dawn
YtvA-YtvA (EL222)
Photoactivation
at 450 nm
Dimerization: seconds Dark state
Dissociation: seconds
LOVTRAP
aLOV2-Zdk
Photoactivation
at 450-490 nm
Dimerization: 1 second Dark state
Dissociation: seconds
LITE
CRY2-CIB1
Photoactivation
at 450 nm
Dimerization: seconds Dark state
Dissociation: 6 min
CRY2olig
CRY2-CRY2
Photoactivation
at 450 nm
Dimerization: seconds Dark state
Dissociation: 6-23 min
BLUF
PAC-PAC
Photoactivation
at 450 nm
Dimerization: seconds Dark state
Dissociation: seconds
PhyB-PIF3 Photoactivation
at 650 nm
Dimerization: seconds Illumination at 750 nm
Dissociation: seconds
PhyB-PIF6 Photoactivation
at 650 nm
Dimerization: milliseconds Illumination at 750 nm
Dissociation: millisec-
onds
Dronpa-Dronpa Photoactivation
at 500 nm
Dimerization: seconds Illumination at 400 nm
Dissociation: seconds
UVR8-COP1 Photoactivation
at 310 nm
Dimerization: seconds Illumination at 290 nm
Dissociation: 1-4 hours
UVR8-UVR8 Photoactivation
at 315 nm
Dimerization: seconds Illumination at 280 nm
Dissociation: 2-24 hours
based on homodimerization of UVR8. Target proteins were fused to UVR8, sequestered into the ER and
then released by UV illumination to travel through the secretory pathway 153.
In conclusion, it appears not feasable to determine the most superior optogenetic dimerization system,
because their kinetic properties are similar, all of them are bioorthogonal and reversible and many have
been designed for specific applications. The PhyB-PIF based systems feature light induced reversibility,
which might be beneficial in various aspects, however it also limits the available imaging channels. Only
the UVR8 based dimerization tool shows rather slow dissociation rate, but even this potential limitation
proved to be valuable for some applications.
1.2.4 Biological Applications of Inducible Dimerization Systems
Due to their versatile nature, inducible dimerization systems have become a powerful technique
with numerous applications and many tailor-made variants to tackle specific biological questions. In
contrast to traditional methods like RNAi or transfection and overexpression, inducible dimerization
facilitates rapid and often reversible manipulation of cellular proteins in spatially defined regions
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of interest 17. Accordingly, induced dimerization has been used to control protein localization and
activity. To this end, proteins can be conditionally targeted to cellular anchors, complex formation or
dissociation can be induced or split proteins are reconstituted. Especially the most recent generation
of dimerization tools provides excellent spatiotemporal resolution and thus applications have become
more and more diverse 15,83.
1.2.4.1 Regulation of Biochemical Activity
When the Schreiber and Crabtree groups first introduced chemically induced dimerization, they were
actually looking for a technique to regulate a proteins activity without changing its localization. As a
result, they developed a broadly applicable concept to manipulate biochemical activity and successfully
applied it to study T-cell receptor signaling. It had been observed earlier that dimerization is a key
signaling event for many receptors. Accordingly, the T-cell receptor zeta could be activated simply by
FK1012-induced homodimerization of FKBP12-fused T-cell-receptors 74. The principle has since been
applied to study the function of various signaling proteins such as the receptor kinases TGF-Beta 154,
ErbB 155 or FGFR1 156,157, Raf/MEK/ERK signaling 142,143 as well as the roles of β-arrestin2 158 or AngII
AT1 and NE α2C-adrenergic receptors 159 in GPCR signaling.
Dimerization induced activation of signaling pathways has also been exploited to initiate cellular events
like proliferation 160,161 or apoptosis. Again, Schreiber and Crabtree established induction of apoptosis
by forcing Fas proteins into proximity, but many other proteins like FADD, Asc, Bid and several caspases
can also be crosslinked to activate the process 80,162,163,164,165,166.
Another variation of the concept is induction of gene transcription by photoactivated dimerization of
DNA-binding domains and transcriptional activators. The LightOn system, for instance, is based on
homodimerization of the engineered protein GAVPO, which combines the VVD-fused DNA-binding
domain of Gal4 and NF-κBs p65 activation domain 130. The same principle was applied in the
Dusk/Dawn system, where homodimerization of the histidine kinase YF1 and the transcriptional
regulator FixJ induces gene expression and also in the LITE system, which relies on crosslinking of the
CRY2/CIB1-fused TALE DNA-binding domain and the transcriptional activator VP64 138,141.
All of the approaches mentioned above are based on target proteins functioning in pathways or
processes, which already feature dimerization as signaling event. To manipulate the activity of proteins
that do not rely on this mechanism, other methods are required 83. Thus, inducible dimerization
has also been extensively used to generate split proteins consisting of two non-functional protein
fragments fused to dimerization domains. Upon dimerization, the protein is either reconstituted or
conformational change exposes an active site so that the protein can resume its original function.
Especially optogenetic dimerization systems are well suited for this approach, since they allow for
spatiotemporal confinement of dimerization and thus very focused control of protein activity.
The Hahn lab, for instance, generated a range of activatable kinases by inserting a FKBP (or iFKBP)
domain at a conserved position in the catalytic domain to render the protein inactive. Rapamycin-
mediated interaction of FKBP with FRB causes a substantial structural alteration and restores the
catalytic activity. These ’allosteric switches’ were initially based on chemically induced dimer-
ization, but soon after combined with photocaged rapamycin (pRab) to yield photoactivatable
kinases 107,167,168,169.
An optimized version of the technique was realized in the ’rapamycin-regulated targeted activation of
pathways’ (RabR-TAP) system that combines inducible activation with protein translocalization. While
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kinase activity is still controlled by photodecaging of rapamycin, the kinase is additionally targeted to
FRB-fused effectors or specific cellular compartments. In consequence, kinase activity can be directed
to downstream effectors of different signaling pathways, which then become active 15,170.
Another application was introduced by the Bertozzi group, who focused on glycobiology and separated
glycotransferases into their catalytic and localization domains to control their activity with the chemical
dimerizer SLF-TMP 19. Two proteases have also been engineered to become chemically activatable:
TEV protease and DnaE intein. These enzymes are particularly interesting as they can regulate protein
ligation and cleavage, which makes them even more powerful when combined with inducible dimer-
ization 83,171,172,173.
Many split proteins were designed to regulate gene expression. Kennedy et al. generated CRY2/CIB1-
tagged, split Gal4 and Cre recombinase that prompt DNA transcription or recombination, respectively,
upon photoinduced reconstitution 122,140. Shimizu-Sato et al., on the other hand, developed the first
approach to reversibly induce DNA transcription in yeast based on photoinduced PhyB and PIF3
dimerization. As several others afterwards, they created a split version of the transcription factor
Gal4 fused to PhyB/PIF3, which activates DNA transcription upon dimerization and is deactivated
upon photoinduced dissociation 116. Later, Müller and colleagues adapted the method to manipulate
gene expression in mammalian systems based on PhyB/PIF6 or UVR8 coupled split transcription
factors 150,174.
A different approach to manipulate protein activity is steric hindrance of protein interaction by dimer-
ization domains. As mentioned above, Wu et al. presented photoactivatable GTPases by introducing
asLOV2-Jα to constitutively active RacI and thus block effector binding in the dark 123. Also engaging
an optogenetic dimerization system, Zhou et al. fused monomeric DronpaK to one terminus and
tetrameric DronpaN to the other terminus of guanine nucleotide exchange factors (GEFs) so that
binding of the two Dronpas would block interaction sites and lock the protein in an inactive state.
Photoactivation with blue light induces dissociation of the Dronpa multimer and thus activates the
caged protein by opening its interaction sites 151.
Similar to activation of proteins, inducible dimerization can also be applied to prompt protein degra-
dation. The concept was first demonstrated in budding yeast by Janse and co-workers, who targeted
proteins of interest to the ubiquitin-proteasome pathway by chemically dimerizing them with protea-
somal subunits 175. Pratt et al. translated the approach to eukaryotic cells and designed a system termed
’split ubiquitin for the rescue of function’ (SURF). Here, proteins are marked for degradation by the
proteasome through addition of a N-terminal degron, but can be rescued upon rapamycin-mediated
reconstitution of a C-terminally bound split ubiquitin 176. A similar strategy was pursued by Nishimura
et al. in an inducible system adapted from the auxin-dependent degradation pathway of plants 177. In
contrast, Stankunas and co-workers demonstrated that dimerization can also be employed to stabilize
proteins by destabilizing the glycogen synthase kinase-3 beta through fusion to FRB*, and restoring its
stability upon dimerization with FKBP12 99.
1.2.4.2 Controlling Protein Localization
Protein translocalization is a key signaling event in cells, facilitating communication between organelles,
exchange of cellular material and signal transduction throughout regulatory networks. It provides
means to rapidly alter intracellular processes and is a crucial factor in the organization of cellular
events. To control protein localization through inducible dimerization, typically a protein of interest
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is crosslinked with an anchor protein that resides at a specific cellular localization. Since the concept
was first introduced by Spencer et al. in 1995, proteins have successfully been targeted to the plasma
membrane, mitochondria, endoplasmatic reticulum, Golgi apparatus, nucleus, ERGIC, peroxisomes,
kinetochores, genomic loci and various other cellular addresses 17,83,178.
Especially the plasma membrane is a popular target, in part because it is comparably easy to address
and distinguish, but mostly because it is involved in fundamental cellular processes like cell migration,
endocytosis or receptor trafficking 179. A large number of dimerization probes has been designed to
manipulate lipid signaling at the plasma membrane, mostly focusing on the second messengers phos-
phatidylinositol 4,5-bisphosphate (PI(4,5)P2) and phosphatidylinositol 3-phosphate (PI3P). In 2006, Suh
et al. and Varnai et al. independently introduced a now commonly applied approach to alter PI(4,5)P2
levels: chemically induced recruitment of PI(4,5)P2 5-phosphatases or 5-kinases to the plasma mem-
brane to decrease or enhance PI(4,5)P2 concentration, respectively 180,181. 5-phosphatases specifically
cleave the phosphate at the C-5 position of PI(4,5)P2 so that a locally increased concentration of 5-
phosphatases, like Inp54p, causes a spatially confined depletion of the second messenger. In contrast,
kinases such as the PI(4)P 5-kinase, transfer a phosphate group to the 5 position of PI(4)P and thus gen-
erate PI(4,5)P2. Suh et al. first demonstrated that the activity of the potassium channel KCNQ is tightly
associated with PI(4,5)P2 levels and since then the approach has been used to study PI(4,5)P2s function
in regulation of other ion channels 182,183, endocytosis 184,185,186, store-operated calcium entry 187,188,
PTEN activation 189 and cell movement 190,191. Fili and co-workers also targeted a phosphatase to Rab5-
positive endosomes and observed effects on maturation and structure 192, while Szentpetery et al. ma-
nipulated PI(4,5)P2 levels in the Golgi membranes 17,179,193.
The most recent approach to alter PI(4,5)P2 concentrations was presented by the Inoue lab and termed
PI(4,5)P2 liberation 194. Here, the amount of free PI(4,5)P2 at the plasma membrane is increased with-
out altering the overall level of PI(4,5)P2 by re-routing the PI(4,5)P2-binding PH domain of PLCδ to the
mitochondria. Inoue and co-workers based their PI(4,5)P2 liberation approach on rapamycin induced
dimerization of FKBP and FRB domains. The Schulz lab adapted the concept to their rCD1 dimerizer
system. Since rCD1-mediated dimerization features rapid reversibility, Schulz and co-workers were able
to fine-tune PI(4,5)P2 levels at the plasma membrane with high temporal resolution 15,195.
Another class of proteins that has been extensively studied with inducible dimerization systems are GT-
Pases. GTPases are monomeric G proteins, which switch between an active GTP-bound form and an
inactive GDP-bound form 17,122. Castellano et al. were amongst the first to conditionally localize the
Rho family GTPase Rac1 to the plasma membrane to elucidate its role in phagocytosis 196,197. Rho fam-
ily GTPases interact with distinct effector proteins regulating the organization of the cytoskeleton 122.
Castellano and co-workers chemically induced dimerization of FRB-fused constitutively active Rac1 and
the FKBP-tagged cell surface receptor CD25 and observed increased uptake of CD25-bound latex beads
through actin-dependent phagocytosis 179. Inoue et al. followed the same principle, but used iRap to
target FRB-fused Rho GTPases to plasma membrane localized Lyn11-FKBP domains. Recruitment of
the GTPases Rac1, Cdc42 and RhoA is achieved rapidly due to iRaps optimized kinetic properties and
accordingly morphological changes such as membrane ruffling or lamellipodia extension could be ob-
served within minutes after dimerizer addition 92.
As mentioned above, Hahn and co-workers chose a different approach and generated a photoactivat-
able Rac1 by fusing it to the asLOV2-Jα domain 123. Here, photoactivation of Rac1 induced membrane
ruffling and protusion, which was also reported by Yazawa et al. who targeted Rac1 to the plasma mem-
brane through photoinduced dimerization of Rac1-FKF1 and CAAX-GI 118. Levskaya and co-workers on
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the other hand, employed light induced dimerization of PhyB and PIF3 to localize Rac1 and two other
Rho-family GTPases (Cdc42 and RhoA) to the plasma membrane by using their GEFs as bait and ob-
served a ’localized lamellipodial bloom’ that could even be guided away from the main cell body with a
focused laser beam 149.
In general, photoactivatable dimerization systems appear to be advantageous to study morphological
effects at the plasma membrane, because they can be applied in a spatially confined fashion. Target-
ing other organelles, however, is technically challenging, especially when it comes to small or less de-
fined structures like the mitochondria or the ER. Thus, the Inoue lab, amongst others, continued to
employ chemical dimerizers (iRap) in order to study the effects of localizing constitutively active Ras to
the Golgi, mitochondria, ER or lysosomes 198,199. Apart from the Rho family, other GTPases, for example
in Raf/MEK/ERK signaling, have also been studied with inducible dimerization systems 200,201. How-
ever, the concepts resemble the previously introduced approach of localization-dependent activation
of GTPases.
A new combination of the split protein approach and dimerization induced recruitment of proteins was
recently presented by Kapitein and co-workers, who employed kinesin, dynein and myosin motors to
drive specific cargo transport 202. Previously, motor proteins were mostly studied with in vitro assays
rather than in live cells, which presents a serious limitation when studying dynamics and specific cargo
preferences. Kapitein et al. generated a split kinesin consisting of a constitutively active motor domain
fused to FKBP and a series of FRB-tagged kinesin tails. In neuronal cells, the motor domain moves along
a microtubule towards the axon or the dendrites, depending on the cargo, while the kinesin tail confers
specificity for a certain vesicle. Consequently, rapamycin-induced reconstitution of the motor and the
tail, causes mislocalization of the vesicles to the axon or the dendrites. The increases amount of vesicles
in a distinct cell region is then used as readout for the kinesin-vesicle interaction 15.
Initially, the assay was only applied in neurons, because their unique organization facilitates an optimal
readout, but Bentley and co-workers adapted the method to other cell types 203,204,205. They engaged a
kinesin motor domain that moves towards the plus end of microtubules, i.e. the cell center and a dynein
motor, which moves towards the minus end of microtubules or the cell periphery. A series of candidate
proteins associating with different vesicles or organelles was then chemically crosslinked to the motor
domains and vesicle accumulation in the periphery or central region was used as a readout 15.
To mitigate the limitations of rapalog-induced dimerization and achieve a better spatiotemporal reso-
lution, three recent studies combined the concept with photoactivatable dimerizers. Specifically, the
Kapitein and Cui labs employed optogenetic approaches based on blue light induced interaction of
LOVpep and ePDZ or CIB1 and CRY2 domains to reconstitute the split motor proteins, while Ballister
and co-workers turned to the photocaged cTMP-Htag dimerizer 206,207,208. All three approaches yielded
an improved spatiotemporal resolution and reversibility, but none represents a signifcant improvement.
In the applications presented so far, inducible dimerization was largely employed to activate proteins or
pathways, but several approaches were also designed to perturb protein activity. Two methods are pre-
dominantly applied, the anchor-away and the knocksideaways technique 209,210. To ’anchor-away’ a
protein, it is targeted to highly-expressed cytoplasmic anchor proteins, for example to the ribosome.
In yeast, this approach has been extensively applied to deplete the nucleus of certain proteins and
study processes like RNA polymerase II termination 211 or fatty acid synthetase (FAS) 212 and to perturb
the transcriptional activator Gal4p 213, cell division cycle protein Cdc6 214 or the histone chaperones
Spt16/6 15,215. However, the method is limited to specific nuclear proteins and depends on nuclear ex-
port of the respective proteins, which is not the case in the knocksideaways approach. Here, proteins
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of interest were knocked down with siRNA and replaced by FKBP-tagged siRNA-resistant proteins that
can be targeted to the mitochondria via rapalog-induced dimerization. Depleting the cytoplasm of the
engineered proteins led to rapid perturbation of the protein function, but the method is not broadly
applicable. Still, knocksideaways was successfully used to study retrograde TGN-to-endosome and also
clathrin-coated vesicle-mediated trafficking 15,210,216,217.
A plethora of additional applications has been generated based on inducible dimerization systems and
while the diversity is ever increasing, the underlying concepts, remain similar. Recently, photocaged
dimerizers generated a lot of attention due to their enhanced spatiotemporal resolution, but only few
applications have exploited their unique properties yet. Manipulation of multiple targets by orthogo-
nal application of different dimerization systems is another approach, which holds great potential, but
remains to be fully established. Thus, even though inducible dimerization systems experienced a vast
improvement over the last 20 years, the will most likely continue to be refined and repurposed over the
next few years 83.
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2 Materials and Methods
2.1 Materials
2.1.1 Chemicals
All chemicals were purchased from the following companies in the highest purity available.
Table 2.1: Frequently used chemicals and suppliers.
CHEMICAL SUPPLIER
2-Propanol J. T. Baker (Deventer, Netherlands)
Acetic acid Sigma-Aldrich (München, Germany)
Acrylamid/Bisacrylamide (37.5:1, 30 % w/v) AppliChem GmbH (Darmstadt, Germany)
Agarose Invitrogen (Darmstadt, Germany)
Ammonium Peroxodisulfate (APS) Serva (Heidelberg, Germany)
Ammonium persulfate (APS) Serva (Heidelberg, Germany)
Ampicillin Sodium Salt (Amp) Gerbu (Gaiberg, Germany)
BafilomycinA1 Sigma-Aldrich (München, Germany)
Bovine serum albumine (BSA) Biomol (Heidelberg, Germany)
Bradford reagent BioRad (Hercules, USA)
Bromophenol Blue Serva (Heidelberg, Germany)
Deoxycholate AppliChem GmbH (Darmstadt, Germany)
Dimethylsulfoxide (DMSO) Serva (Heidelberg, Germany)
Ethanol Thermo Fisher Scientific (Waltham, USA)
Ethylenediaminetetraacetic adic (EDTA) Gerbu (Gaiberg, Germany)
G418 disulfate salt Sigma-Aldrich (München, Germany)
Glycerol Gerbu (Gaiberg, Germany)
Glycine Carl Roth GmbH (Karlsruhe, Germany)
Kanamycin (Kan) Gerbu (Gaiberg, Germany)
Low Melting Point Agarose Thermo Fisher Scientific (Waltham, USA)
Methanol Sigma-Aldrich (München, Germany)
Milk powder, blotting grade Carl Roth GmbH (Karlsruhe, Germany)
N,N,N’,N’-tetramethylethylendiamin (TEMED) Serva (Heidelberg, Germany)
NP-40 Sigma-Aldrich (München, Germany)
Orange G Sigma-Aldrich (München, Germany)
Paraformaldehyde/PBS (4%) Morphisto (Frankfurt, Germany)
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Phenylmethylsulfonylfluoride (PMSF) Serva (Heidelberg, Germany)
Phosphate buffered saline Thermo Fisher Scientific (Waltham, USA)
Puromycin Sigma-Aldrich (München, Germany)
Rapamycin Biomol (Heidelberg, Germany)
SLF’-TMP AG Wu (Dortmund, Germany)
Sodium azide Sigma-Aldrich (München, Germany)
Sodium chloride (NaCl) Sigma-Aldrich (München, Germany)
Sodium dodecyl sulfate (SDS) Carl Roth GmbH (Karlsruhe, Germany)
Sucrose Sigma-Aldrich (München, Germany)
Trimethoprim (TMP) Sigma-Aldrich (München, Germany)
Tris-(hydroxymethyl)-aminomethan (Tris) Santa Cruz Biotechnology (Dallas, USA)
Triton X-100 Thermo Fisher Scientific (Waltham, USA)
Tween-20 Serva (Heidelberg, Germany)
Wortmannin Sigma-Aldrich (München, Germany)
β-Mercaptoethanol Serva (Heidelberg, Germany)
2.1.2 Enzymes and Standards
The following enzymes and standards were used in this PhD thesis.
Table 2.2: Frequently used enzymes, standards, and suppliers.
ENZYME/STANDARD SUPPLIER
DpnI Thermo Fisher Scientific (Waltham, USA)
FastDigest Restriction Enzymes Fermentas (St. Leon-Rot, Germany)
GeneRuler 1 kb DNA Ladder Fermentas (St. Leon-Rot, Germany)
Phusion HF PCR Master Mix Thermo Fisher Scientific (Waltham, USA)
Prestained Protein Marker New England Biolabs (Frankfurt, Germany)
Protease Inhibitor Cocktail cOmplete Roche (Grenzach-Wyhlen, Germany)
RedSafe Nucleic Acid Staining Solution iNtRON Biotechnology (Gyunggi-Do, South Korea)
RedTaq DNA Polymerase Sigma-Aldrich (München, Germany)
Shrimp Alkaline Phosphatase (SAP) Fermentas (St. Leon-Rot, Germany)
T4 DNA Ligase Fermentas (St. Leon-Rot, Germany)
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2.1.3 Cell Culture Media and Reagents
All media and reagents were purchased from the following companies in the highest quality available.
Table 2.3: List of frequently used media and reagents and suppliers.
MEDIUM/REAGENT SUPPLIER
Dulbecco’s Phosphate Buffered Saline (DPBS) Sigma-Aldrich (München, Germany)
Dulbecco’s Modified Eagle Medium (DMEM) Sigma-Aldrich (München, Germany)
Earl’s Balanced Salt Solution (EBSS) Sigma-Aldrich (München, Germany)
Fetal Bovine Serum (FBS) Thermo Fisher Scientific (Waltham, USA)
Hank’s Balanced Salt Solution (HBSS) Sigma-Aldrich (München, Germany)
Insulin Solution Sigma-Aldrich (München, Germany)
Minimum Essential Medium Eagle (MEME) Sigma-Aldrich (München, Germany)
Non-Essential Amino Acid Solution Sigma-Aldrich (München, Germany)
Opti-MEM Reduced Serum Medium Life Technologies (Darmstadt, Germany)
Penicillin-Streptomycin Sigma-Aldrich (München, Germany)
Sodium Pyruvate Solution Sigma-Aldrich (München, Germany)
Trypsin-EDTA Solution Sigma-Aldrich (München, Germany)
X-tremeGENE HP DNA Transfection Reagent Roche (Grenzach-Wyhlen, Germany)
2.1.4 Antibodies
Primary and secondary antibodies were obtained in the highest quality available and selected to meet
requirements for immunofluorescence or immunoprecipitation experiments.
Table 2.4: Frequently applied antibodies and suppliers
ANTIBODY SUPPLIER
Anti-Actin Merck-Millipore (Darmstadt, Germany)
Anti-Atg14L BioCat GmbH (Heidelberg, Germany)
Anti-Beclin1 Abcam (Cambridge, United Kingdom)
Anti-GFP Cell Signalling (Danvers, USA)
Anti-HA Abcam (Cambridge, United Kingdom)
Anti-His Cell Signalling (Danvers, USA)
anti-LC3B Cell Signalling (Danvers, USA)
Anti-mCherry Abcam (Cambridge, United Kingdom)
anti-PI3K Class III Abcam (Cambridge, United Kingdom)
anti-tRFP Evrogen (Moscow, Russia)
Anti-UVRAG Abcam (Cambridge, United Kingdom)
AlexaFluor488 Goat Anti-Mouse IgG Jackson ImmunoResearch (Baltimore, USA)
AlexaFluor488 Goat Anti-Rabbit IgG Jackson ImmunoResearch (Baltimore, USA)
DyLight405 Goat anti-Mouse IgG Jackson ImmunoResearch (Baltimore, USA)
DyLight405 Goat anti-Rabbit IgG Jackson ImmunoResearch (Baltimore, USA)
DyLight647 Mouse Anti-Rabbit IgG Jackson ImmunoResearch (Baltimore, USA)
DyLight649 Rat Anti-Mouse IgG Jackson ImmunoResearch (Baltimore, USA)
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2.1.5 Kits
The following kits were used in this PhD thesis.
Table 2.5: Frequently used kits and suppliers
KIT SUPPLIER
BigDye Terminator v3.1 Cycle Sequencing Kit Life Technologies (Darmstadt, Germany)
E.Z.N.A. Cycle Pure Kit VWR (Darmstadt, Germany)
E.Z.N.A. Gel Extraction Kit VWR (Darmstadt, Germany)
E.Z.N.A. Plasmid Maxi Kit VWR (Darmstadt, Germany)
E.Z.N.A. Plasmid Mini Kit VWR (Darmstadt, Germany)
GFP- and RFP-Trap Chromotek (Planegg-Martinsried, Germany)
SuperSignal Blotting Detection Reagent Thermo Fisher Scientific (Waltham, USA)
Western Blotting Detection Reagent GE Healthcare (München, Germany)
2.1.6 Consumables
All consumables were obtained from the following companies in the highest quality available.
Table 2.6: List of frequently used consumables and suppliers.
CONSUMABLE SUPPLIER
Cell culture dishes (60 mm, 100 mm, 150 mm) Sarstedt (Nümbrecht, Germany)
Cell culture flasks (75 cm2, 175 cm2) Sarstedt (Nümbrecht, Germany)
Cell Scraper Falcon GmbH (Gräfeling-Locham, Germany)
Cloning cylinders (150µL) Sigma-Aldrich (München, Germany)
CryoPure Tubes Sarstedt (Nümbrecht, Germany)
Electroporation cuvettes Peqlab (Erlangen, Germany)
Eppendorf tube (0.5 mL, 1.5 mL, 2.0 mL, 5.0 mL) Eppendorf (Hamburg, Germany)
Falcon Tube (50 mL, 15 mL) Falcon GmbH (Gräfeling-Locham, Germany)
Filter Paper Thermo Fisher Scientific (Waltham, USA)
Glass Bottom Chambers (4-well , 8-well) Sarstedt (Nümbrecht, Germany)
Glass Bottom Dishes (35 mm) MatTek Corporation (Ashland, USA)
Immersion Oil Olympus (Hamburg, Germany)
Lens Cleaning Tissue Thorlabs Inc. (Austin, USA)
Multiwell plates (6-well, 12-well, 96-well) Sarstedt (Nümbrecht, Germany)
Nitrocellulose Membrane GE Healthcare (München, Germany)
Parafilm Sigma-Aldrich (München, Germany)
PCR Strips and Tubes Sarstedt (Nümbrecht, Germany)
Pipette tips (1 - 10µL, 20 - 200µL, 100 - 1000µL) Nerbe Plus GmbH (Winsen/Luhe, Germany)
Serological pipettes (5 mL, 10 mL, 25 mL) Sarstedt (Nümbrecht, Germany)
Surgical Disposable Scalpels/Syringes Braun (Aschaffenburg, Germany)
Syringe Filters (0.22µm) Sarstedt (Nümbrecht, Germany)
UltraCruz Autoradiography Film Santa Cruz Biotechnology (Dallas, USA)
UV Curvettes Sarstedt (Nümbrecht, Germany)
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2.1.7 Instruments
The following instruments were used in the course of this thesis.
Table 2.7: Frequently used instruments.
INSTRUMENT SUPPLIER
ABI PRISM 3130x1 Genetic Analyzer Life Technologies (Darmstadt, Germany)
AlphaImager HP Alpha Innotec (Kasendorf, Germany)
BioPhotometer Eppendorf (Hamburg, Germany)
Blotting Cassette GE Healthcare (München, Germany)
Centrifuge 5415C Eppendorf (Hamburg, Germany)
Centrifuge 5415R Eppendorf (Hamburg, Germany)
Centrifuge 5424R Eppendorf (Hamburg, Germany)
Centrifuge 5804R Eppendorf (Hamburg, Germany)
Easypet Pipetting Aid Eppendorf (Hamburg, Germany)
EPS 301 Power Supply GE Healthcare (München, Germany)
FACS Aria Flow Cytometry System BD Biosciences (Heidelberg, Germany)
Gene Pulser Xcell System BioRad (Hercules, USA)
Heatable Magenetic Stirrer IKA (Staufen, Germany)
HORIZON 58 Gel Casting System Life Technologies (Darmstadt, Germany)
Inverted Microscope Axiovert 40 CFL Carl Zeiss Microscopy GmbH (Jena, Germany)
Microwave Siemens (München, Germany)
MilliQ Water/Millipore Advantage A Merck Millipore (Billerica, USA)
Mini-PROTEAN Tetra Handcast Systems BioRad (Hercules, USA)
Mini-Trans-Blot Cell BioRad (Hercules, USA)
NanoDrop 2000c Thermo Fisher Scientific (Waltham, USA)
New Brunswick INNOVA 4430 Eppendorf (Hamburg, Germany)
OptiMax X-ray Film Processor PROTEC (Oberstenfeld, Germany)
Pipettes Gilson Inc. (Middelton, USA)
QBT Block Heater Grant Instruments (Cambridge, UK)
Safty Cabinet Herasafe HS12 Thermo Fisher Scientific (Waltham, USA)
Shaker ST5 Ingenieurbüro CAT (Staufen, Germany)
Shaking Water Bath SW23 Julabo (Seelbach, Germany)
Standard Power Pack P25 Biometra GmbH (Göttingen, Germany)
Steri-Cycle CO2 Incubator Thermo Fisher Scientific (Waltham, USA)
Thermomixer Comfort Eppendorf (Hamburg, Germany)
T-Personal 48 Thermocycler Biometra GmbH (Göttingen, Germany)
Tube Rotator Stuart Equipment (Staffordshire, UK)
Vacusafe Comfort IBS Tecnomara GmbH (Fernwald, Germany)
Vortex Genie 2 Scientific Industries Inc. (New York , USA)
Water Bath WNB 45 Memmert GmbH ( Schwabach, Germany)
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2.1.8 Bacterial Strains
The following bacterial strains were used for plasmid expression.
Table 2.8: Bacterial strains.
E. coli STRAIN GENOTYPE SUPPLIER
XL-1 Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac Agilent Technologies
[F’proAB lacIqZ∆M15 Tn10 (Tetr)] (Waldbronn, Germany)
SCS110 rpsL (Strr) thr leu endA thi-1 lacY galK galT ara tonA Agilent Technologies
tsx dam dcm supE44 ∆(lac-proAB) [F’ traD36 proAB lacIqZ∆M15] (Waldbronn, Germany)
2.1.9 Eucaryotic Cell Lines
The following eucaryotic cancer cell lines were obtained from ATCC or generated in this PhD thesis.
Table 2.9: Eucaryotic cell lines.
CELL LINE ORIGIN MORPHOLOGY ATCC NUMBER
HEK293T Human embryonic kidney Epithelial (adherent) CRL-1573
HeLa Human cervical adenocarcinoma Epithelial (adherent) CCL-2
MCF7 Human mammary gland Epithelial (adherent) HTB-22
Table 2.10: Stably transfected eucaryotic cell lines.
CELL
LINE
EXPRESSED PROTEIN EXPRESSION PLASMID FLUORESCENT
PROTEIN
HEK293T Atg14L w0734 pmCherry-2xFKBP’-Atg14L mCherry
HEK293T Beclin1-FKBP’ w0735 pmCherry-2xFKBP’-Beclin1 mCherry
HEK293T Beclin1∆143-234–FKPB’ w1420 pmCherry-2xFKBP’-Beclin1 (1-142,
235-451)
mCherry
HEK293T Beclin1∆143-272–FKBP’ w1456 pmCherry-2xFKBP’-Beclin1 (1-142,
273-451)
mCherry
HEK293T mCherry-FKBP’ w0254 pmCherry-2xFKBP’ mCherry
HEK293T Vps34-Nanobody-FKBP’ w1634 Vps34-Nano-mCherry-2xFKBP mCherry
MCF7 Atg5 w0356 pEGFP-Atg5 EGFP
MCF7 LC3 w0385 pEGFP-LC3 EGFP
MCF7 LC3 w0606 pmCherry-EGFP-LC3 EGFP/mCherry
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2.1.10 Buffers and Growth Media
The following bacterial or mammalian cell culture growth media and buffers were used.
Table 2.11: Composition of used bacterial growth media.
MEDIUM COMPOSITION
GYT Medium 1 x 30 % (v/v) Glycerin
0.25 % (w/v) Tryptone
0.125 % (w/v) Yeast Extract
LB Medium 1 x 1 % (w/v) Tryptone
1 % (w/v) NaCl
0.5 % (w/v) Yeast Extract
TSS Medium 1 x 10 % (w/v) PEG
5 % (w/v) DMSO
50 mM MgCl2
Table 2.12: Composition of used growth media for mammalian cells.
MEDIUM COMPOSITION
HeLa Medium 1 x MEME
10 % (v/v) FBS
1 % (v/v) NEAA
1 mM Sodium Pyruvate
HEK293T Medium 1 x DMEM
10 % (v/v) FBS
1 % (v/v) NEAA
1 mM Sodium Pyruvate
MCF7 Medium 1 x MEME
10 % (v/v) FBS
1 % (v/v) NEAA
1 mM Sodium Pyruvate
0.01 mg/mL Insulin
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Table 2.13: Composition of used buffers and solutions.
BUFFER COMPOSITION
BME Buffer 1 x 100 mM BME
62.5 mM Tris-HCl pH 6.8
2 % (w/v) SDS
Dilution Buffer 1 x 10 mM Tris-HCl pH 7.5
150 mM NaCl
0.5 mM EDTA
DNA Loading Buffer 5 x 30 % (w/v) Sucrose
20 % (v/v) Glycerin
0.2 % (w/v) Orange G
Laemmli Buffer 4 x 250 mM Tris-HCl pH 6.8
40 % (v/v) Glycerol
5 % (w/v) SDS
0.005 % (w/v) Bromophenol
Blue
Lysis Buffer 1 x 10 mM Tris-HCl pH 7.5
150 mM NaCl
0.5 mM EDTA
0.5 % (v/v) NP–40
RIPA Buffer 1 x 10 mM Tris-HCl pH 7.5
150 mM NaCl
0.5 mM EDTA
0.1 % (w/v) SDS
1 % (w/v) Triton X–100
1 % (w/v) Deoxycholate
SDS Running Buffer 10 x 250 mM Tris-HCl
1.92 mM Glycine
1 % (w/v) SDS
TAE Buffer 50 x 2 M Tris-HCl pH 8.0
1 M Acetic Acid
50 mM EDTA
TBST Buffer 10 x 1.5 M NaCl
200 mM Tris-HCl pH 7.5
1 % (v/v) Tween–20
Transfer Buffer 1 x 190 mM Glycine
25 mM Tris-HCl pH 8.3
20 % (v/v) Methanol
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2.1.11 Expression Plasmids
The following mammalian expression plasmids were used in this PhD thesis.
Table 2.14: Expression Plasmids.
EXPRESSION PLASMID EXPRESSED PROTEIN SOURCE
w0180 CherryC1-LC3 Cherry-LC3 AG Wu
w0254 pmCherry-2xFKBP mCherry-FKBP’ AG Wu
w0276 pOPIN(n)EGFP-Atg14L EGFP-Atg14L AG Wu
w0323 pcDNA4-Vps34-Flag Vps34-FLAG AG Wu
w0356 EGFP-Atg5 EGFP-Atg5 AG Wu
w0359 pTagBFP-2xDHFR-KX TagBFP-2xeDHFR-CAAX AG Wu
w0363 pEGFPC1-2xeDHFR-KX EGFP-2xeDHFR-CAAX AG Wu
w0385 pEGFP-LC3 EGFP-LC3 AG Wu
w0456 pOPIN-NHis-3C_Vps15 His-Vps15 DPF
w0476 pOPIN-His-MBP_Vps15 His-MBP-Vps15 DPF
w0500 pOPIN(n)Citrine_Beclin1 mCitrine-Beclin1 DPF
w0505 pOPIN(n)EGFP_Beclin1 EGFP-Beclin1 DPF
w0506 pOPIN(n)EGFP_Rubicon EGFP-Rubicon DPF
w0507 pOPIN(n)EGFP_UVRAG EGFP-UVRAG DPF
w0508 pOPIN(n)EGFP_Vps15 EGFP-Vps15 DPF
w0509 pOPIN(n)EGFP_Vps34 EGFP-Vps34 DPF
w0547 pOPIN(n)Citrine_Vps15 mCitrine-Vps15 DPF
w0548 pOPIN(n)Citrine_Vps34 mCitrine-Vps34 DPF
w0550 pOPIN(n)Cherry_Beclin1 mCherry-Beclin1 DPF
w0571 pOPIN(n)Citrine_UVRAG mCitrine-UVRAG DPF
w0599 mKate2-giantin-N1 mKate2-Giantin AG Wu
w0601 mKate2-Cb5-ER-N1 mKate2-Cb5 AG Wu
w0606 pCherry_EGFP LC3 mCherry-EGFP-LC3 AG Wu
w0734 pCherryC1-2xFKBP-Atg14L mCherry-2xFKBP’-Atg14L This Thesis
w0735 pCherryC1-2xFKBPmt-Beclin1 mCherry-2xFKBP’-Beclin1 This Thesis
w0736 pCherryC1-2xFKBPmt-Vps34 mCherry-2xFKBP’-Vps34 This Thesis
w0808 pOPIN(n)Citrine_Atg14L mCitrine-Atg14L This Thesis
w0932 pmCherry_2xFKBPmt_N-Vps34 Vps34-mCherry-2xFKBP’ This Thesis
w1135 pCherry-2xFKBPmt-UVRAG mCherry-2xFKBP’-UVRAG This Thesis
w1136 mKate2-3xNLS mKate2-3xNLS AG Wu
w1155 pOPIN(c)EGFP_Vps34 EGFP-Vps34 DPF
w1156 pOPIN(c)Cherry_Vps34 mCherry-Vps34 DPF
w1220 pEGFP-eDHFR_N23C-L28C-NUC EGFP-eDHFR-NLS AG Wu
w1233 pCherryC1-2xFKBPmt-Beclin1 E191L mCherry-FKBP’-Beclin1_E191L This Thesis
w1234 pCherryC1-2xFKBPmt-Beclin1 R205L mCherry-FKBP’-Beclin1_R205L This Thesis
w1239 pTagBFP-2xeDHFR-Cb5 TagBFP-eDHFR-Cb5 This Thesis
w1290 pCherryC1-2xFKBPmt-Beclin(146-271) mCherry-FKBP’-Beclin1(1-145, 272-451) This Thesis
w1338 pCherryC1-2xFKBPmt-Beclin1_mt2 mCherry-FKBP’-Beclin1_E191L_A257L This Thesis
w1372 pCherryC1-2xFKBPmt-Beclin1_mt3 mCherry-FKBP’-
Beclin1_E191L_A219L_A257L
This Thesis
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w1402 pCherryC1-HA-2xFKBPmt-Beclin1 mCherry-HA-FKBP’-Beclin1 This Thesis
w1403 pCherryC1-HA-2xFKBP-Beclin1_E191L mCherry-HA-FKBP’-Beclin1 E191L This Thesis
w1404 pCherryC1-HA-2xFKBP-Beclin1_R205L mCherry-HA-FKBP’-Beclin1 R205L This Thesis
w1405 pCherryC1-HA-2xFKBP-Beclin1_mt2 mCherry-HA-FKBP’-Beclin1_E191L_A257L This Thesis
w1406 pCherryC1-HA-2xFKBP-Beclin1_mt4 mCherry-HA-FKBP’-
Beclin1_E191L_A219L_A257L_E226L
This Thesis
w1408 pCherryC1-2xFKBPmt-Beclin1_mt4 mCherry-FKBP’-
Beclin1_E191L_A219L_A257L_E226L
This Thesis
w1420 pmCherry-2xFKBP-Beclin1∆143-234 mCherry-FKBP’-Beclin1∆143-234 This Thesis
w1421 pHA-Beclin1 HA-Beclin1 This Thesis
w1422 pHA-Beclin1_E191L HA-Beclin1 E191L This Thesis
w1423 pHA-Beclin1_R205L HA-Beclin1 R205L This Thesis
w1424 pHA-Beclin1_E191L_A257L HA-Beclin1 E191L A257L This Thesis
w1425 pHA-Beclin1_E191L_A219L_A257L_E226L HA-Beclin1 E191L A219L A257L E321L This Thesis
w1456 pmCherry-2xFKBP-Beclin1∆143-272 mCherry-FKBP’-Beclin1∆143-272 This Thesis
w1457 pmCherryC1-2xFKBP-Beclin1∆143-278 mCherry-FKBP’-Beclin1∆143-278 This Thesis
w1518 mCherry-2xFKBP-Beclin1_1-234 mCherry-FKBP’-Beclin1(1-234) This Thesis
w1519 mCherry-2xFKBP-Beclin1_1-272 mCherry-FKBP’-Beclin1(1-272) This Thesis
w1520 mCherry-2xFKBP-Beclin1_K265A mCherry-FKBP’-Beclin1 K265A This Thesis
w1582 pHA-2xFKBPmt-Beclin1∆143-234 mCherry-FKBP’-Beclin1∆143-234 This Thesis
w1583 pHA-2xFKBPmt-Atg14L HA-FKBP’-Atg14L This Thesis
w1584 pHA-2xFKBPmt HA-FKBP’ This Thesis
w1587 mCherry-2xFKBP-Beclin1_267-451 mCherry-FKBP’-Beclin1(267-451) This Thesis
w1588 mCherry-2xFKBP-Beclin1_N268A mCherry-FKBP’-Beclin1 N268A This Thesis
w1593 mCherry-2xFKBP-Beclin1_V269A mCherry-FKBP’-Beclin1 V269A This Thesis
w1600 mCherry-2xFKBP-Beclin1_F270A mCherry-FKBP’-Beclin1 F270A This Thesis
w1608 mCherry-FKBP-Beclin1_265-72A mCherry-FKBP’-Beclin1 265-72A This Thesis
w1615 pTagBFP-2xeDHFR-hERGIC53 TagBFP-eDHFR-ERGIG53 This Thesis
w1616 pTagBFP-2xeDHFR-ActA TagBFP-eDHFR-ActA This Thesis
w1634 Vps34-Nano-mCherry-2xFKBP Vps34-nanobody-mCherry-FKBP’ This Thesis
w1719 mCherry-2xFKBP-Beclin1∆328-394 mCherry-FKBP’-Beclin1∆328-394 This Thesis
w1745 FLAG-BecnS FLAG-BecnS This Thesis
The following mammalian expression plasmids were used in this PhD thesis.
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2.2 Methods
2.2.1 Methods in Molecular Biology
2.2.1.1 Polymerase Chain Reaction
Polymerase chain reaction (PCR) is a popular technique in molecular biology to amplify DNA fragments
by several orders of magnitude. The method relies on the enzyme DNA polymerase, which is able to
generate new DNA strands complementary to a template DNA. The enzyme is guided by a primer that
binds to the template DNA and serves as starting point for amplification. The process itself is controlled
by thermal cycling, providing the appropriate temperatures for DNA denaturation, primer annealing
and elongation of the new DNA strand by the DNA polymerase. Since the generated DNA fragments
serve as templates themselves in the next cycle, amplification proceeds exponentially until the reaction
is terminated. This facilitates fast and specific reproduction of DNA fragments for analysis or to create
recombinant DNA constructs 218.
2.2.1.1.1 Site-directed Mutagenesis
Site-directed mutagenesis was applied to introduce point-mutations into a DNA sequence. A specific
primer was designed and the PCR master mix was prepared according to table 2.15. The PCR pro-
grame was performed in a T-Personal 48 Thermocycler as described (see table 2.15). Afterwards the
template DNA was removed by digestion with DpnI. 1µL DnpI (10 U/µL) was added to the PCR product
and the mixture was incubated at 37 ◦C for at least one hour. The PCR product was then purified using
a E.Z.N.A. Cycle Pure Kit and transformed into E.coli XL1-Blue cells (6µL). Finally, introduction of the
point-mutation was confirmed by DNA sequencing.
Table 2.15: Site-directed mutagenesis PCR master mix composition and programe.
MASTER MIX Vtot = 50µL
Phusion HF PCR Master Mix 2 x 25µL
DMSO 100 % 2.5µL
Template 20 ng
Forward primer 100µM 0.5µL
ddH2O up to 50µL
PCR PROGRAM
98 ◦C 30 s
98 ◦C 15 s }
i 29x55 ◦C 30 s
72 ◦C 4 min
72 ◦C 10 min
2.2.1.1.2 Insert Amplification PCR
Polymerase chain reaction was used to amplify DNA fragments for subcloning. Oligonucleotide primers
specific for the respective template plasmid were designed and the annealing temperature (Tm) was
calculated. The PCR master mix was prepared and the PCR was performed in a Thermocycler (table
2.16). The PCR product was then analyzed by agarose gel electrophoresis and purified with a E.Z.N.A.
Cycle Pure Kit.
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Table 2.16: Insert amplification PCR composition and program
MASTER MIX Vtot = 50µL
Phusion HF PCR Master Mix 2 x 25µL
Template 20 ng
Forward primer 10µM 2µL
Reverse primer 10µM 2µL
ddH2O up to 50µL
PCR PROGRAM
98 ◦C 30 s
98 ◦C 8 s }
i 36xTm 45 s
72 ◦C 45 s
72 ◦C 7 min
2.2.1.1.3 Colony PCR
Colony PCR was used to determine whether plasmid constructs contain the correct DNA insert. The
respective construct was transformed into E.coli and spread onto agar plates containing an appropriate
antibiotic. Single colonies were picked and resuspended in the PCR mix (see table 2.17). In parallel, each
of the selected colonies was replicated by streaking it onto a new agar plate. The PCR was performed in
a Thermocycler according to the program in table 2.17 and the PCR products were analyzed by agarose
gel electrophoresis.
Table 2.17: Colony PCR composition and program.
MASTER MIX Vtot = 20µL
Bacterial cells
RedTaq DNA Polymerase 2 x 10µL
Forward primer 10µM 1µL
Reverse primer 10µM 1µL
ddH2O up to 20µL
PCR program
96 ◦C 4 min
96 ◦C 30 s }
i 26x55 ◦C 30 s
72 ◦C 2.5 min
72 ◦C 7 min
2.2.1.1.4 DNA Sequencing
The nucleotide sequence of plasmid constructs was analyzed using the BigDye Terminator v3.1 Cycle
Sequencing Kit. The PCR master mix was prepared according to table 2.18 and PCR was performed
in a Thermocycler. Afterwards, the DNA was precipitated by adding 50µL Ethanol, 10µL ddH2O, 2µL
EDTA (100 mM) and 2µL sodium acetate (3 M) and centrifugation at over 13.000 rpm for 20 minutes.
The supernatant was then discarded and the pellet was washed with 200µL 70 % ethanol followed by
10 minutes centrifugation at over 13.000 rpm. The supernatant was again discarded and the pellet was
dried at 100 ◦C for 5 minutes. The DNA sequence was then determined with a ABI PRISM 3130x1 Genetic
Analyzer by the service facilities at the Max-Planck-Institute in Dortmund (ZE Biotechnologie).
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Table 2.18: Sequencing PCR composition and program.
MASTER MIX Vtot = 10µL
BigDye Terminator 2µL
Sequencing Buffer 5 x 2µL
Template 200 ng
Primer 10µM 2µL
ddH2O up to 10µL
PCR program
96 ◦C 4 min
96 ◦C 10 s }
i 26x50 ◦C 5 s
60 ◦C 4 min
2.2.1.2 Agarose Gel Electrophoresis
Agarose gel electrophoresis was performed to determine the length of the DNA fragments or to separate
and purify them. Agarose gels with a concentration of 1 % (w/v) were employed for both purposes. The
gels were prepared by solubilizing the agarose with RedSafe Nucleic Acid Staining Solution (20 000 x) in
TAE buffer (see table 2.13) and allowing the solution to polymerize in a HORIZON 58 gel casting system.
DNA loading buffer (see table 2.13) was added to the samples and the gels were run in TAE buffer at
95 V until the fragments were sufficiently separated. GeneRuler 1 kb DNA Ladder served as reference for
DNA size and quantity. The gels were analyzed in an AlphaImager HP under UV light at a wavelength of
302 nm.
To purify DNA fragments, the respective band was extracted from the gel and the DNA was isolated with
a E.Z.N.A. Gel Extraction Kit.
2.2.1.3 Preparation and Transformation of Competent Cells
Competent bacterial cells are widely used in molecular biology as they are able to take up, multiply
and express extracellular DNA. This is termed transformation and typically induced by a heat or electro
shock to permeabilize the cellular membrane.
2.2.1.3.1 Electrocompetent Cells
To prepare electrocompetent E.coli XL-1 Blue cells, 10 mL LB-medium were inoculated with 100µL of
bacterial culture and incubated overnight at 37 ◦C shaking at 170 rpm. This starting culture was used to
inoculate 1 L LB medium and the cells were returned to the 37 ◦C shaker until they reached an OD600 of
0.5. The bacterial cells were then harvested by centrifugation for 12 minutes at 5000 rcf and 4 ◦C. The
supernatant was discarded and the pellet was washed three times by resuspending it in 10 % glycerol
and subsequent centrifugation for 12 minutes at 5000 rcf and 4 ◦C. Finally, the bacterial pellet was resus-
pended in icecold 3 mL GYT medium, aliquoted to 80µL and stored at – 80 ◦C.
To transform electrocompetent cells, 1 ng to 100 ng DNA were added to the thawed bacterial solution
and transferred into a cold electroporation curvette. Membrane permeabilization was induced by ex-
posing the bacteria to a short pulse at 1.8 kV, 200Ω and 25µF. The bacterial cells were then incubated in
1 mL LB medium at 37 ◦C and 170 rpm for 1 h. Finally, the transformed cells were harvested by centrifu-
gation at 10 000 rpm for 1 minute and streaked onto a agar plate containing the appropriate antibiotic.
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2.2.1.3.2 Chemically Competent Cells
Chemically competent E.coli XL-1 Blue or SCS110 cells were prepared by inoculating 100 mL LB medium
with 30 mL overnight culture prepared as previously described and growing the bacterial cells until an
OD600 of 0.8 was reached. Afterwards the cells were harvested by centrifugation at 2000 rpm and 4 ◦C for
15 minutes. The pellet was resuspended in 10 mL TSS medium, aliquoted to 300µL and stored at – 80 ◦C.
For transformation, the chemical competent cells were gently mixed with 1 ng to 100 ng DNA and incu-
bated on ice for 30 minutes. Membrane permeabilization was then achieved by a 1 minute heat shock
at 42 ◦C. The cells were then again incubated on ice for 5 minutes and afterwards transferred into 1 mL
LB medium. After 1 h incubation at 37 ◦C and 170 rpm, the cells were harvested by centrifugation at
10 000 rpm for 1 minute and streaked onto an agar plate containing the appropriate antibiotic.
2.2.1.4 Preparation of Plasmid DNA
Plasmid DNA was isolated from transformed E.coli XL-1 Blue or SCS110 cells using the E.Z.N.A. Plas-
mid Mini Kit or the E.Z.N.A. Plasmid Maxi Kit for larger DNA amounts. Therefore, the plasmid was
transformed into bacterial cells and a single colony was picked to inoculate 2 mL to 4 mL LB medium
containing the appropriate antibiotic. The culture was incubated at 37 ◦C for 12 h to 16 h shaking at
170 rpm. The bacterial cells were then harvested by centrifugation at 13.000 rpm for 1 minute and the
plasmid DNA was isolated according to the supplier’s instructions.
For use in mammalian cells, the plasmid DNA was further purified by ethanol precipitation. To pre-
cipitate the DNA, it was initially incubated with 0.1 volumes of sodium acetate (3 M) at room tempera-
ture for 30 minutes. Then, two volumes of ethanol were added and the sample was centrifuged at over
13.000 rpm for 20 minutes. The supernatant was discarded and the pellet was washed with 200µL 70 %
ethanol. After 10 minutes of centrifugation at over 13.000 rpm, the supernatant was again discarded and
the pellet was dried at 100 ◦C for 5 minutes. Finally, the pellet was resuspended in ddH2O and the DNA
concentration was determined.
2.2.1.5 Determining DNA Concentration
The concentration of DNA fragments or plasmids was determined by measuring absorbance at 260 nm
using a NanoDrop 2000c.
2.2.1.6 Restriction Enzyme Digest
Restriction enzymes are endonucleases that recognize specific, typically palindromic nuleotide se-
quences of 4 bp to 6 bp and catalyze their cleavage. Restriction enzyme digestion of DNA plasmids
or PCR products was performed with FastDigest Restriction Enzymes following the suppliers instruc-
tions. Typically, 0.1µg to 4µg of the respective DNA sample were incubated with 1 U to 3 U of restriction
enzyme for up to 3 h at 37 ◦C and the enzyme was thermally inactivated afterwards. If only a single re-
striction enzyme was used, the DNA fragments were additionally dephosphorylated prior to ligation to
prevent religation of the vector. To this end, the sample was incubated with 1 U SAP for 30 minutes at
37 ◦C. Before ligation, the DNA samples were purified by gel extraction or with the E.Z.N.A. Cycle Pure
Kit.
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2.2.1.7 Ligation of DNA Fragments
DNA ligases are enzymes, which catalyze covalent joining of DNA strands and are widely applied to
combine DNA fragments from different sources. For ligation of DNA fragments, T4 DNA Ligase was
used according to the suppliers instructions. Usually, DNA vectors were combined with specific inserts
in a ratio of 1:3 or 1:6 (vector to insert) and incubated with 1 U ligase for 12 - 16 hours at 16 ◦C. Afterwards,
the ligase was thermally inactivated and the ligation product was transformed into E.coli XL-1 Blue cells.
2.2.2 Methods in Cell Biology
All procedures involving direct handling of mammalian cells were performed in a safety cabinet. Me-
dia, trypsin-EDTA and DPBS were typically pre-warmed in a 37 ◦C water bath, whereas the remaining
reagents were used at room temperature.
2.2.2.1 Passaging of Cells
Mammalian cells were maintained in complete DMEM (HEK293T) or MEME (MCF7 and HeLa) growth
medium supplemented with 10 % heat-inactivated FBS, 1 % glutamine and 1 % non-essential amino
acids. MCF7 growth medium further contained 0.1 % insulin solution. For routine subculturing, the cells
were seeded into 100 mm cell culture dishes, 75 cm2 or 175 cm2 flasks and kept at 37 ◦C in a humidified
5 % CO2 / 95 % air atmosphere. Cells were passaged at 80 % confluency by removing the growth medium,
washing with 5 - 10 mL DPBS and incubated with 1 mL 0.05 % trypsin-EDTA solution. Once the cells
were detached, complete growth medium was added to deactivate the trypsin. The cell number was
determined using a Neubauer cell counting chamber and an Axiovert 40 CFL inverted microscope. The
cell density was then adjusted according to the cell lines requirements and the cells were transferred
into a new culture vessel containing the appropriate growth medium.
2.2.2.2 Cryopreservation of Cells
For crypreservation the cells were trypsinized as previously described (see 2.2.2.1) and resuspended in
5 - 10 mL complete growth medium. The cell suspension was transferred to a falcon tube and the cells
were harvested by centrifugation at 200 g for 5 minutes. The supernatant was discarded and the cells
were resuspended in complete growth medium containing 10 % cell culture grade DMSO. The cells were
then aliquoted to cryovials and frozen slowly to – 80 ◦C. For long-term storage the cells were transferred
to liquid nitrogen.
2.2.2.3 Transient Transfection of Cells
Transfection is a commonly applied method to introduce nucleic acids into eukaryotic cells and ex-
press exogenous proteins. Here, plasmid DNA was transiently transfected into mammalian cells using
X-tremeGENE HP DNA Transfection Reagent, which employs non-liposomal lipids for DNA delivery. For
transfection the cells were harvested as described before (see 2.2.2.1) and approximately 4×105 cells
were seeded onto 35 mm glass bottom dishes in a total volume of 1.8 mL complete growth medium. A
total amount of 2µg DNA was mixed with 200µL Opti-MEME reduced serum medium and 1µL trans-
fection reagent. The mixture was incubated a room temperature for at least 15 minutes and then added
dropwise to the cells. The transfected cells were incubated at 37 ◦C in a humidified 5 % CO2 / 95 % air
atmosphere for 16 - 48 hours before further treatment.
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2.2.2.4 Generation of Stable Cell Lines
If permanent expression of DNA constructs was desired, stable cell lines were generated by integrating
the respective nucleic acids into the cellular genome. To this end, the nucleic acids were cloned into
vectors encoding kanamycin resistance for selection in bacteria and neomycin or puromycin resistance
for selection in mammalian cells (table 2.10).
Selective conditions were determined by establishing a dose-response curve. Untransfected cells were
seeded onto a 24-well plate and maintained until they reached a confluency of 80 %. The cells were then
exposed to increasing concentrations of G418 or puromycin for one week during which the medium was
exchanged every 2 - 3 days. Afterwards the number of viable cells was compared between wells and the
lowest concentration of antibiotic sufficient to kill the majority of cells per well was determined. For
G418 this resulted in a selective concentration of 0.4 mg/mL and 0.5µg/mL for puromycin.
To generate stable cells, approximately 1×106 cells were seeded onto a 100 mm dish and transfection
was performed as previously described (see 2.2.2.3). Due to the increased cell number, the total DNA
amount was elevated to 10µg mixed with 1 mL Opti-MEME reduced serum medium and 10µL trans-
fection reagent. The cells were then incubated for 24 hours at 37 ◦C in a humidified 5 % CO2 / 95 %
air atmosphere. Afterwards, the growth medium was replaced with fresh medium containing G418 or
puromycin at selective concentrations. The cells were then maintained under selective conditions for 2 -
3 weeks until formation of distinct cell colonies could be observed. The colonies were screened for the
respective fluorescent marker using an Axiovert 40 CFL inverted microscope and positive colonies were
isolated using cloning cylinders. Therefore, the growth medium was completely removed, the cells were
washed with 5 - 10 mL DPBS and the cloning cylinders were placed around the positive colonies. The
cylinders were stabilized by embedding them in 1 % (w/v) low melting point agarose. Once the agarose
was solidified, 40µL 0.05 % trypsin-EDTA solution were added into each cloning cylinder and the dish
was transferred to the 37 ◦C incubator until the cells detached. Then, each cylinder was filled to capacity
with complete growth medium, the cells were resuspended by pipetting up and down and finally the cell
suspension was transferred onto a 12-well plate. The were maintained under selective conditions until
they reached 80 % confluency before transferring them onto 60 mm dishes and lastly 100 mm dishes 219.
Before further analyzing the stable cells, part of them was cryopreservated as described before (see
2.2.2.2). The remaining cells were kept in culture and the expression level, molecular weight and cel-
lular distribution of the introduced protein were analyzed by western blotting or confocal microscopy
as described in section 2.2.3.1 and 2.2.4. Based on the results, cells from one isolated colony were cho-
sen for fluorescence-activated cell sorting (FACS) to separate fluorescent from non-fluorescent cells (see
2.2.2.4.1). The sorted cells were seeded onto a 35 mm dish and grown under selective conditions until
sufficient cell numbers for cryopreservation were achieved. Finally, the stably expressed protein was
again analyzed by western blotting and confocal microscopy. For routine maintenance, the stable cells
were kept in complete growth medium supplemented with reduced concentrations of selection agents,
i.e. 0.2 mg/mL G418 and 0.25µg/mL puromycin.
2.2.2.4.1 Flow Cytometry
Flow cytometry is a powerful method to analyze large numbers of single cells regarding the distribution
of certain properties such as viability, cell size and fluorescence. In order to analyze cells by FACS, sin-
gle cells are channeled past an excitation light source and a fluorescence microscope which measures
and records a fluorescence signal for each cell. Based on the acquired data, cells featuring the desired
properties are then separated from the remaining population 220. Here, FACS was applied to isolate cells
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permanently expressing a fluorescent marker from non-transfected cells in order to obtain a pure pop-
ulation and homogenous fluorescence, i.e. expression level. Cell sorting was carried out by the FACS
facilities at the Max-Planck-Institute in Dortmund using a FACS Aria Flow Cytometry System with ap-
propriate lasers and filter settings for TagBFP (407 nm laser), EGFP (488 nm laser) and mCherry (633 nm
laser).
2.2.2.5 Fixation and Immunofluorescence Labeling of Cells
Immunofluorescence labeling of cells is commonly applied to stain specific cellular components with
fluorescent labels by targeting them with an antibody. Fixation of cells was applied in order to preserve
them for prolonged periods before imaging or to prepare the cells for immunostaining. To this end,
the cells were grown in glass bottom dishes or chambers, which provide appropriate optical qualities
for confocal microscopy. Fixation, blocking and staining conditions were optimized for each antibody
individually, since they are highly dependent on the specificity and stability of the antibody and the
properties of the antigen. For fixation, the cells were washed with DPBS and then immobilized by ad-
dition of either 4 % PFA/DBPS or ice-cold methanol. PFA-fixed cells were incubated for 10 minutes at
room temperature while methanol-fixed cells were incubated at – 20 ◦C for 10 minutes. After immobi-
lization, the cells were washed three times for 5 minutes with DBPS and then incubated in 0.1 - 0.5 %
Triton X-100/DPBS for 10 minutes to permeabilize the cellular membrane. Following permeabilization,
the cells were again washed three times in DBPS and then blocked in 1 - 10 % BSA or FBS or both in
DPBS for 30 - 60 minutes. For immunostaining, the cells were incubated with the primary antibody in
1 - 3 % BSA or FBS in DPBS for up to 12 hours at RT or 4 ◦C. Afterwards, the cells were washed three times
with DPBS again and then incubated with the secondary antibody for 30 to 60 minutes under the same
conditions used for primary antibody labeling. Finally, the cells were washed with DBPS and stored in
DBPS at 4 ◦C.
2.2.2.6 Modulation and Quantification of Autophagy
2.2.2.6.1 Induction and Inhibition of Autophagy
In mammalian cells, autophagy was induced or inhibited by exposing the cells to starvation or targeting
specific autophagy phases with autophagy modulators. To induce autophagy, the cells were serum-
starved by incubation in EBSS for 1 - 4 hours or in HBSS for 30 minutes to 2 hours. Typically, MCF7 and
HeLa cells were starved in EBSS, while HEK293T cells were starved in HBSS.
Autophagosome formation was inhibited by addition of BafilomycinA1, which disturbs vacuolar-type
H+-ATPases in the lysosomal membrane and thereby prevents fusion of the autophagosome with the
autolysosome. BafilomycinA1 was used at a final concentration of 100 nM for up to 2 hours. In order
to inhibit the kinase activity of Vps34 and prevent autophagosome formation, the cells were treated
with the non-specific PI3K inhibitor Wortmannin. Wortmannin was applied at a final concentration
of 500 nM for up to 2 hours. If starvation-independent autophagy induction was desired, the cells
were treated with Rapamycin, which inhibits the kinase mTOR and thus mimics cellular starvation.
Rapamycin was applied at a final concentration of 500 nM for up to 4 hours.
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2.2.2.6.2 Quantification of Autophagy
Autophagy levels were analyzed by confocal laser scanning microscopy in fixed or living cells or by west-
ern blotting for distinctive autophagy marker proteins. In confocal microscopy, autophagy was quanti-
fied based on the number and area of autophagosomes and autolysosomes visualized by fluorescently
labeled marker proteins. Since the fluorescently tagged autophagic vesicles appear as distinctive puncta
within the cytoplasm, these assays are commonly referred to as ’puncta counts’. Several markers were
employed to distinguish between the different autophagy phases. The autophagic protein Atg5 is a
marker for the isolation membrane, i.e. for the onset of autophagy. EGFP-tagged LC3 was used as marker
for autophagosome formation including all processes prior to fusion with the lysosome, while tandem
mCherry-GFP-tagged LC3 was employed to monitor autophagic flux. The latter is based on the pH-
sensitivity of EGFP, which is quenched in the acidic environment of the lysosome lumen while mCherry
remains fluorescent. Thus, tandem mCherry-EGFP-tagged LC3 is often used to distinguish between au-
tophagosomes and autolysosomes and monitor both of them simultaneously. In the fluorescence assay,
colocalization of mCherry and EGFP signals represents a compartment which has not fused with the
lysosome yet, whereas mCherry fluorescence alone corresponds to autolysosomes 14.
For microscopy-based autophagy assays, stable MCF7 and HeLa cell lines expressing the respective
marker proteins were generated (see table 2.10). Typically, the stable cells were additionally transfected
with one or more proteins of interest and autophagy was induced or inhibited as previously described
(see 2.2.2.6.1). For quantification of autophagy levels based on puncta counts, confocal images were
acquired and processed as described in section 2.2.4 and 2.2.4.2.
In addition to the fluorescence assays, autophagy levels were also monitored by western blotting. Here,
LC3 and p62 were employed as markers for autophagic flux and autophagic degradation, respectively.
LC3 is conjugated to PE during autophagy and while its nonlipidated form LC3-I can be detected in
basal conditions as well, the lipidated form LC3-II can only be observed upon autophagy induction.
Even though, LC3-II has a higher molecular weight, it shows faster migration than LC3-II during SDS-
PAGE, possibly due to its increased hydrophobility. In western blotting, appearance of LC3-II bands
corresponds to induction of autophagy and thus autophagy flux can be monitored by detecting LC3-I
and LC3-II. In contrast to LC3, p62 or SQSTM1 bind to polyubiquitinated proteins, which in conse-
quence become autophagic cargo and serve as an index of autophagic degradation. Hence, increased
levels of p62 correspond to autophagy inhibition, whereas a decrease in p62 represents increased levels
of autophagy 14. For western blot based assays, HEK293T cells stably expressing the proteins of interest
were generated (see table 2.10) and treated as previously described (see 2.2.2.6.1). Afterwards, the cell
lysates were blotted and endogenous LC3 and p62 were detected with appropriate primary antibodies
(see 2.2.3.1).
2.2.2.7 Induction of Heterodimerization
2.2.2.7.1 Chemically Induced Dimerization
Chemically induced dimerization (CID) was applied to localize proteins of interest to the plasma mem-
brane, the mitochondria, ER, ERGIC or Golgi apparatus. To this end, a protein of interest, tagged with
the dimerization domain FKBP’ and a fluorescent marker protein, was expressed along with a eDHFR-
tagged localization signal. Typically, the eDHFR-constructs contained TagBFP as marker, whereas the
FKBP’-constructs were labeled with mCherry, mCitrine or EGFP. To target the plasma membrane, the
CAAX domain of KRas was used as localization signal, while listerial actin A (ActA) was used for the mi-
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tochondria, cytochrome b5 (Cb5) for the ER, hERGIC53 (human ER-Golgi intermediate compartment
53 kDa protein) for the ERGIC and Giantin for the Golgi apparatus. In order to induce dimerization of
the eDHFR- and FKBP’-domains, the cells were incubated with 2µM SLF’-TMP for up to 4 hours either
in complete growth medium or in starvation medium. To reverse the dimerization, the cells were treated
with 2µM TMP for up to 4 hours.
2.2.2.7.2 Photoinduced Dimerization
Photoinducible dimerization was used to mislocalize proteins of interest to the plasma membrane.
Here, the proteins of interest were modified with a eDHFR-dimerization domain while the localization
signal (CAAX domain of KRas) was fused to a HaloTag. To achieve similar expression levels of both com-
ponents, the proteins were expressed from one vector containing a ribosomal skipping sequence (2A
peptide sequence) inbetween the modified proteins. Typically, the eDHFR-constructs were tagged with
mCitrine or mTurquoise, whereas the HaloTag-CAAX construct was HA-tagged. In contrast to chem-
ically induced dimerization, the cells were pre-treated with 5µM Nvoc-TMP-CI in complete growth
medium for 1 hour, washed twice with DPBS and incubated for 1 hour in complete growth medium or
starvation medium again. Afterwards, the cells were washed with DPBS and dimerization was induced
by intensive bleaching with a 405 nm confocal laser. Laser irradiation serves to cleave off the caging
group from the TMP moiety of Nvoc-TMP-CI, which can then interact with eDHFR. Dimerization was
reversed by addition of 5µM TMP.
2.2.3 Biochemical Methods
2.2.3.1 Western Blotting
Western blotting is a widespread technique in molecular and cell biology that facilitates specific detec-
tion and quantification of proteins. To this end, protein are extracted from cellular lysate, separated
based on their molecular weight, transferred onto a membrane and specifically labeled by antibodies.
2.2.3.1.1 Preparation of Cell Lysates
To generate whole cell lysates, cells were cultured in 35 mm, 60 mm, 100 mm or 150 mm dishes until
they reached 80 % confluency. To harvest the cells, the dish was placed on ice, growth medium was
aspirated and 2 - 5 mL ice-cold DPBS were added. The cells were then scraped off the dish, transferred
into a pre-cooled tube and centrifuged at 500 g and 4 ◦C for 3 minutes. Afterwards, the supernatant
was discarded and the cell pellet was gently resuspended in 1 mL ice-cold DPBS. This procedure was
repeated twice. After washing, the cells were resuspended in 50 - 200µL ice-cold lysis or RIPA buffer (see
2.13) supplemented with cOmplete protease inhibitor and 1 mM PMSF. The cell solution was incubated
on ice for 30 minutes followed by 15 minutes centrifugation at over 13 000 rpm and 4 ◦C. Finally, the
supernatant was transferred to a pre-cooled tube and stored at – 20 ◦C until further use.
2.2.3.1.2 Determination of Protein Concentration
A Bradford assay was employed to determine protein concentration in whole cell lysates. The assay re-
lies on the unique properties of the dye Coomassie Brilliant Blue, which shifts its absorption maximum
from 465 - 595 nm upon protein binding in acidic solutions. Protein concentration can thus be deter-
mined by measuring absorption at 595 nm and relating the result to a BSA standard curve 221.
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The assay was performed in UV cuvettes and a BioPhotometer using the respective lysis buffer as con-
trol. To determine protein concentrations, 995µL Bradford reagent were mixed with 5µL cell lysate and
absorbance at 595 nm was measured.
2.2.3.1.3 Immunoprecipitation
Immunoprecipitation was applied to isolate specific proteins and protein complexes from whole cell
lysate. Here, immunoprecipitation was performed with GFP- or RFP-Traps by Chromotek according to
the manufacturer’s instructions. The Traps are based on magnetic agarose beads coupled to nanobodies
against GFP or RFP and their derivatives, which facilitates highly efficient isolation of GFP- and RFP-
fusion proteins. For immunoprecipitation, whole cell lysate was generated as previously described (see
2.2.3.1.1) and mixed with 300µL dilution buffer. Afterwards, 10 - 25µL bead slurry were pipetted into
500µL ice-cold dilution buffer and magnetically separated. The supernatant was discarded, the beads
were washed twice in the same fashion and finally added to the diluted cell lysate. The mixture was tum-
bled end-over-end for at least 1 hour at 4 ◦C and then magnetically separated. The beads were washed
twice with 500µL ice-cold dilution buffer, transferred into a fresh tube and resuspended in 30 - 100µL
SDS sample buffer. In order to dissociate the immunocomplex from the beads, the samples were boiled
at 100 ◦C for 10 minutes. Finally, the beads were magnetically separated and the supernatant was ana-
lyzed by SDS-PAGE or stored at – 20 ◦C.
2.2.3.1.4 SDS-PAGE
Sodiumdodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) is a commonly used method to
separate proteins based on their molecular weight. SDS is a anionic detergent, which binds to denatured
proteins proportionally to their molecular mass and gives them a negative charge. Proteins in complex
with SDS are thus attracted towards a positively charged electrode in an electric field. During gel elec-
trophoresis, these proteins migrate through a polyacrylamide gel towards an anode. Due to differing
pore sizes in the gel, the migration speed depends on the protein size. Thus, larger proteins migrate
slower and can be visualized as higher bands on a polyacrylamide gel, whereas smaller proteins migrate
faster and are represented in lower bands.
To prepare samples for SDS-PAGE, cell lysates were generated as previously described and the protein
concentration was determined (see 2.2.3.1.1 and 2.2.3.1.2). The protein concentration was adjusted to
equal levels by adding ddH2O and the lysate was mixed with 4 x Laemmli buffer (see 2.13). Afterwards,
the samples were boiled at 100 ◦C for 10 minutes.
SDS-polyacrylamide stacking and separating gels were prepared according to Jiang et al. 222 as shown in
table 2.19. Typically, 8 % gels were used to analyze larger proteins like p62 and 13.5 % gels were used to
visualize smaller proteins like LC3. The gels were prepared with a Mini-PROTEAN® Tetra handcasting
system, placed in the tank and covered with SDS running buffer (see 2.13). The samples were loaded
onto the gel along with Prestained Protein Marker and the electrophoresis was performed at 90 V until
the samples reached the separating gel. Afterwards, the voltage was increased to 120 V and electrophore-
sis was continued until the desired degree of separation was reached.
2.2.3.1.5 Electroblotting
After SDS-PAGE, the proteins were electrotransferred onto a nitrocellulose membrane in order to make
them accessible to antibody staining. As before, an electric current is applied to initiate migration of
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Table 2.19: Composition of stacking and separating SDS-Polyacrylamide gels.
STACKING GEL Vtot = 10 mL
ddH2O 6.8 mL
Acrylamide/ 30 % (w/v) 1.7 mL
Bisacrylamide
Tris-HCl pH 6.8 1.0 M 1.25 mL
SDS 10 % (w/v) 100µL
APS 10 % (w/v) 100µL
TEMED 10µL
SEPARATING GEL 8 % / 13.5 % Vtot = 24 mL
ddH2O 11.04/6.6 mL
Acrylamide/ 30 % (w/v) 6.24/10.8 mL
Bisacrylamide
Tris-HCl pH 8.8 1.5 M 6.24 mL
SDS 10 % (w/v) 240µL
APS 10 % (w/v) 120µL
TEMED 14.4/9.6µL
the proteins from the gel onto the membrane. A wet blotting system was employed for the protein
transfer and used according to the manufacturer’s instructions. Typically, the transfer sandwich was
assembled in ice-cold transfer buffer (see 2.13) as follows: sponge, filter paper, SDS-polyacrylamide gel,
nitrocellulose membrane, filter paper, sponge. It was then moved to the transfer tank, which was placed
on ice and filled to capacity with ice-cold transfer buffer. Electrotransfer was performed at 100 V for
30 - 40 minutes depending on the molecular weight of the transferred protein.
2.2.3.1.6 Blocking and Immunostaining
To prevent unspecific protein binding, the nitrocellulose membrane was blocked with 5 % skim milk
in TBST buffer (see 2.13) for 1 hour after electrotransfer. After blocking, the membrane was washed
three times for 5 minutes in TBST and then exposed to the primary antibody. Conditions for the im-
munostaining were highly dependent on the respective primary antibody (see table 2.20). Typically, the
membrane was incubated with the primary antibody at 4 ◦C overnight while gently shaking. The mem-
brane was again washed three times for 5 minutes in TBST and incubated with the secondary antibody
at 1:10,000 dilution in 5 % milk/TBST for 1 hour. Depending on the primary antibody, anti-mouse or
anti-rabbit HRP was used as secondary antibody. Finally, the membrane was again washed three times
for 5 minutes in TBST and stored in TBST buffer until detection.
Table 2.20: Immunostaining conditions of primary antibodies.
Antigen Source Dilution Conditions
Actin Mouse 1:10,000 0.02 % NaN3, 4
◦C overnight / RT for 1 hour
GFP Rabbit 1:1000 5 % BSA, 0.02 % NaN3, 4
◦C overnight
LC3B Rabbit 1:1000 0.02 % NaN3, 4
◦C overnight
mCherry Mouse 1:1000 5 % Milk, 0.02 % NaN3, 4
◦C overnight
p62 Rabbit 1:10,000 5 % Milk, 0.02 % NaN3, 4
◦C overnight / RT for 1 hour
tRFP (BFP) Rabbit 1:500 0.02 % NaN3, 4
◦C overnight
2.2.3.1.7 Detection and Quantification
Detection of the western blot membrane was performed by visualizing the HRP-labeled protein through
addition of a chemiluminescent substrate, which emits light when exposed to HRP. ECL Blotting Sub-
strate or SuperSignal Blotting Substrate was applied to the membrane according to the manufacturer’s
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instructions and incubated for 1 - 2 minutes. Afterwards, the membrane was fixed in the film cassette
and an autoradiography film was placed on top of the membrane. Depending on the protein concentra-
tion and quality of the primary antibody, the film was exposed for up to 1 hour and then developed with
an OptiMax X-ray Film Processor. The protein concentration and expression level was then quantified
with ImageJ by analyzing the band intensities relative to the intensity of the actin bands, which were
typically used as internal control. However, due to variations in loading and transfer efficiency, west-
ern blot is considered a semi-quantitative method and provides a relative comparison of protein levels
rather then an absolute measure of protein concentrations 223.
2.2.3.1.8 Stripping Western Blot Membranes
Western blot membranes can be stripped off the secondary or primary antibodies in order to detect
proteins with a similar molecular weight with antibodies from different source organisms or to re-probe
protein bands. If only the secondary antibody needs to be removed, a gentle sodium azide strip is com-
monly applied, whereas a harsh BME strip is used to remove primary and secondary antibodies. To strip
a western blot membrane, it is first washed three times for 5 minutes in TBST and then incubated in ei-
ther 1 mM sodium azide/TBST for 1 hour at RT or in BME buffer for 30 minutes at 50 ◦C. Afterwards, the
membrane is again washed three times for 5 minutes in TBST and then blocked, stained and detected
as previously described (see 2.2.3.1.6 and 2.2.3.1.7).
2.2.4 Microscopy
2.2.4.1 Confocal Laser Scanning Microscopy
Confocal laser scanning microscopy is a widely used technique to image fluorescently labeled macro-
molecules in fixed or living cells. In contrast to conventional light microscopy, where the whole sample
is illuminated, confocal microscopes scan the specimens with a focused laser beam thus optically
sectioning the sample. In consequence, only restricted regions of the specimen are illuminated while
light from other parts is excluded, leading to an increased maximum lateral and axial resolution 224.
Confocal laser scanning microscopy was routinely applied to analyze subcellular localization, abun-
dance and behavior of proteins of interest in MCF7 or HeLa cells. To this end, the cells were transfected
with fluorescently labeled proteins or immunolabeled with appropriate dyes and fixed as previously
described (see 2.2.2.3 and 2.2.2.5). Confocal images of fixed and living cells were obtained with a Leica
TCS SP5 laser scanning microscope using a 63 x 1.4 NA oil objective. Fixed cells were imaged at room
temperature while experiments with living cells were performed in a 37 ◦C/5 % CO2 incubator. Typical
excitation and detection settings for each fluorescent probe are listed in table 2.21. If combinations
of probes with similar excitation and emission maxima were imaged, the detection bandwidth was
adjusted to avoid bleed-through. Routinely, images were recorded at 5 - 60 % laser power in sequential
mode with a scanning speed of 100 Hz, a line average of one, a frame average of three and a size of
1024 pixel×1024 pixel. The zoom, gain and pinhole were adjusted for each experiment individually.
2.2.4.2 Data Processing
Data acquired by confocal laser scanning microscopy was analyzed and quantified using ImageJ 225.
Several macros were created and optimized to quantify autophagy levels based on puncta counts and to
49
MATERIALS AND METHODS
Table 2.21: Confocal imaging settings.
PROBE EXCITATION LASER DETECTION
BANDWIDTH
TagBFP
Diode 405 nm, Model: Cube 1162002/AF 420 - 480 nmDyLight405
mTurquoise
EGFP
Argon 488 nm, Model: LGK 7872 ML05 500 - 550 nm
Alexa488
mCitrine Argon 514 nm, Model: LGK 7872 ML05 530 - 550 nm
mCherry DPSS 561 nm, Model: YLK 6120 T02 600 - 650 nm
mKate Helium Neon 594 nm, Model: LGK 7512 P 610 - 650 nm
DyLight647/9 Helium Neon 633 nm, Model: LGK 7654-15 665 - 680 nm
analyze the efficiency of protein mislocalization to the plasma membrane by inducible heterodimeriza-
tion.
Autophagy levels were estimated from the percentage of puncta area within total cell area. Measuring
puncta area proved to be superior to counting the number of puncta, as the size variation of autophagic
compartments provides valuable information in itself. Furthermore, certain autophagy modulators (e.g.
BafilomycinA1) induced formation of large, clustered autophagosomes that cannot be appropriately
separated by thresholding. Analysis of EGFP-LC3 or EGFP-Atg5 puncta area was performed with the
’EGFP Puncta Count’ macro (see A.1). The macro initially provides the images as a merge of all chan-
nels (e.g. TagBFP-Marker, EGFP-LC3, mCherry-POI), then the region on interest (ROI) is selected for
each image individually to exclude non-transfected cells. Afterwards the channels were split, aligned
and the puncta area was selected by manually adjusting the threshold in the EGFP channel. In this case,
automated thresholding appeared to be disadvantageous due to varying fluorescence intensities. The
area of the thresholded particles was then measured and the same procedure was repeated for the cell
area. Afterwards, Microsoft Excel and OriginPro were used to calculate the percentage of puncta area in
cell area, to determine outliers and to calculate the weighted arithmetic mean and weighted standard
error of the mean (SEM). Each dataset contained three replicates of twenty data points, each point rep-
resenting one cell. The significance level was set to 0.05 (5 %) and statistical significance was tested by
performing a Student’s t-test. All of the data was normalized against a control determined in fed condi-
tions, i.e. prior to autophagy induction.
Autophagic flux was monitored by performing tandem mCherry-EGFP-tagged LC3 puncta counts and
quantified with the ’mCherry-EGFP Puncta Count’ macro (see A.1). As before, a ROI was selected man-
ually and puncta and cell area were measured by thresholding the mCherry and EGFP channels. After-
wards, binary masks were generated from the thresholded selection of the puncta area. To determine
the puncta area of particles exclusively tagged with mCherry, the EGFP channel was subtracted from the
mCherry channel and the area of the remaining puncta was analyzed. The number of EGFP-, mCherry-
or tandem-tagged particles was determined based on the same principle. Statistical analysis was per-
formed as previously described.
In order to quantify the efficiency of heterodimerization at the plasma membrane, the ratio of mean
fluorescence intensity at the plasma membrane to mean fluorescence intensity in the cytoplasm was
determined and compared for the POI and a membrane-localized marker protein (see A.1). To this
end, the confocal images were transformed into 32-bit images, background fluorescence was subtracted
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and a ROI was selected. The plasma membrane was selected by thresholding in the marker channel, a
binary mask was generated from the selection and the inverted selection (cytoplasm) and the masks
were multiplied with 32-bit images of the POI and marker channel to eliminate background fluores-
cence. Afterwards, the mean fluorescence intensity and area was measured in the resulting images and
membrane-to-cytoplasm ratios of the total fluorescence intensity were calculated and analyzed using
Microsoft Excel and OriginPro.
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3 Results and Discussion
The aim of this PhD thesis was to develop and apply the knock off/on system to modulate and study the
mechanism of autophagosome formation and maturation. To this end, conditional translocalization
of target proteins through reversible chemically induced dimerization of bait proteins with cellular an-
chors was first established and then applied to different autophagic prey proteins. The effects of knock
off/on were then analyzed using different autophagy markers as read-out and various cellular anchors.
Analysis focused especially on the function of the class III PI3K complex (PI3K complex hereafter) within
the autophagy process.
3.1 Establishing the Knock Off and On Strategy
The knock off and on strategy is based on a bait-and-prey principle, in which localization-dependent
function of prey proteins is disrupted by re-routing them to another cellular compartment via in-
teraction with bait proteins. Typically, the bait protein is exogenous and overexpressed, so that
mislocalization of the bait-prey complex results in depletion of the endogenous prey protein. Here,
chemically inducible dimerization of FKBP’- and eDHFR domains was employed to re-route autophagy
proteins to the plasma membrane and thus perturb their function within the autophagy process. To
this end, target proteins were N-terminally fused to two copies of FKBP’ and labeled with a fluorescent
protein. The CAAX-domain of KRas was chosen as the plasma membrane anchor and fused to a
fluorescent protein as well as two copies of eDHFR. Dimerization was induced by addition of SLF’-TMP,
termed ’dimerizer’, and reversed by addition of TMP, termed ’competitor’, as described above (see
2.2.2.7.1). SLF’-TMP was selected, because it is bioorthogonal in eukaryotic systems, rapidly reversible
and has been shown to induce dimerization within less than a minute 18. The combination of these
properties, especially the rapid kinetics, make it superior to most of the chemical heterodimerizers
available to date.
Initially, the knock off and on system was tested focusing on the PI3K complex, which is crucial
for autophagosome formation and directly participates in isolation membrane formation. The key
components of the PI3K complex, Beclin1, Vps34, Atg14L and UVRAG, were fused to FKBP’ and the
efficiency and speed of membrane recruitment after dimerizer addition were analyzed with confocal
laser scanning microscopy. Preliminary experiments confirmed that each of the proteins could be
re-routed to the plasma membrane and released from it within less than 10 minutes after addition of
SLF’-TMP and TMP, respectively. No cell line-dependent differences in dimerization and dissociation
kinetics or transfection efficiency could be observed in HeLa, HEK293T or MCF7 cells. MCF7 cells
were chosen for further experiments as they feature a well defined plasma membrane and are very
responsive to autophagy induction.
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3.1.1 Knock Off Induces Translocalization of Exogenous PI3K Prey Proteins
The knock off and on principle is based on the assumption that inducible translocalization of highly
overexpressed bait proteins to the plasma membrane results in re-routing of their endogenous inter-
action partners (prey) and thus disrupts their local function. In order to confirm that mislocalization
of PI3K complex proteins actually perturbed their respective interaction partners, co-localization of
bait and prey proteins at the plasma membrane was examined. To this end, PI3K complex bait pro-
teins were fused to mCherry-FKBP’ and targeted to the plasma membrane through dimerization with
TagBFP-eDHFR-CAAX. Subsequently, localization of different EGFP-tagged PI3K prey proteins was an-
alyzed. Since all PI3K proteins are either cytoplasmic or ER-resident, they only enrich at the plasma
membrane through interaction with FKBP’-tagged PI3K proteins.
The dimerization experiments showed that Atg14L and Beclin1 or UVRAG and Beclin1 could function as
bait for each other (see Figure 3.1). Vps34 or p150 could neither be used as bait nor translocated to the
plasma membrane through interaction with Beclin1, Atg14L or UVRAG (see Figure B.1). However, Vps34
could function as a bait for p150.
Interaction of Beclin1 with Atg14L and UVRAG is well documented in literature and our findings are
thus in agreement with previously published results. In fact, Atg14L and UVRAG were first identified as
Beclin1 binding proteins in yeast by the Ohsumi group and later in mammalian cells by Mizushima and
colleagues, who also established that Atg14L and UVRAG bind mutually exclusive to Beclin1 forming
two distinct PI3K complexes 4,226. Various studies showed that Beclin1 and Atg14L/UVRAG can be co-
purified in immunoprecipitation experiments 4,8,9,226,227,228 and that the proteins co-localize in punctate
structures upon starvation-induced autophagy 10,38,229,230. Matsunaga and co-workers also employed a
CAAX-domain to target GFP-Atg14L to the plasma membrane of A549 and HEK293T cells and reported
translocalization of immunostained endogenous Beclin1. Interestingly, they could also partially attract
endogenous Vps34 to the plasma membrane through interaction with GFP-Atg14L-CAAX, which is con-
sistent with various immunoprecipitation experiments confirming interaction of Atg14L/UVRAG and
Vps34 4,8,9,227. The same applies to Beclin1, which binds directly to Vps34 through its ECD domain.
Based on these results, it appears implausible that Vps34 could only serve as a bait for the kinase p150
in the knock off and on system, so we hypothesized that the presence of at least one additional PI3K
protein was required to mislocalize the whole complex. This assumption was originally derived from an
EM structure of the PI3K complex suggesting that p150 acts as a bridge between Vps34 and Beclin1 231.
However, this could not be confirmed experimentally even though different combinations of PI3K com-
plex proteins with varying baits and preys were tested (see Figure B.1). Finally, a crystal structure of
the whole UVRAG-containing PI3K complex, published in 2015, indicated that the complex assembles
from a Vps34/p150 heterodimer in combination with a Beclin1 heterodimer containing either Atg14L
or UVRAG 5. This is consistent with our observations, as the different heterodimers could be assembled
at the plasma membrane after knock off. To test whether we could induce mislocalization of the whole
complex, all PI3K complex proteins were expressed simultaneously with FKBP’-Beclin1 as a bait. In-
deed, as shown in Figure 3.1D, expression of four PI3K complex proteins facilitated translocalization of
the whole complex to the plasma membrane. This is in agreement with previously published findings
and shows that FKBP-tagged bait proteins can be used to re-route their direct and indirect endogenous
interaction partners to the plasma membrane.
After establishing that the main PI3K complex proteins could be used as a bait for each other, the
analysis was extended to potential PI3K-interacting proteins, such as Rubicon, DFCP1, WIPI or Atg16L.
However, while Atg16L could attract Atg12-5 to the plasma membrane, none of the other proteins was
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Figure 3.1: Co-localization of exogenous PI3K complex proteins at the plasma membrane of MCF7 cells after
2 hours starvation in EBSS and 30 minutes treatment with SLF’-TMP. Scale bar: 10µm. A FKBP’-Beclin1 attracts
Atg14L to the plasma membrane after dimerizer treatment. B FKBP’-Beclin1 and UVRAG co-localize at the plasma
membrane. C FKBP’-Vps34 attracts p150 to the plasma membrane upon SLF’-TMP addition. D The whole UVRAG-
containing PI3K complex is mislocalized to the plasma membrane using FKBP’-Beclin1 as bait.
re-routed after mislocalization of the PI3K bait proteins (see Table 3.1). Atg12 and Atg5 bind covalently
to each other and Atg16L stabilizes this interaction further to form a stable multimeric complex, which
has been well characterized in literature 35,232. Therefore, it is not surprising that Atg16L re-routes Atg12-
5 to the plasma membrane and still serves as good proof of principle for the knock off and on system.
Rubicon has been reported to transiently interact with Beclin1 in the UVRAG-containing PI3K com-
plex 228. Thus we analyzed whether translocalization of UVRAG or Beclin1 also caused Rubicon re-
routing. However, neither UVRAG nor Beclin1 could recruit Rubicon to the plasma membrane even if
all three proteins were expressed simultaneously. This suggests that Rubicon can only interact with the
Beclin1-UVRAG heterodimer within the complete PI3K complex. In order to test this hypothesis, Ru-
bicon, Beclin1, UVRAG, Vps34 and p150 could be expressed simultaneously using one PI3K protein as
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Table 3.1: Co-localization of exogenous FKBP’-bait proteins and potential prey proteins at the plasma
membrane of MCF7 cells. Autophagy was induced by starvation in EBSS. The cells were treated with
SLF’-TMP for at least 30 minutes.
PREY / BAIT Beclin1 Atg14L UVRAG Vps34 Atg16L
Beclin1 –   × ×
Atg14L  – × × ×
UVRAG  × – × ×
Vps34 × × × – ×
p150 × × ×  ×
Rubicon × × × × ×
WIPI × × × × ×
DFCP1 × × × × ×
Atg16L × × × × –
Atg12-5 × × × × 
FBKP-tagged bait and eDHFR-CAAX as membrane anchor. As demonstrated before, dimerizer addition
should induce mislocalization of the PI3K complex to the plasma membrane, which might then attract
Rubicon as well. However, expression and imaging of six fluorescently labeled proteins is technically
challenging, because the transfection efficiency is presumably low and the choice of fluorescent tags
is limited. The latter is due to spectral bleed-through, which occurs between fluorophores with over-
lapping emission/excitation spectra and causes artifacts that are especially difficult to identify when
co-localization is analyzed.
DFCP1 and WIPI bind to the PI3Ps generated by Vps34 7,233, but were not recruited to the plasma mem-
brane by Vps34, Beclin1, Atg14L or Atg16L mislocalization. This indicates that expression of one PI3K
complex component alone is not sufficient to assemble the whole complex and facilitate PI3P genera-
tion at the plasma membrane. Similar to Rubicon, DFCP1 and WIPI could potentially be re-routed by
attracting the whole PI3K complex to the membrane, but again the analysis are impeded by experimen-
tal limitations. Further, binding of DFCP1 and WIPI to PI3Ps may depend on additional factor such as
membrane curvature.
3.1.2 Knock Off Induces Mislocalization of Endogenous PI3K Prey Proteins
To confirm that endogenous target proteins are indeed translocalized to the plasma membrane after
knock off of PI3K bait proteins, we performed immunofixation and co-immunoprecipitation experi-
ments. Immunofixation was employed to visualize the cellular distribution of endogenous prey pro-
teins in regard to overexpressed FKBP’-PI3K bait proteins before and after dimerizer treatment. Initially,
the specificity of anti-Beclin1, anti-UVRAG, anti-Atg14L and anti-Vps34 antibodies was tested by im-
munostaining fluorescently labeled, overexpressed proteins. To this end, mCherry-FKBP’-tagged Be-
clin1, UVRAG, Atg14L and Vps34 were introduced into HEK293T cells and immunostained in the pres-
ence or absence of the dimerizer. As shown in Figure B.2, all of the tested antibodies co-localize well with
their target proteins, which becomes especially clear after mislocalization to the plasma membrane.
This confirms that the antibodies are specific for their target proteins in the cellular environment.
Next, FKBP’-Beclin1, -UVRAG and -Atg14L were introduced into different cell lines and immunostain-
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Figure 3.2: Expression and localization of PI3K complex proteins. A RNA expression of Beclin1, UVRAG and Atg14L
in HEK293T, HeLa and MCF7 cells. Data was provided by The Human Protein Atlas 234,235. B FKBP’-mCherry-
Beclin1 is mislocalized to the plasma membrane of HEK293T cells and attracts endogenous UVRAG after 2 hours
starvation in EBSS and 30 minutes treatment with SLF’-TMP. C Endogenous Atg14L is mislocalized to the plasma
membrane of HeLa cells through interaction with FKBP’-mCherry-Beclin1 after 2 hours starvation in EBSS and
30 minutes treatment with SLF’-TMP.
ing was performed against their respective endogenous interaction partners. HEK293T, HeLa and MCF7
cells were chosen since they feature different expression levels of PI3K complex proteins and thus dis-
play distinct phenotypes. As shown in Figure 3.2A, Beclin1 expression is significantly higher than UVRAG
or Atg14L RNA levels in all cell lines, but reduced in MCF7 cells. In contrast, UVRAG levels higher in
MCF7 cells than in HEK293T or HeLa cells, while Atg14L expression is low, but consistent in all three cell
lines.
As shown in Figure B.4 immunostaining of endogenous UVRAG indicates that the protein localizes to
small punctate structures in HEK293T cells and to the plasma membrane of HeLa and MCF7 cells re-
gardless of dimerizer addition. In HEK293T cells, however, UVRAG translocalizes to the plasma mem-
brane upon addition of SLF’-TMP, even though it still remains in punctate structures (see Figure 3.2B).
In contrast to previous studies reporting that UVRAG mainly localizes to puncta in the perinuclear re-
gion 4,9,10,11, here puncta could be detected throughout the whole cell and even outside of cells. This
suggests that a least part of the observed punctate structures are artifacts from the immunolabeling
procedure. The same applies to the immunofluorescence signal at the plasma membrane observed in
HeLa and MCF7 cells. In general, immunolabeling outcomes depend heavily on the cell type as well
as the fixation and permeabilization procedure and false positive labeling at the plasma membrane has
been described on several occasions 236. Still, endogenous UVRAG was mislocalized to the plasma mem-
brane upon knock off of FKBP’-Beclin1 in HEK293T cells, which is consistent with previous results and
indicates that in principle the localization of endogenous target proteins can be regulated by the knock
off and on strategy.
In contrast to UVRAG, Atg14L immunofluorescence is very consistent in all three cell lines and shows
punctate structures in proximity of the ER or ERGIC region (see Figure B.5), which is in agreement with
previously published results 4. However, upon addition of SLF’-TMP and knock off of FKBP’-Beclin1 to
the plasma membrane, Atg14L localization is only affected in HeLa cells. Here, the protein is re-routed
to the plasma membrane, which is consistent with the data obtained for exogenous Atg14L (see Figure
3.2C). Similar as for UVRAG labeling, the fixation or permeabilization procedure might have altered the
original localization of Atg14L in HEK293T and MCF7 cells so that no immunofluorescence could be
detected at the plasma membrane.
Immunostaining against endogenous Beclin1 shows a diffused cytoplasmic distribution with distinct
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Figure 3.3: Immunoprecipitation and fractionation of HEK293T cell lysates to analyze interaction of PI3K complex
proteins. Cells were transfected with TagBFP-eDHFR-CAAX as well as mCherry-FKBP’, mCherry-FKBP’-UVRAG and
mCherry-FKBP’-Atg14L and starved in EBSS for 2 hours. Scale bar: 10µm. A Co-immunoprecipitation of endoge-
nous Beclin1. FKBP’-UVRAG and -Atg14L, but not mCherry-FKBP’, interact with endogenous Beclin1 in the pres-
ence or absence of SLF’-TMP. B After treatment with SLF’-TMP, endogenous Beclin1 levels are decreased in cytosol
fraction of cells expressing FKBP’-UVRAG and -Atg14L while Beclin1 is enriched in the plasma membrane fraction
of the same cells.
punctate structures throughout the whole cell, which are most defined in HeLa cells (see Figure B.6) and
have been reported before 230,237,238. Curiously, the subcellular localization of endogenous Beclin1 was
not affected by knock off of FKBP’-UVRAG or -Atg14L in any cell line suggesting that the proteins are
not interacting or that Beclin1 is trapped in the cytoplasm. However, this would be in stark contrast to
previous results where exogenous Beclin1 could be mislocalized to the plasma membrane and appears
to bind tightly to UVRAG and Atg14L. Other possible explanations might be immunolabeling artifacts
or residual FKBP’-bait proteins in the cytoplasm engaging the majority of endogenous Beclin1. The
later appears rather unlikely, since no immunofluorescence whatsoever could be detected at the plasma
membrane and even if the fluorescence signal was attenuated by cytoplasmic FKBP’-UVRAG-Beclin1
interaction, it should not be completely abolished. Immunolabeling artifacts cannot be completely ex-
cluded and even though different fixation and permeabilization approaches were tested to optimize the
immunostaining conditions, the procedure might have altered Beclin1s in situ distribution 236. There-
fore, co-immunoprecipitation of FKBP’-UVRAG and Atg14L was employed to investigate whether native
Beclin1 could still interact with the modified PI3K proteins.
Co-immunoprecipitation was carried out in HEK293T cells using a RFP-Trap to pull down overexpressed
mCherry-FKBP’, mCherry-FKBP’-UVRAG and mCherry-FKBP’-Atg14L before and after treatment with
SLF’-TMP. Western blotting analysis showed that Beclin1 is indeed pulled down by both, FKBP’-UVRAG
and -Atg14L in the presence or absence of the dimerizer (see Figure 3.3A). This confirms that interac-
tion between Beclin1, Atg14L and UVRAG is not disrupted by the mCherry-FKBP’-tag and suggests that
FKBP’-UVRAG or -Atg14L should function as Beclin1 baits.
In order to test whether endogenous Beclin1 can be mislocalized by knock off of UVRAG or Atg14L, the
plasma membrane of SLF’-TMP treated cells was isolated and Beclin1 levels in the membrane and the
cytosol were compared. To this end, lysates of HEK293T cells expressing TagBFP-eDHFR-CAAX and the
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mCherry-FKBP’-tagged bait proteins were fractionated using the Minute Plasma Membrane Protein Iso-
lation Kit. Afterwards, the cytosol and plasma membrane fractions were analyzed by western blotting
as shown in Figure 3.3B. In the cytosol fraction, Beclin1 levels are decreased by 3-fold in UVRAG knock
off cells and by 5-fold in Atg14L knock off cells compared to the control cells expressing only mCherry-
FKBP’. In the plasma membrane fraction, however, Beclin1 levels are increased by a factor of three and
seven after UVRAG and Atg14L knock off, respectively, whereas it is barely detectable in the control cells.
This indicates that most of the Beclin1 population was indeed re-routed to the plasma membrane after
knock off of UVRAG and Atg14L.
Taken together, the results suggest that the availability of endogenous target proteins in the cytoplasm
can indeed be regulated by knock off of exogenous FKBP’-bait proteins. Knock off of endogenous
UVRAG and Atg14L was directly detected by immunostaining, while immunoprecipitation and western
blotting confirmed that endogenous Beclin1 can be mislocalized to the plasma membrane.
3.1.3 Nanobodies as Bait in the Knock Off and On System
The knock off and on system employs a bait-and-prey principle that requires relatively stable interaction
of the target proteins. However, many proteins bind only transiently to each other or require additional
binding partners to stabilize their interaction. Vps34, for instance, binds directly to Beclin1s ECD, but
in the knock off/on system the two proteins can only serve as a bait for each other in the presence of
the entire PI3K complex. In order to overcome this limitation and target proteins directly and specifi-
cally, we tested whether nanobodies can be used as bait to mislocalize autophagy proteins to the plasma
membrane.
Typically, mammalian antibodies are comprised of two identical heavy and two light chains featuring
variable domains which confer specificity for an antigen. This structural concept is very conserved in
mammals, however, Camelidae express an additional type of antibodies consisting of only two homod-
imeric heavy chains with a variable domain, referred to as single-domain antibodies or nanobodies.
Compared to the tetrameric antibodies, nanobodies are smaller, easier to obtain, exceptionally stable,
soluble in aqueous solutions and can be efficiently expressed in bacterial systems 239,240.
Here, an anti-Vps34 nanobody introduced by Rostislavleva et al. was fused to an FKBP’ domain to in-
ducibly mislocalize endogenous Vps34 5. In their report Rostislavleva et al. generated a nanobody spe-
cific for yeast Vps34 as described by Pardon et al. and used it to crystallize the yeast PI3K complex 241. In
the course of their studies, they additionally employed hydrogen-deuterium exchange mass spectrom-
etry to confirm that the nanobody specifically recognizes the helical domain of yeast Vps34, but none
of the other PI3K complex proteins (see Figure 3.4). As we intended to target human Vps34, the amino
acid sequence of the nanobody was initially optimized for mammalian codon usage and its specificity
was analyzed by immunoprecipitation and confocal laser scanning microscopy.
For the confocal microscopy analysis, the FKBP’-tagged nanobody, the membrane anchor TagBFP-
eDHFR-CAAX and the target, EGFP-Vps34, were introduced into starved MCF7 cells and dimerization
was induced by addition of SLF’-TMP. As shown in Figure 3.5A, most of the exogenous Vps34 was re-
routed to the plasma membrane after knock off of the nanobody and only a small fraction remained
cytoplasmic. Yet, the translocalization efficiency appears to be lower than in previous analysis with a
similar setup (see section 3.1.2), possibly because part of the nanobodies are occupied by endogenous
Vps34. This effect was not observed before, but it is likely that the nanobody has a much higher affinity
to Vps34 than p150, which was previously used as bait. Taken together, the confocal microscopy data
indicates that the anti-Vps34 nanobody binds specifically to Vps34, but we still performed immunopre-
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Figure 3.4: The anti-Vps34 nanobody, adjusted from Rostislavleva et al. 5. A Vps34-specific nanobody binding
to an epitope on the helical domain of Vps34 (red). The interaction is mainly mediated by the complementarity-
determining regions CDR1 (yellow) and CDR3 (magenta) with no significant contribution from CDR2 (green).B
Amino acid sequence of the anti-Vps34 nanobody.
cipitation to obtain an additional confirmation.
Co-immunoprecipitation was performed in lysates of starved HEK293T cells expressing Nano-mCherry-
FKBP’ and Vps34, which was C- or N-terminally tagged with EGFP. The anti-Vps34 nanobody was em-
ployed as bait and the pull down was performed using a RFP-Trap. Subsequent western blotting showed
that only the N-terminally tagged variant of EGFP-Vps34 could be pulled down by the nanobody sug-
gesting that the C-terminal EGFP-tag perturbs binding and potentially even Vps34s function. We thus
used only N-terminally labeled Vps34 in the subsequent assays. Since N-terminally labeled Vps34 was
readily pulled down by the nanobody, we assumed that the nanobody binds specifically to Vps34 in the
cell (Figure 3.5B). However, it should be noted that the assay would be even more reliable if the endoge-
nous instead of overexpressed Vps34 was analyzed, but we were not able to obtain an anti-Vps34 anti-
body of acceptable quality and thus refrained from further analysis. Nevertheless, the combined imag-
ing and co-immunoprecipitation data confirms that the nanobody binds specifically to mammalian
Vps34 and thus we proceeded to study the effect of Vps34 mislocalization using the nanobody as bait.
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Figure 3.5: Interaction of the anti-Vps34 nanobody with overexpressed Vps34. A The nanobody attracts EGFP-
Vps34 to the plasma membrane of MCF7 cells that were starved for one hour in EBSS and simultaneously treated
with SLF’-TMP. Scale bar: 10µm. B Immunoprecipitation of the Vps34 using the anti-Vps34 nanobody as bait. Only
N-terminally EGFP-tagged Vps34 can be immunoprecipitated by the Nano-mCherry-FKBP’ construct indicating
that the C-terminal tag disrupts the binding and that the nanobody is specific for Vps34. Lysates were generated
from HEK293T cells after one hour starvation in EBSS and treatment with SLF’-TMP.
3.2 Modulation of Autophagosome Formation with Knock Off and On
After establishing that endogenous PI3K prey proteins can be re-routed to the plasma membrane
through interaction with FKBP’-modified bait proteins, we analyzed whether mislocalization would
affect the localization dependent protein function during autophagosome formation. To assess
autophagy flux, autophagic structures were labeled with characteristic marker proteins, such as LC3,
Atg5 or WIPI and monitored by fluorescence microscopy or immunoblotting.
Fluorescently labeled autophagosomes can be detected as puncta within the cytoplasm and provide a
well established read-out for the autophagy level: a large amount of puncta indicates a strong induction
of autophagy and a low puncta number represents a basal level of autophagy. The most commonly
applied marker to monitor autophagosome formation with fluorescence microscopy is EGFP-LC3,
because it remains bound to the inner and outer autophagosomal membrane throughout the entire
autophagy process. Initially, we tested whether knock off of FKBP’-Beclin1 affects the amount of EGFP-
LC3 puncta in MCF7 cells stably expressing the marker protein. mCherry-FKBP’-Beclin1, the control
construct mCherry-FKBP’ and TagBFP-eDHFR-CAAX were introduced into the EGFP-LC3-MCF7 cells,
autophagy was induced by serum starvation and the autophagy level was assessed in the presence and
absence of the dimerizer and competitor. Throughout this thesis, the amount of autophagic puncta was
quantified by measuring the percentage of puncta area in cell area as weighted average using an ImageJ
macro specifically designed for this purpose as opposed to counting the number of puncta. The latter is
often used, but we found the puncta area per cell area to be the most accurate measure for autophagic
activity as it accounts for varying cell and puncta sizes.
As shown in Figure 3.6 Beclin1 mislocalization leads to a significant reduction of EGFP-LC3 puncta
in the cytoplasm. Quantification of the imaging data shows that the autophagosome population is
decreased by more than 50 % within 10 minutes after knock off. Longer exposure to the dimerizer did
not lower the amount of autophagic puncta further, suggesting that severe autophagy disruption can be
achieved almost immediately after Beclin1 knock off. Similarly, knock on by TMP addition restored the
autophagosome level almost completely within a time-frame of 10 minutes. In contrast, mislocalization
of the control construct mCherry-FKBP’ caused no significant change in the puncta levels, confirming
that the previously described effect was indeed caused by knock off and on of Beclin1. Based on these
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Figure 3.6: Knock off of Beclin1 perturbs autophagosome formation in EGFP-LC3-MCF7 cells. A The number of
EGFP-LC3 puncta is not affected by mislocalization of the control construct mCherry-FKBP’. B The amount of EGFP-
LC3 puncta is significantly decreased after knock off of mCherry-FKBP’-Beclin1 and subsequent mislocalization of
PI3K complex proteins. C Quantification of the percentage of EGFP-LC3 puncta area of total cell area. Beclin1 knock
off severely decreases the amount of puncta and autophagosome formation is disturbed. Error bars: weighted mean
± SEM (n≥ 60); ** = p≤ 0.01; *** = p≤ 0.001; statistical significance was determined by pairwise comparison to the
starvation condition.
promising results, we extended the analyzes to the remaining PIK3 complex proteins and included
EGFP-Atg5 as an additional marker for the early phase of autophagosome formation.
3.2.1 Perturbation of PI3K Proteins Impairs Autophagosome Formation
Our initial experiments showed that mislocalization of FKBP’-Beclin1 significantly decreased the
amount of EGFP-LC3 labeled autophagosomes, supposedly due to impaired autophagosome biogen-
esis. However, due to the dynamic nature of autophagy, the number of autophagosomes at one specific
time point is not representative for autophagy flux, but rather corresponds to the ratio between the rate
of autophagosome generation and the rate of conversion into autolysosomes 242. Hence, a decrease in
autophagosome number can be caused by autophagy inhibition upstream of autophagosome genera-
tion or by acceleration of the autophagosome turnover rate. To distinguish between the two scenarios,
we employed the autophagy modulator BafilomycinA1 (see Figure 3.7A), which inhibits the lysosomal
V-ATPase and thus prevents autophagosome-lysosome fusion. If autophagosome formation is impaired
by mislocalization of PI3K bait proteins, the autophagosome number should also be decreased in the
presence of BafilomycinA1.
Initially, BafilomycinA1 treatment was optimized in EGFP-LC3-MCF7 cells expressing FKBP’-Beclin1
and an optimal treatment duration of two hours was determined (see Figure 3.7C). Afterwards, the PI3K
bait proteins FKBP’-Beclin1, -Atg14L, and the anti-Vps34 nanobody, were introduced into EGFP-LC3-
MCF7 cells, autophagy was triggered by serum starvation and mislocalization was induced by dimerizer
addition in the presence or absence of BafilomycinA1. Finally, the amount of autophagosomes was de-
tected by confocal microscopy and quantified with ImageJ as described before.
As shown in Figure 3.8A, knock off of Beclin1, Atg14L and anti-Vps34 nanobody substantially reduced
the autophagosome number in untreated and BafilomycinA1-exposed cells, while autophagosome lev-
els remained undisturbed in the presence of the competitor. Mislocalization of FKBP’ alone had no
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Figure 3.7: BafilomycinA1 prevents lysosomal fusion of autophagosomes. A Molecular structure of BafilomycinA1.
B Treatment with BafilomycinA1 provokes accumulation of large EGFP-LC3 labeled autophagosomes in MCF7 cells.
Scale bar: 10µm. C After two hours treatment with BafilomycinA1 no further increase in autophagic activity can be
observed.
impact on autophagosome levels regardless of BafiloymycinA1 treatment. This is a strong indication
that knock off of PI3K bait proteins indeed disrupts autophagosome formation rather than promot-
ing autophagosome conversion. It further confirms our initial hypothesis that PI3K knock off induces
mislocalization of endogenous prey proteins that are essential for autophagosome biogenesis. The au-
tophagic activity was also reduced to a similar extent regardless of which PI3K protein was used as bait,
which makes sense since all of the targeted prey proteins function within the same complex.
However, LC3 is a rather unspecific autophagy marker when it comes to differentiating distinct au-
tophagy phases, as it remains bound to the autophagosomal membrane throughout the whole biogen-
esis process. Atg5, on the other hand, is a very specific marker for the early stages of autophagosome
formation as it only localized to the phagophore. In the hierarchy of autophagic complexes, the PI3K
complex is upstream of the Atg12-5-16L complex 243 and accordingly, PI3K protein knock off should pre-
vent Atg5 puncta formation. To investigate whether this is actually the case, we performed EGFP-Atg5
puncta counts using the same PI3K bait proteins and treatment conditions as for the LC3 puncta counts.
As can be discerned form Figure 3.8B, the Atg5 puncta population is also significantly reduced after mis-
localization of FKBP’-Beclin1, Atg14L or the Vps34-specific nanobody, while TMP addition or knock off
of FKBP’ had no impact. The effect is consistent, even in the presence of BafilomycinA1. This confirms
our previous conclusion that knock off of PI3K bait proteins leads to mislocalization of endogenous PI3K
proteins and inhibits their localization-dependent function in autophagosome formation.
Compared to results obtained by others with PI3 kinase inhibitors or knock down of PI3K complex pro-
teins, the reduction of autophagic activity achieved by PI3K protein knock off is in a similar range of
50 to 60 % . Wu and co-workers, for instance, reported a 70 % decrease of the GFP-LC3 puncta number
in MEFs after three hours treatment with the PI3 kinase inhibitor Wortmannin 244 and Blommart et al.
observed a 80 to 90 % reduction of autophagosomes in rat hepatocytes after exposure to wortmannin or
LY294002, another PI3 kinase inhibitor 245. This was later confirmed by the Condongo lab, who reported
a similar effect in HT-29 cells 246. However, wortmannin and LY294002 are not specific for the class III
PI3 kinase Vps34 and target all PI3 kinases, which might cause unwanted side effects and lead to more
severe autophagy disruption. In contrast, knock down of PI3K proteins is very specific and might be
more comparable to protein knock off, especially since no specific inhibitors for the PI3K proteins have
been reported yet. Matsunaga and colleagues knocked down Atg14L in A549 cells and observed a 50 %
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Figure 3.8: Knock off of PIK3 complex proteins perturbs autophagosome formation. Cells were starved in EBSS
and/or treated with SLF’-TMP, TMP or BafilomycinA1 for 2 hours. Error bars: weighted mean ± SEM (n≥ 60);
** = p≤ 0.01; *** = p≤ 0.001; statistical significance was determined by pairwise comparison to the starvation condi-
tion; data was normalized against the fed condition. A The amount of EGFP-LC3 puncta is significantly decreased
after knock off of FKBP’-Beclin1, -Atg14L and -anti-Vps34 nanobody in the presence or absence of BafilomycinA1.
Mislocalization of FKBP’ alone shows no effect. B Mislocalization of FKBP’-Beclin1, -Atg14L and -anti-Vps34
nanobody, but not FKBP’, causes a significant decrease of Atg5-labeled puncta in the presence or absence of
BafilomycinA1. This is a strong indication that knock off of PI3K complex proteins severely disturbs autophago-
some formation.
decrease in the GFP-LC3 puncta number 228, which is in agreement with results by Zhong et al. show-
ing that Atg14L knock down causes a 40 % reduction in the degradation of long-lived proteins in NIH
3T3 cells 229. Itakura and co-workers showed that knock down of Atg14L or Vps34 reduced the GFP-LC3
puncta number by approximately 70 % in Hela cells 4, while Kim et al. reported a 50 % reduction after
Beclin1 knock down in HT22 hippocampal cells 247. Xing et al. found a similar effect of Beclin1 knock
down in neuronal cells 248. Hence, PI3K protein knock off is equally efficient as protein knock down or
inhibitor treatment, but much more specific than PI3K inhibitors and less technically challenging then
protein knock down. Here, a substantial reduction of autophagic activity was achieved within two hours,
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which is on a similar time scale as most inhibitor treatments, but much faster than gene silencing. How-
ever, since dimerization of FKBP’ and eDHFR domains takes only seconds, we assumed that autophagy
disruption can be achieved within a much faster time frame and proceeded to study the dynamics of
PI3K protein knock off further.
3.2.2 Dynamics of Autophagosome Formation
The previous analysis established that autophagosome biogenesis can be modulated with the knock off
and on system, so we focussed on the temporal and functional aspects of autophagy modulation next.
We initially analyzed the dynamics of Beclin1 perturbation and the resulting reduction of EGFP-LC3
puncta and then turned to a more specific PI3K complex marker, WIPI2b.
First, the speed of SLF’-TMP induced FKBP’-Beclin1 translocalization from the cytoplasm to the plasma
membrane (PM) was quantified by monitoring the mean fluorescence intensity (MFI) at the plasma
membrane by confocal microscopy. mCherry-FKBP’-Beclin1 and EGFP-eDHFR-CAAX were introduced
into MCF7 cells, dimerization was induced by SLF’-TMP and the ratio of mean fluorescence intensity in
the cytoplasm and at the plasma membrane was determined every minute for half an hour. Afterwards,
FKBP’-Beclin1 re-localization was triggered by TMP addition and the MFI was monitored for another 10
minutes. Simultaneously, the amount of EGFP-LC3 puncta was quantified as described before.
The analysis showed that the cytoplasmic pool of FBKP’-Beclin1 was completely translocalized to the
plasma membrane within 10 minutes after dimerizer addition and dissociated from the plasma mem-
brane at the same rate upon addition of TMP (see Figure 3.9). Autophagosome formation, however, is
effectively inhibited within 6 minutes of FKBP’-Beclin1 mislocalization and completely restored within
4 minutes of competitor addition. This indicates that modulation of about 60 to 70 % of the exoge-
nous FKBP’-Beclin1 population is sufficient to disrupt or restore autophagosome formation. These re-
sults demonstrate that the knock off/on approach is suitable to disrupt autophagosome formation on
a minute time scale, which is much faster than the traditional knock down/out approach and makes it
possible to study the dynamics of autophagosome formation. In order to test whether we can indeed
detect differences in the time line of autophagy disruption after knock off of individual PI3K complex
proteins, we employed the PI3K activity marker WIPI2b in subsequent analysis.
WIPI2b belongs to an ancient seven-bladed β-propeller protein family and has been proposed to
bridge PI3P generation and LC3 lipidation 249. It is a PI3P effector, which is essential for LC3 lipida-
tion and specifically binds to Atg16L, supposedly to recruit the Atg5-12-16L complex to the forming
phagophore 233. WIPI2b puncta counts have been employed to quantify early autophagy events (up-
stream of Atg5-12-16L) in previous studies, mostly using stable EGFP-WIPI2b U2OS or HEK293A cell
lines. Here, we followed a protocol provided by the Ktistakis lab and immunostained endogenous
WIPI2b in MCF7 cells transiently transfected with TagBFP-eDHFR-CAAX and a mCherry-FKBP’-tagged
PI3K bait protein 250. Stable EGFP-WIPI2b HEK293A cells were tested as well, but even after prolonged
starvation the dynamic range was not large enough to detect differences in the amount of autophagic
puncta. MCF7 cells showed an ample amount of endogenous WIPI2b puncta after moderate starvation
and were used for subsequent experiments. The cells were starved for 2 hours before SLF’-TMP induced
dimerization and then the amount of puncta was monitored in two-minute-intervals for half an hour.
Figure 3.10 displays the dynamics of autophagy inhibition after knock off of FKBP’, FKBP’-Beclin1,
FKBP’-Atg14L and the anti-Vps34 nanobody. As expected, knock off of FKBP’ alone had no impact
on WIPI2b puncta formation (Figure 3.10 A). Perturbation of Beclin1 or its interaction partners (Fig-
ure 3.10 B/C) led to a depletion of WIPI2b structures within 4 to 8 minutes. The half-time was estimated
64
Figure 3.9: Dynamics of Beclin1 knock off. EGFP-LC3-MCF7 cells expressing mCherry-FKBP’-Beclin1 were starved
in EBSS for 4 hours and then treated with SLF’-TMP and TMP. Error bars: weighted mean ± SEM (n≥ 20). A FKBP’-
Beclin1 is completely mislocalized to the plasma membrane after 10 minutes SLF’-TMP treatment and the EGFP-
LC3 puncta number is reduced. After 10 minutes exposure to TMP, FKBP’-Beclin1 re-localizes to the cytoplasm and
the EGFP-LC3 puncta level is restored. B Quantification of FKBP’-Beclin1 mislocalization and EGFP-LC3 puncta
number. Translocalization of FKBP’-Beclin1 to the plasma membrane is completed after 10 minutes treatment with
the dimerizer, but autophagosome formation is inhibited within 6 minutes of SLF’-TMP addition. Addition of the
competitor releases FKBP’-Beclin1 back into the cytoplasm within 10 minutes, while autophagic activity is restored
within 4 minutes.
to t1/2 = 3 minutes for FKBP’-Beclin1 and t1/2 = 4 minutes for FKBP’-Atg14L. Interestingly, ectopic plasma
membrane localization of endogenous Vps34 using the nanobody as bait (Figure 3.10 D) led to an im-
mediate halt in WIPI2b puncta formation (t1/2 = 2 minutes). WIPI2b binds to the PI3Ps generated by
Vps34, so it should be most sensitive to disruption of the kinase function. However, Vps34s kinase activ-
ity appeared to be completely abolished after mislocalization to the plasma membrane or by removing
Beclin1 or Atg14L/UVRAG from the PI3K complex. Previous studies showed that 65 % of the cellular
PI3P pool are generated by Vps34 251 and that WIPI2b puncta formation is PI3P-dependent 233,252. Our
results suggest that the autophagosomal PI3P pool was severely diminished within minutes after knock
off in our setup and could not be recovered even 30 minutes after PI3K protein mislocalization. Dooley
et al. further showed that ectopic localization of WIPI2b to the plasma membrane is sufficient to attract
the Atg12-5-16L complex, induce LC3 lipidation and generate phagophore-like structures 233. However,
formation of WIPI2b structures was not observed at the plasma membrane after knock off so that it ap-
pears unlikely that PI3P generation is reestablished at the plasma membrane.
Interestingly, perturbation of different PI3K complex components led to distinct patterns of autophagy
inhibition. Mislocalization of endogenous Beclin1, i.e. knock off of Atg14L, caused a partial disrup-
tion of WIPI2b puncta formation, whereas perturbation of Beclin1s binding partners or endogenous
Vps34 completely inhibited autophagosome formation. These results suggest that the Beclin1-Atg14L
heterodimer regulates Vps34 activity and PI3P production at the autophagosome formation site. It has
been reported by Zhong and others that Atg14L enhances Vps34 activity in a Beclin1-dependent man-
ner 229,253,254, but our results indicate that Vps34 is only fully functional within the PI3K complex. This is
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Figure 3.10: Knock off of PIK3 complex proteins perturbs formation of WIPI2b-labeled autophagosomes. MCF7
cells were starved in EBSS for 2 hours and then treated with SLF’-TMP. Error bars: weighted mean ± SEM (n≥ 20);
* = p≤ 0.05, ** = p≤ 0.01; statistical significance was determined by student’s t-test against the starvation condition;
data was normalized against the fed condition. A Mislocalization of FKBP’ alone has no effect on WIPI2b puncta
formation. B FKBP’-Beclin1 knock off causes a significant reduction of WIPI2b puncta within 4 minutes after dimer-
izer addition. C -Atg14L knock off. D The amount of WIPI2b puncta is significantly decreased within 2 minutes after
knock off of FKBP’-anti-Vps34 nanobody.
in agreement with insights obtained from a recently published study on the structure of the UVRAG-
containing PI3K complex. Here, the kinase activity of the yeast p150-Vps34 dimer was significantly
lower than the activity of the complete PI3K complex and deletion of Vps34s only contact with the Be-
clin1/UVRAG dimer, the CBR1 loop, resulted in a phenotype similar to Vps34 deletion (see Figure 3.11) 5.
Interestingly, mislocalization of endogenous Beclin1 (see Figure 3.10 C) has a less impact on WIPI2b
puncta formation than knock off of Belcin1 interaction partners. This could denote a hierarchy within
the PI3K complex in which Beclin1 is least important for PI3P production.
The distinct time lines of autophagy disruption for the individual bait proteins support this hypothe-
sis. In our setup, mislocalization of endogenous Vps34 perturbed autophagosome formation the fastest,
followed by the Beclin1 interactome (most likely Atg14L or UVRAG) and Beclin1 alone. However, it re-
mains questionable, whether we can deduce a hierarchical order of PI3K complex protein function from
the chronological order of autophagy inhibition. Vps34 is certainly most important for PI3P production,
which is in keeping with our observations, but without further evidence it appears presumptuous to
conclude that Atg14L or UVRAG are more meaningful to Vps34 function than Beclin1. Problematic in
our setup are the fast kinetics of autophagy inhibition and protein knock off making it technically chal-
lenging to monitor the events in real time. One simple possibility to slow down the knock off process
and stretch the dynamic range would be to apply less dimerizer. Alternatively one could perform the
experiment in live cells with a photoinducible dimerizer. Another option may be to slow down cellular
processes by lowering the surrounding temperature. This would minimize the chance that the detected
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Figure 3.11: Structure of yeast Vps34 in the UVRAG-containing PI3K complex by Rostislavleva et al. 5. A Vps34s
distinct structural features (C2HH and CBR1 loop). B The Vps34 CBR1 loop binds yeast Beclin1/UVRAG CC2. This
is similar to the CBR1 loop of class IA PI3Ks contacting the coiled coil (iSH2 CC) of the regulatory subunit. C Effects
of Vps34 C2 mutants on temperature-sensitive growth. Deletion of Vps34 C2, C2HH or CBR1 prevents growth at
37 ◦C as opposed to full-length Vps34 (FL) or the wild type strain.
temporal differences are merely due to varying cell culture or fixation conditions and may allow to de-
termine the order of events more reliably.
Taken together, the results presented here show that autophagy can be modulated on a time scale of sec-
onds to minutes with the knock off and on approach. Given the right methodological setup, this makes
it feasible to determine not only the hierarchical, but also the spatiotemporal relationship of individual
autophagy proteins or protein complexes. Using WIPI2b as a marker, we could further show that the
PI3K complex proteins are functionally dependent on each other and potentially also on the cellular
environment.
3.2.3 Dynamics of Autophagosome Formation and Maturation
After characterizing the effect of PI3K complex protein mislocalization on autophagosome formation,
we focussed on maturation and autophagy flux. To this end we employed an assay developed by Kimura
et al. The approach is based on tandem mCherry-EGFP-labeled LC3 and exploits the pH sensitivity of
EGFP to distinguish between autophagosomes and autolysosomes 255. Typically, lysosomes feature a
pH value of 4 to 5. Due to differences in their chromophores, mCherry fluorescence is stable at pH
values below 5, while EGFP fluorescence is quenched in acidic environments. Accordingly, autophago-
somes are labeled by both fluorescent proteins and appear yellow, whereas autolysosomes display only
mCherry fluorescence and appear red. Thus, an increased number of yellow and red puncta indicates
increased autophagy flux. A decreased number of yellow puncta without concomitant decrease of red
puncta suggests that lysosomal turnover is blocked, while the opposite scenario indicates inhibition of
autophagosome maturation. Based on these patterns, one can apply the tandem LC3 assay to distin-
guish between autophagy inhibitors and inducers or determine the time point of autophagy modula-
tion. Here, we employed this approach to further characterize the effect of PI3K protein knock off on
autophagy flux.
Initially, we performed a preliminary experiment to evaluate the mCherry-EGFP-LC3-MCF7 cell line, the
fixation method and the quantification approach. Especially the immunofixation protocol is critical in
this assay, since many fixation reagents are basic or neutral and can alter the pH value of the cellular
environment. This could dequench EGFP in the lysosome and cause unwanted artifacts. To avoid this,
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the immunofixation was carefully optimized prior to conducting any analysis. Afterwards, HA-tagged
FKBP’ and FKBP’-Beclin1 were introduced into the stable cells and autophagy was induced by starva-
tion. Simultaneously, the cells were treated with dimerizer, competitor or BafilomycinA1. Finally, the
amount of autophagosomes and autolysosomes was quantified using an ImageJ macro specifically de-
signed for the purpose (see section A.1.2).
As shown in Figure B.8, the cells responded as expected to nutrient starvation, knock off/on or
BafilomycinA1 treatment. The amount of autophagosomes and autolysosomes increased after starva-
tion and was significantly decreased after Beclin1 mislocalization, but remained constant upon FKBP’
knock off. Addition of TMP restored autophagy in cells expressing FKBP’-Beclin1, but did not affect
the control cells. Upon BafilomycinA1 treatment, the amount of autophagosomes was substantially
increased in both setups, while the amount of autolysosomes remained similar to fed conditions. As
BafilomycinA1 blocks lysosomal fusion, this phenotype was expected and confirms that the chosen fix-
ation conditions and quantification approach were appropriate.
Since the results suggested that the tandem LC3 assay was functional, we proceeded to study the dynam-
ics of Beclin1 mislocalization. In order to achieve a better temporal resolution, autophagy was induced,
Beclin1 was knocked off by dimerizer addition and the amount of autophagic vesicles was monitored
every two minutes for half an hour. As a negative control, the analysis was also performed with FKBP’
alone. As shown in Figure 3.12, knock off of FKBP’ alone had no impact on the autophagosome forma-
tion pattern or lysosomal turnover. The amount of both populations increased over time, which is due
to the permanent starvation signal.
Knock off of Beclin1, however, almost immediately halted the generation of autophagosomes. This was
accompanied by a substantial decrease in autolysosomes, approximately 10 minutes later. The reduc-
tion of autolysosomes is probably to due to the reduced supply of autophagosomes. If autolysosomal
turnover was impaired by Beclin1 mislocalization as well, the autolysosome number should increase
further and eventually remain constant. If the turnover rate was accelerated by Beclin1 mislocalization,
the autolysosome number should drop immediately. These results confirm that mislocalization of en-
dogenous Beclin1 interaction partners indeed affects autophagosome formation, but not maturation.
This is in keeping with data from previous EGFP-LC3 and -Atg5 puncta counts (see Figure 3.8) and also
agrees well with the results of the WIPI2b puncta counts (see Figure 3.10). Knock off of Beclin1 inhib-
ited WIPI2b puncta formation within a similar time frame and to a similar degree as observed for the
autophagosome population in the tandem LC3 assay.
The tandem LC3 assay also gives some indication about the lifetime of autophagic structures. After
autophagosome formation is inhibited by knock off, it takes about 10 to 15 minutes before the major-
ity of autolysosomes is degraded (see Figure 3.12B). Several studies reported autophagosomal lifetimes
of 30 to 40 minutes, depending on the cell lines and starvation conditions 52,54,256,257,258. However, our
assay does not represent the whole autophagosomal lifetime. Since Beclin1 knock off re-routes inter-
acting proteins from forming autophagosomes in all stages, we can only speculate about the fate of
these structures afterwards. It remains questionable, whether PI3K complex proteins are required for
closure of autophagosomes, what triggers closure and whether autophagosomes can be closed regard-
less of their size. Several studies suggested that removal of LC3 and PI3Ps from the outer membrane
of the closed autophagosome triggers the dissociation of Atg proteins and initiates transport and fu-
sion 259. As mislocalization of PI3K complex proteins disrupts PI3P generation and LC3 recruitment is
ultimately dependent on PI3P effectors, knock off of Beclin1 could have a similar effect. Yet, it appears
unlikely that every autophagosomes is fit to mature when Beclin1 mislocalization occurs. Furthermore,
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Figure 3.12: Knock off of FKBP’-Beclin1 perturbs formation of autophagosomes. mCherry-EGFP-LC3-MCF7 cells
were starved in EBSS for 2 hours and then treated with SLF’-TMP for up to 30 minutes. Error bars: weighted mean
± SEM (n≥ 40); ** = p≤ 0.01; statistical significance was determined by student’s t-test against the starvation condi-
tion; data was normalized against the fed condition. A Mislocalization of FKBP’ alone has no effect on autophago-
some or autolysosome formation. B FKBP’-Beclin1 knock off causes a significant decrease of autophagosome num-
ber within 2 minutes after dimerizer addition. The amount of autolysosomes decreases with a delay of 10 minutes,
supposedly due to the lowered supply of autophagosomes.
membrane curvature is a crucial factor in autophagosome elongation and closure. The Atg12-5-16L or
LC3-PE complexes, for instance, bind to the highly curved membrane or rim of the phagophore, but not
to the flat membrane of the mature autophagosome 260,261,262. Membrane curvature is, among other
factors, dependent on membrane length. Thus, it is likely that the autophagosomal membrane has to
overcome a certain threshold before closure is even possible. Since autophagosomes are not generated
in a synchronized fashion, only a fraction of autophagic structures can reach this threshold before Be-
clin1 is mislocalized and membrane elongation is interrupted. Hence, the delay between inhibition of
autophagosome formation and clearance of autolysosomes we observed here, is probably more repre-
sentative for the average time between autophagosome closure and complete lysosomal degradation.
It would be interesting to determine the disposition of the unclosed autophagic structures, but this can
only be achieved with electron or super-resolution microscopy and remains technically challenging.
One could, however, perform the tandem LC3 assay with autophagic proteins representative for specific
autophagy phases, such as mTORC1, ULK1 or Atg16L and compare the time span between inhibition of
autophagosome generation and completion of lysosomal degradation. If differences are detectable, this
could yield further information about dynamics of autophagosome maturation.
Taken together, the tandem LC3 assay delivered valuable information about the impact of Beclin1 mis-
localization on autophagy flux. It confirmed that Beclin1 knock off rapidly perturbs autophagosome for-
mation and the results are in agreement with previous experiments. Further, the approach is a valuable
addition to the toolbox of autophagy assays, as it allows to monitor the impact of autophagy modulation
on autophagosomes and autolysosomes simultaneously.
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3.3 UVRAGs Function in Autophagy
A major obstacle in studying autophagy is the highly dynamic nature of autophagosome formation and
the accordingly short lifetime of autophagosomes. While traditional techniques like gene knock out or
knock down delivered valuable information about hierarchical relationships and spatial distribution of
autophagy proteins, they failed to capture the temporal context 263. An example for the limitations of
chronic perturbations is the current debate about the elusive role of UV radiation resistance-associated
gene protein (UVRAG) within the autophagy process.
UVRAG was first described in 1990 as cDNA, which partially complements the UV sensitivity of xero-
derma pigmentosum cells 264. More than a decade later, Liang et al. identified UVRAG as Beclin1 in-
teraction partner and suggested a role within the autophagic pathway 8,265. In their study Liang and co-
workers observed that autophagosome formation was enhanced by UVRAG overexpression in a Beclin1-
dependent manner and severely reduced by UVRAG knockdown. This led to the conclusion that Beclin1
and UVRAG induce autophagy cooperatively. Two years later, Liang et al. reported further that UVRAG
associates with endosomes and enhances autophagosomal maturation by interacting with the homo-
typic fusion and vacuole protein sorting (HOPS) complex. Thus, they proposed two distinct functions
of UVRAG within the autophagy process: Beclin1-dependent induction of autophagosome formation
and C-Vps-dependent promotion of lysosomal fusion 9. Shortly after, Itakura et al. reported that UVARG
knock down had no effect on autophagosome formation and suggested that UVRAG functions only in
autophagosome maturation 4. Supporting this notion, they also discovered that Atg14L and UVRAG
bind mutually exclusive to Beclin1s CCD domain to generate two distinct PI3K complexes, containing
either Atg14L or UVRAG. Since Atg14L had been functionally associated with autophagosome formation
in several studies before, Itakura and co-workers proposed a model in which Atg14L initially occupies
the common Beclin1 binding side to induce autophagosome formation and is then replaced by UVRAG
to promote autophagosome maturation. Contradicting this model, He et al. recently observed that
UVRAG binds PI3Ps through its C2-domain and is then localized to the ER. Here it interacts with the
RINT-1 containing ER-tether to control Golgi-to-ER COPI transport 10. They suggested that UVRAG dis-
sociates from the tether upon autophagy induction to cooperate with Beclin1 and PI3Ps to initiate Atg9
trafficking. UVRAG has been associated with Atg9 trafficking before 266, as part of the Bif1-containing
PI3K complex, but He and co-workers first observed that UVRAG depletion impaired Atg9 translocaliza-
tion to punctate structures.
Recently, an additional autophagy-related activity of UVRAG was uncovered by Ganley and colleagues.
They studied the involvement of the UVRAG-containing PI3K complex in autophagosome-lysosome ref-
ormation and identified UVRAG as a target of mTOR1 phosphorylation 267. They observed that Vps34
activity was enhanced to prevent lysosomal tubulation in response to mTORC1-mediated phosphory-
lation of UVRAG, while trafficking processes prior to lysosomal fusion remained unimpaired. This sug-
gests a function of the UVRAG-PI3K complex in lysosomal fusion or recovery.
Finally, the recently solved structure of the UVRAG-containing PI3K complex from yeast further indi-
cated different roles of the two PI3K complexes, rather than redundant functions of Atg14L and UVRAG 5.
Here, the kinase activity of the different PI3K complexes on small and large vesicles was compared.
While the activities on small vesicles were similar, the UVRAG-PI3K complex showed a substantially
higher activity on giant, low-curvature vesicles. This might relate to its function on endosomal mem-
branes or closed autophagosomes, and would suggest a model in which Atg14L and UVRAG exhibit
complementary roles in autophagosome formation and maturation, respectively.
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Besides its function in autophagy, UVRAG is involved in various other processes, such as maintaining
genomic stability, retrograde Golgi-ER transport and many other vesicular trafficking or fusion pro-
cesses 10,11,12,268. This makes it even more difficult to pinpoint its exact role in autophagy, since vesicular
transport pathways are naturally intertwined 13. From a methodological point of view, the controversy
about UVRAGs function in autophagy further highlights, that traditional techniques like knock down or
out have certain limitations, which could be compensated by using an inducible dimerization system.
Therefore, we employed the knock off and on system to rapidly mislocalize UVRAG to the plasma mem-
brane and disrupt its localization-dependent function. Afterwards, we used the previously introduced
autophagy assays to study the effect of UVRAG knock off on autophagosome progression.
3.3.1 Generation of an UVRAG-specific Beclin1
In order to specifically perturb endogenous UVRAG, we created a UVRAG-specific version of Beclin1
that is deficient in Atg14L-binding. Different strategies to disrupt the Beclin1-Atg14L interaction, like
point mutations or truncations, were explored. Interaction of the resulting Beclin1-constructs with
Atg14L/UVRAG was analyzed by confocal microscopy and co-immunoprecipitation as described be-
fore. Typically, the modified FKBP’-Beclin1 was knocked off to the plasma membrane of MCF7 cells and
co-localization with UVRAG or Atg14L was probed by confocal imaging or western blotting. To quantify
the imaging data, the mean fluorescence intensity (MFI) at the plasma membrane and in the cytoplasm
was calculated and normalized to the bait.
Based on a study by Li et al. we initially replaced one to four charged residues in the coiled coil domain
of Beclin1 by leucine, which supposedly yields a more stable Beclin1 homodimer and should prevent
Atg14L binding while maintaining interaction with UVRAG 269.However, contrary to what Li et al. ob-
served, the first two point mutations did not significantly disrupt Beclin1-Atg14L interaction and even
the triple or quadruple mutations failed to disrupt the interaction completely (see Figure 3.14A). In fact,
the co-immunoprecipitation data indicates that the point mutations rather decreased Beclin1s affinity
for UVRAG, while Atg14L binding was left unaffected. The imaging data shows that after dimerizer addi-
tion, the MFI of the FKBP’-bait proteins is about three times higher at the plasma membrane than in the
Figure 3.13: Structure of Beclin1, modified from Fuet al. 270 and Rostislavleva et al. 5. Beclin1 contains three identi-
fied domains, the BH3 domain, the CCD and the ECD. Atg14L and UVRAG interact with Beclin1 via its CCD domain.
To generate UVRAG-specific Beclin1-U, the CCD domain was truncated at 143-243aa and the remaining domains
were re-connected with a flexible linker.
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Figure 3.14: Interaction of Beclin1-U and Atg14L or UVRAG in MCF7 cells after 2 hours starvation in EBSS and
30 minutes treatment with SLF’-TMP. A FKBP’-Beclin1-U cannot mislocalize Atg14L to the plasma membrane sug-
gesting that the construct is deficient in Atg14L binding. FKBP’-Beclin1-U attracts UVRAG to the plasma membrane
indicating that UVRAG binding is maintained regardless of the truncation. B FKBP’-Beclin1∆CCD cannot attract
Atg14L or UVRAG to the plasma membrane.
cytoplasm (see Figure 3.14B). If wild type Beclin1 is used as bait, the MFI of Atg14L and UVRAG is about
two times higher at the plasma membrane indicating that most of the prey proteins were depleted from
the cytoplasm. In keeping with the co-immunoprecipitation results, the MFI of Atg14L/UVRAG is also
1.5 - 2.5× higher at the plasma membrane if mutated Beclin1 is employed as bait, whereas it is substan-
tially reduced for the non-binding control, i.e. FKBP’ alone (see Figure 3.14 A). This confirms further,
that the point mutations suggested by Li et al. do not prevent Beclin1-Atg14L interaction.
Thus, we proceeded to truncate the CCD of Beclin1 starting at the N-terminal and re-connected the
remaining fragments via a flexible glycine-serine linker (see Figure 3.13). Since Beclin1’s evolutionary
conserved domain (ECD) and the CCD overlap 271, part of the ECD was also truncated in the initial ex-
periments (see Table 3.2). The constructs were tested in the same manner as described before and it
turned out that truncating part of the CCD (143-234 aa or 143-266 aa) prevented binding of Atg14L, but
merely weakened UVRAG interaction. As shown in Figure 3.14, Beclin1∆143-234 (Beclin1-U) shows sim-
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Table 3.2: Co-localization of exogenous FKBP’-bait proteins and potential prey proteins at the plasma
membrane of MCF7 cells. Autophagy was induced by starvation in EBSS and the cells were treated with
SLF’-TMP for at least 30 minutes.
BAIT/PREY Atg14L Interaction UVRAG Interaction
Beclin1∆143-234 × 
Beclin1∆143-266 × 
Beclin1∆143-272 × ×
Beclin1∆265-271 (A)  
Beclin1∆171-272 × ×
Beclin1∆201-272  
Beclin1∆235-272  
Beclin1∆328-394  
Beclin1_1-142 × ×
Beclin1_1-234  
Beclin1_1-272  
Beclin1_267-451 × ×
Beclin1_1-144 228 × ×
Beclin1_88-272 228  
Beclin1_142-272 228  
Beclin1_273-450 228 × ×
Beclin1_1-148 229 × –
Beclin1_86-267 229  –
Beclin1_142-267 229  –
Beclin1_142-335 229  –
Beclin1_242-448 229 × –
Beclin1_176-266 269  
ilar MFI ratios for Atg14L as FKBP’ alone and cannot be pulled down by EGFP-Atg14L, but is readily by
EGFP-UVRAG. In addition, UVRAG co-localizes well with Beclin1-U at the plasma membrane of MCF7
cells after dimerizer addition (see Figure B.9). The MFI ratio of UVRAG is in a similar range as that of
Beclin1 indicating that UVRAG-binding is maintained in the truncated construct. Truncation of the
whole CCD (143-272 aa) abolished binding of both Atg14L and UVRAG, suggesting that the C-terminal
region of Beclin1s CCD is crucial for interaction with UVRAG. This was later confirmed when the struc-
ture of the UVRAG-containing PI3K complex was reported 5 and showed that Beclin1 and UVRAG inter-
act along their entire length, but that their CCDs from a heterodimer stabilizing the interaction. Since
Beclin1∆143-234, termed Beclin1-U, served our purpose best, it was employed to specifically mislocal-
ize UVRAG and study the effect on autophagosome formation.
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3.3.2 Generation of an Atg14L-specific Beclin1
To distinguish between the effects of UVRAG and Atg14L knock off, we also attempted to generate a
Atg14L-specific Beclin1, which is deficient for interaction with UVRAG. Based on our previous observa-
tion that the C-terminal region of Beclin1s CCD domain is involved in UVRAG binding, Beclin1s CCD
was truncated from the C-terminal to perturb Atg14L binding. The resulting constructs were analyzed
by confocal microscopy.
Unfortunately none of the modified Beclin1 baits was specific for Atg14L alone. As show in Table 3.2,
truncating the C-terminal part of the CCD (235-272 aa or 201-272 aa) did not affect Atg14L- or UVRAG-
binding, while truncation of 171-272 aa abolished interaction with both proteins. Modification of the
flexible loop between Beclin1s CCD and ECD had also no effect and the BH3 domain (1-142 aa) or ECD
(267-451 aa) alone were not sufficient for Atg14L or UVRAG interaction. Based on a report by Cheng et
al., Beclin1 was additionally truncated at 328-394 aa to yield the splice variant BECN1s, which is sup-
posedly specific for Atg14L. However, confocal microscopy showed that all BECN1s constructs can still
attract UVRAG to the plasma membrane, indicating that the Beclin1-UVRAG interaction is not substan-
tially perturbed in these constructs.
A high-resolution structure of the Atg14L-containing PI3K complex is not available yet, but the domain
organization and length of the CCD domain of UVRAG and Atg14L are similar, suggesting that the inter-
action of Atg14L with Beclin1 is similar to UVRAG 5. Furthermore, Li et al. determined that UVRAG binds
with higher affinity to Beclin1 (Kd = 0.24± 0.06µM) than Atg14L (Kd = 3.22± 0.95µM) and proposed that
UVRAG is able to disrupt the Beclin1-Beclin1 homodimer, while Atg14L is not 269. Consequently, it may
not be possible to perturb the Beclin1-UVRAG interaction and simultaneously preserve Atg14L-binding.
Thus, we abandoned the idea to employ an Atg14L-specific Beclin1 as bait in the knock off/system. How-
ever, as previously demonstrated, nanobodies can be conveniently combined with the knock off/on ap-
proach, so that an anti-Atg14L nanobody could be a reasonable alternative to Beclin1 as bait. Unfortu-
nately, an anti-Atg14L-nanobody is not commercially available yet and since generation of customized
nanobodies is still rather costly, this approach was not pursued.
3.3.3 UVRAGs Function in Autophagosome Formation and Maturation
To further characterize UVRAG’s function in autophagy, we used the UVRAG-specific Beclin1-U as bait
to mislocalize endogenous UVRAG and study the effect on autophagosome formation and maturation.
EGFP-LC3, -Atg5 and WIPI2 were employed as markers for autophagosome formation in different stages.
In addition, the EGFP-mCherry-LC3 assay was utilized to dissect the dynamics of autophagosome gen-
eration and maturation.
Initially, FKBP’-Beclin1-U was introduced into stable EGFP-LC3-MCF7 or EGFP-Atg5-MCF7 cells and
autophagy was induced by starvation. Simultaneously, knock off was induced or prevented by addition
of SLF’-TMP and TMP, respectively. As an additional control, the experiments were performed in the
presence and absence of BafilomycinA1. Finally, the amount of autophagic puncta was quantified as
previously described.
As shown in Figure 3.15A, perturbation of endogenous UVRAG reduced the amount of EGFP-LC3 puncta
significantly. The effect is independent of BafilomycinA1 treatment and phenotypically similar to knock
off of Beclin1 or Atg14L. This suggests that UVRAG is required during autophagosome formation, but
gives no indication about the exact time point. Thus, we used the isolation membrane marker EGFP-
Atg5 to investigate whether UVRAG re-routing affects the very early stages of autophagosome forma-
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Figure 3.15: Knock off of endogenous UVRAG perturbs late stages of autophagosome formation. Cells were starved
in EBSS and/or treated with SLF’-TMP, TMP or BafilomycinA1 for 2 hours. Error bars: weighted mean ± SEM
(n≥ 60); ** = p≤ 0.01; *** = p≤ 0.001; statistical significance was determined by pairwise comparison to the star-
vation condition; data was normalized against the fed condition. A The amount of EGFP-LC3 puncta is significantly
decreased after knock off of FKBP’-Beclin1-U and in the presence or absence of BafilomycinA1. Mislocalization of
the remaining PI3K bait proteins has a similar effect, while knock off of FKBP’ alone shows no effect. B Mislocaliza-
tion of FKBP’-Beclin1, -Atg14L and -anti-Vps34 nanobody, but not Beclin1-U or FKBP’, causes a significant decrease
of Atg5-labeled puncta in the presence or absence of BafilomycinA1. This is a strong indication that UVRAG is not
participating in early autophagosome formation.
tion. Interestingly, Beclin1-U knock off had no significant impact on Atg5 puncta formation, regardless
of BafilomycinA1 treatment (see Figure 3.15B). This implies that UVRAG is either not involved in forma-
tion of the isolation membrane or that its function is redundant. To explore this in more detail, we then
evaluated the dynamics of WIPI2b puncta formation in response to UVRAG perturbation. WIPI2b marks
an even earlier stage of isolation membrane formation than Atg5 and is specific for the autophagosomal
PI3P (see section 3.2.2).
As displayed in Figure 3.16 and B.10A, WIPI2b puncta formation is not impaired by Beclin1-U knock
off either. In fact, the phenotype after Beclin1-U knock off is almost identical to the control conditions,
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Figure 3.16: Knock off of Beclin1-U has no effect on WIPI2b puncta formation. MCF7 cells were starved in EBSS
for 2 hours and then treated with SLF’-TMP for up to 30 minutes. Error bars: weighted mean ± SEM (n≥ 20); data
was normalized against the fed condition. Mislocalization of Beclin1-U has no effect on WIPI2b puncta formation,
similar to FKBP’ alone. Knock off of the remaining PI3K bait proteins causes a significant reduction of WIPI2b
puncta. This supports the previous observation that UVRAG is not necessary for early autophagosome formation.
where only FKBP’ was re-routed to the plasma membrane. This further supports the notion that UVRAG
is not involved in isolation membrane formation, but participates in a later stage of autophagosome
formation or fusion.
Next, we employed the tandem LC3 assay to monitor the dynamics of autophagosome formation and
maturation. Autophagy was induced, Beclin1-U was knocked off and the yellow and red puncta popu-
lations were monitored every two minutes for half an hour (see Figure 3.17). Intriguingly, the autolyso-
some population was instantly affected by UVRAG mislocalization and dropped significantly within two
minutes of dimerizer addition. Within four minutes, the amount of autolysosomes was reduced to the
basal level and continuously decreased over the course of 30 minutes. The autophagosome population,
on the other hand, showed a gradual decline over the whole observation period and was only signif-
icantly decreased after 8 minutes. However, dimerizer addition immediately reduced the autophago-
some population, suggesting that UVRAG mislocalization directly affects autophagosome generation.
Preliminary experiments further showed that autophagosome formation is not recovered for at least
two hours after knock off (see Figure B.10B).
The results generated by the tandem LC3 assay can be translated into two scenarios. In the first scenario,
UVRAG exhibits a vital function during autophagosome maturation and formation, which is impaired
by knock off. Alternatively, UVRAG negatively regulates autolysosome turnover, so that mislocalization
accelerates autolysosome clearance. The latter model is supported by the rapid reduction of the au-
tolysosome population instantly after dimerizer addition. This could indicate that absence of UVRAG
increases the autolysosome formation and turnover rate. Consequently, autophagosomes are processed
faster, while still being generated at the same rate. This would ultimately cause a reduction in the au-
tophagosome population and account for the slow decrease of yellow puncta.
The increased autolysosomal turnover rate might also lead to activation of a feedback loop down-
regulating autophagosome generation, for instance, via mTORC1 re-activation due to sufficient replen-
ishment of amino acids 257. In this model, UVRAG is only involved in autolysosome turnover, but not
in the fusion process, which does not integrate well with previously published data and even our own
observations.
76
Figure 3.17: Knock off of Beclin1-U modulates autophagosome formation and maturation. EGFP-mCherry-LC3-
MCF7 cells were starved in EBSS for 2 hours and then treated with SLF’-TMP for up to 30 minutes. Error bars:
weighted mean ± SEM (n≥ 40); * = p≤ 0.05, ** = p≤ 0.01, *** = p≤ 0.001; statistical significance was determined by
student’s t-test against the starvation condition; data was normalized against the fed condition. A Mislocalization
of endogenous UVRAG causes a significant decrease of autolysosome number within 2 minutes after dimerizer ad-
dition. This is accompanied by a concomitant decrease in the autophagosome population. B Effect of Beclin1-U
knock off on EGFP-mCherry-LC3 puncta formation compared to mislocalization of FKBP’ and Beclin1. Knock off
of FKBP’-Beclin1 perturbs only formation of autophagosomes while mislocalization of endogenous UVRAG causes
a significant decrease in the both populations. Mislocalization of FKBP’ alone has no effect on autophagosome or
autolysosome formation.
In the EGFP-LC3 puncta counts, we observed that UVRAG mislocalization caused a substantial reduc-
tion in the autophagosome population. This was also consistent in the presence of the lysosomal fusion
inhibitor BafilomycinA1, which entirely abolishes formation of autolysosomes. Without BafilomycinA1,
the reduced autophagosome number might be due to the increased turnover rate or a regulating feed-
back loop triggered by UVRAG mislocalization. However, upon BafilomycinA1 treatment, re-routing of
UVRAG should have no effect and autophagosome formation should proceed normally. Since this is
in stark contrast to our observations, it appears unlikely that the reduced autophagosome number is
a consequence of UVRAG negatively regulating autolysosome generation and degradation. Moreover,
several studies have reported a supporting role of UVRAG in membrane fusion and vesicular transport
processes 10,13,266. Thus it would be surprising if UVRAG exhibited a completely opposed function dur-
ing autophagosome maturation, which is essentially a combination of transport and fusion.
In an alternative scenario, UVRAG positively regulates the late stages of autophagosome formation,
transport and fusion with the lysosome. Several studies support this theory. Liang et al. observed
early on that UVRAG interacts with the HOPS complex to activate the small GTPase Rab7 and stimulate
autophagosome-lysosome fusion 9. Sun et al. and others later determined that this interaction is inhib-
ited by Rubicon, which negatively regulates UVRAG in a mTORC1-dependent manner 65,267,272,273. Com-
bination of these results yields the following model: In nutrient-rich conditions, UVRAG is phosphory-
lated by mTORC1. This enhances its interaction with Rubicon, inhibits the lipid kinase activity of Vps34
and prevents UVRAG-HOPS interaction. Upon starvation, mTORC1 is deactivated, UVRAG is dephos-
phorylated and Rubicon is released 273. Dissociation from Rubicon facilitates interaction with Vps16, a
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Figure 3.18: Different roles of UVRAG in autophagosome formation and maturation 65,273,274. A In nutrient-rich
conditions UVRAG interacts with the PI3K complex at the endosome and is phosphorylated by mTORC1. This en-
hances interaction with Rubicon, which prevents activation of the HOPS complex. At the Golgi, UVRAG associates
with RINT-1-containing ER tether and coordinates COPI vesicle transport. B Proposed model for UVRAGs functions
in autophagy. Upon autophagy induction, Bif-1 associates with UVRAG and coordinates fusion with Atg9 vesicles
to support autophagosome formation. In parallel, phosphorylation of UVRAG by mTORC1 is abolished, Rubicon
dissociates from the PI3K complex and UVRAG associates with the HOPS complex. Consequently, HOPS activates
Rab7, which regulates transport and lysosomal fusion of autophagosomes.
subunit of the HOPS complex, and activates Rab7 9,65. Vps39, a component of the HOPS complex serves
as a GEF for Rab7, exchanging GDP for GTP to activate the small GTPase and stimulate its localization
to late endosomes, lysosomes and late autophagosomes 275,276. The active, GTP-bound Rab7 exhibits at
least three autophagy-related functions. First, it binds to Rubicon to sequester it from UVRAG, which
further increases HOPS’ GEF activity and enhances Vps34s kinase activity. Second, GTP-bound Rab7
coordinates autophagosome trafficking by connecting autophagosomes with the microtubule motors
kinesin and dynein through FYCO1 and ORP1L/RILP, respectively 59,275,277,278. Finally, active Rab7 is in-
volved in recruitment of SNARE complexes and tethering factors to promote fusion of autophagosomes
and lysosomes or late endosomes (see Figure 3.18) 279,280,281,282.
Removing UVRAG from this setup would thus prevent activation of Rab7 via the HOPS complex, which
leads to impaired autophagosome trafficking and lysosomal fusion. UVRAG mislocalization should fur-
ther decrease the kinase activity of Vps34 and therefore reduce production of PI3Ps at the autophago-
somal membrane. Since PI3Ps have been shown to attract the tethering factor TECPR1 283 and FYCO1,
which is involved in trafficking, this might further impact autophagosome maturation. Consequently,
UVRAG mislocalization should almost completely abolish maturation of autophagosomes into au-
tolysosomes. This is in agreement with the results of the tandem LC3 assay, where we observed a dra-
matic reduction in the autolysosome population immediately after knock off. Assuming autolysosome
generation is stopped immediately after UVRAG mislocalization, it further implies that previously ex-
isting autolysosomes are cleared within less than four minutes. This is consistent with data by Elrick et
al., who determined that the majority of autolysosomes in human dermal fibroblasts is degraded within
four minutes 284.
However, this does not entirely explain the concomitant reduction of autophagosomes. The Atg5 and
WIPI2b puncta counts showed that UVRAG is probably not involved in early autophagosome forma-
tion, so that UVRAG-dependent autophagy disruption at this point appears unlikely. Re-activation of
mTORC1 or an alternative feedback loop due to a restored nutrient supply is not a satisfying explana-
tion either, as the cells were continuously exposed to starvation and the autolysosomal turnover rate
78
should remain constant. In addition, we observed a severe reduction in the autophagosome popula-
tion in the presence of BafilomycinA1, indicating that UVRAG mislocalization also impairs autophago-
some formation. Consistent with this, Liang et al. reported that the UVRAG-containing PI3K complex
is essential for autophagosome formation and other studies further associated UVRAG with the gener-
ation of Atg9 vesicles from the Golgi apparatus 8. He and co-workers observed that UVRAG positively
regulates the RINT-containing ER tethering complex to coordinate Golgi to ER COPI vesicle transport
in basal conditions. Upon autophagy induction, UVRAG dissociates from the ER tether and joins the
PI3K complex to facilitate Atg9 trafficking 10. Takahashi et al. further determined that Atg9 vesicle for-
mation and trafficking is critically dependent on interaction of the N-BAR-domain-containing protein
Bif-1 with UVRAG in the PI3K complex. Bif-1 co-localizes with Atg9 vesicles, but also the Golgi/TGN and
phagophore initiation sites. Due to its BAR-domain, it might be involved in generation and fusion of
Atg9 vesicles to support autophagosome formation 260,266,285,286. UVRAG mislocalization should abolish
interaction of Bif-1 with the PI3K complex and disturb Atg9 vesicle trafficking and fusion. Since Atg9 is
essential for autophagosome formation, this would explain the decreased autophagosome number in
absence of UVRAG.
Given the collective evidence, we propose a model in which UVRAG is first involved in generation, trans-
port and fusion of Atg9 vesicles to support autophagosome formation and later coordinates trafficking
and lysosomal fusion of the closed autophagosome (see Figure 3.18). How these functions integrate with
each other from a spatiotemporal and regulatory perspective remains to be established. Rubicon and
mTORC1 appear to be essential regulators of UVRAG activity, but based on current knowledge, they only
control part of UVRAGs autophagy-related function. In the future, it would be interesting to dissect this
further. For instance, it might be beneficial to determine whether Atg9 and Bif-1 are affected by UVRAG
mislocalization and how the cellular distribution of mTORC1 and Rubicon changes. The same applies
for Rab7, the HOPS complex or other related fusion factors. The knock off and on system is ideally suited
for analysis like this, as it allows to modulate and monitor cellular events in real time and in live cells. It
may thus be a powerful tool to finally resolve UVRAGs elusive role in autophagy.
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3.4 Spatial Organization of Autophagosome Biogenesis
Aside from targeting proteins to the plasma membrane for autophagy disruption, the knock off and
on system can also be employed to localize proteins to other cellular compartments, such as the ER,
ERGIC, Golgi or mitochondria. All of these compartments have been linked to autophagy as potential
membrane sources or autophagosome formation sites, but the actual origin of the autophagosome re-
mains to be determined (see section 1.1.2.3).
Recently, accumulating evidence promoted the ER as the principle autophagosome formation site. The
Yoshimori and Ktistakis labs, for instance, observed generation of omegasomes, cup-shaped, PI3P-
enriched structures, at the ER membrane 38,39. Most reports agree further, that the autophagosome
originates from omegasomes, which may arise from all ER membranes, including ER exit sites 287
and mitochondria-ER-contact sites 40. In keeping with this, several groups demonstrated membrane
continuity between the ER or the outer mitochondrial membrane and the autophagosomal mem-
brane 40,41,42. However, it has also been shown, that Golgi and ERGIC can contribute lipids to the isola-
tion membrane 43,44 and interact with Atg9-vesicles, which are essential for membrane elongation and
closure in yeast 2,3,37.
To investigate, which compartments are actually involved in the process, we recruited part of the au-
tophagic machinery to the ER, ERGIC, Golgi or mitochondria and studied the effect on autophagosome
formation. Cellular anchors featuring an eDHFR domain were created for each compartment and the
knock off and on system was employed to re-route FKBP’-modified Beclin1 towards the anchor proteins.
The minimal ER targeting domain cytochrome b5 (Cb5) was chosen as the ER anchor 288, ERIG53 for the
ERGIC 289, the Golgi membrane protein Giantin for the Golgi 290 and the bacterial protein ActA for the
mitochondria 291. As shown in Figure B.11, all of the targeting domains could efficiently localize TagBFP-
eDHFR to the respective compartments, where it co-localized well with the specific markers.
In the next step, Beclin1 was re-routed to the cellular anchors and the effect on LC3 puncta formation
was analyzed. mCherry-FKBP’-Beclin1 and the negative control mCherry-FKBP’ were introduced into
EGFP-LC3-MCF7 cells and dimerization or dissociation were induced by addition of SLF’-TMP or TMP,
respectively.
As an initial test, FKBP’-Beclin1 was localized to the ER without induction of autophagy to determine
whether the presence of PI3K proteins attracted by Beclin1 would be sufficient to stimulate autophago-
some formation. However, as shown in Figure 3.19 the number of autophagosomes after Beclin1 mislo-
calization remained similar to control levels and significantly lower than after serum starvation. These
results indicate that autophagosome formation cannot be induced by translocalization of PI3K proteins
alone and suggests that upstream signals are required for successful autophagy initiation.
A potential upstream regulator missing in our setup might be the kinase ULK1, which has been shown
to phosphorylate Beclin1 on Ser14 to enhance the activity of Atg14L-containing PI3K complexes and is
crucial for autophagosome formation 292. In fact, several studies showed that autophagosome biogene-
sis is severely impaired after knock out/down of ULK1 in yeast and mice 294,295,296,297. Moreover, a study
by Itakura and Mizushima analyzing the hierarchy of mammalian Atg proteins during autophagosome
biogenesis showed that Atg14L and ULK1 appear simultaneously at the autophagosome formation site
to generate the phagophore, which then becomes an autophagosome 243,293. It would be of interest to
translocalize both, the ULK1 and PI3K complexes, to the ER and study the effect on autophagy induction
in order the define the minimal core machinery required for autophagosome generation.
In this study, however, we focused on the spatial organization of autophagosome formation. Autophagy
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Figure 3.19: Hierarchy of autophagy protein complexes. A Re-routing PI3K complex proteins to the ER using
FKBP’-Beclin1 as bait. Autophagosome formation was evaluated by quantification of EGFP-LC3 puncta in MCF7
cells and autophagy was induced by 2 h starvation in EBSS. No effect on autophagosome formation could be de-
tected. Error bars: weighted mean ± SEM (n≥ 60). B Order of marker proteins recruited to distinct autophagic
structures based on data obtained in yeast and mammalian cells 293.
was induced by serum starvation in the subsequent experiments and the analysis were extended to
the remaining compartments. As shown in Figure 3.20, no significant effect on LC3 puncta formation
could be detected after re-routing exogenous Beclin1 to the ERGIC, Golgi or mitochondria, whilst the
autophagy level was substantially increased after targeting FKBP’-Beclin1 to the ER in starvation con-
ditions. In combination with the observations from previous experiments showing a severe disruption
of autophagosome formation after mislocalization of PI3K proteins to the plasma membrane, these re-
sults give new insights into the ’hierarchy’ of autophagosome formation sites. The ER appears to be the
principal site of autophagosome biogenesis, while the ERGIG, Golgi and mitochondria can serve as sec-
ondary autophagosome formation sites. Only the plasma membrane cannot serve as autophagosome
initiation site, even in severe starvation conditions.
In the literature, all of these compartments have been proposed as potential membrane source or au-
tophagosome formation site and experimental evidence can be found to support any scenario. Mari
et al. attempted to reconcile the contradictory results in a single model and proposed that the mem-
brane source and autophagosome formation sites are specific to certain tissues, cells types and stress
stimuli 293. Depending on the given conditions, the autophagosome is then assembled from the most
optimal reservoir. This would grant a sufficient supply of lipids without affecting the cell or tissue func-
tion.
Alternatively, Mari et al. suggested that the phagophore may be derived from a certain compartment
and is later supplied with lipids from various other membranes or Atg9-positive vesicles 293. For the cell,
this setup provides the highest flexibility and guarantees that autophagy can progress even if one mem-
brane source is exhausted by prolonged starvation.
However, both of these models neglect the role of the ER-specific omegasome, which appears to be re-
quired as a scaffolding membrane during pre-autophagosomal membrane assembly 6. The ER is also
one of the major cellular lipid sources, along with mitochondria and lipid droplets, which are highly
connected with the ER. Thus, it seems sensible that the compartment is a major lipid contributor during
autophagosome biogenesis. In line with this, the Ktistakis and Yoshimori labs determined that Atg14L,
a crucial part of the PI3K complex, localizes mostly to the ER 38,39. Further, ER-resident proteins, like the
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Figure 3.20: Re-routing PI3K complex proteins to different compartments using FKBP’-Beclin1 as bait. Au-
tophagosome formation was evaluated by quantification of EGFP-LC3 puncta in MCF7 cells. Autophagy was in-
duced by 3 h starvation in EBSS. Error bars: weighted mean ± SEM (n≥ 60); * = p≤ 0.05. A ER targeting of FKPB’-
Beclin1 causes a significant increase in LC3-puncta. B Re-routing of PI3K complex proteins to the ERGIC has no
significant effect on autophagosome formation. C Induced Golgi localization of FKBP’-Beclin1 does not affect LC3-
puncta formation. D Autophagosome formation is not influenced by increased PI3k protein concentrations at the
mitochondria.
Beclin1 interaction partner VMP1, have been directly associated with generation of autophagosomes
from omegasomes 298,299. Taken together, this yields a third possible scenario in which phagophores are
exclusively assembled within omegasomes at the ER. Afterwards, the phagophore is supplied with lipids
from the remaining compartments or associates with different membrane sources before becoming a
closed autophagosome 293.
Our results support all three hypothesis to some extent, but point mostly towards the latter model. We
observed that autophagosomes can be assembled from the ER, ERGIC, Golgi and mitochondria. How-
ever, the ER appeared to be the primary site of autophagosome formation - at least under the given
conditions. It remains to be determined, whether the effect is consistent in different cell lines or star-
vation conditions. Our data contradicts the second model stating that autophagosomes assemble from
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a specific a site. If there was one exclusive site of autophagosome formation, translocalization of PI3K
complex proteins to the other compartments should disrupt the process in a similar fashion as mislocal-
ization to the plasma membrane. Based on our results, it appears likely that autophagosomes are most
efficiently generated at the ER, but may originate from other compartments as well. Yet, this would also
imply that omegasomes are either not entirely ER-specific or not absolutely necessary for autophago-
some biogenesis. This is further complicated by the fact, that the ER is not spatially constricted and in
transient contact with all other compartments 6.
In order to determine, whether the ER is indeed the principal autophagosome formation site, one could
repeat the experiment in different cell or tissues types and also vary the stress signals. If the autophago-
some formation site is specific to certain tissues or stimuli, different conditions should enhance au-
tophagosome formation from distinct compartments in a consistent manner. In addition, it would be
of interest to target the ULK1 and PI3K complexes simultaneously to the each tested compartment as
described above. In any case, inducible translocalization of autophagy complexes to different cellular
compartments is a valuable tool to study the spatial organization of autophagosome formation. In fu-
ture, it will be of interest to dissect the autophagy process further using inducible localization.
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4 Conclusions and Perspectives
The knock off and on system is the first attempt to modulate autophagy with inducible chemical dimer-
ization. A major advantage of this technique are the fast dimerization and dissociation kinetics of SLF’-
TMP-mediated dimerization as well as the broad applicability and the simple application. In contrast to
altering gene expression, chemical autophagy modulators or other dimerization systems, knock off/on
facilitates rapid, tunable and specific perturbation of the autophagy process in vivo. In this study, au-
tophagosome formation could be inhibited on a time scale of minutes, but the dimerization speed could
probably be even faster at higher concentrations of SLF’-TMP or with an optically pure compound. Sim-
ilar results can only be achieved with small molecule inhibitors (or inducers) and many of those lack
specificity or show time- and dose-dependent side effects 14. The knock off/on approach can also be
customized to target virtually any cellular protein of interest, especially in combination with nanobod-
ies. In this study, we successfully employed an anti-Vps34 nanobody as bait for endogenous Vps34. This
gives rise to a range of new applications and is only limited by the high cost of generating customized
nanobodies at present.
Here, we applied the knock off/on strategy to disrupt the localization-dependent function of the PI3K
complex during autophagosome formation. Using the autophagy markers EGFP-Atg5, -LC3, -WIPI2b
and EGFP-mCherry-LC3, we monitored the dynamics of PI3K complex mislocalization and studied the
effect on autophagy progression. It turned out that the Atg14L-containing PI3K complex is essential for
formation of the isolation membrane and the autophagosome, as knock off of any PI3K complex pro-
tein completely abolished autophagosome biogenesis. This PI3K complex is, however, not required for
lysosomal fusion or degradation of the autolysosome. Since the main function of the Atg14L-PI3K com-
plex is the generation of PI3Ps, we suppose that the depletion of the PI3P pool at the autophagosome
formation site is the underlying cause of the autophagy inhibition we observed. Since the phenotype
was also stable for several hours, we further assume that the PI3Ps required for autophagosome forma-
tion are exclusively generated by Vps34. In order to confirm this hypothesis, one could target a PI3P-
phosphatase, like MTM1, to the autophagosome formation site and thus deplete it of PI3P. Alternatively,
the anti-Vps34 nanobody could be employed to recruit Vps34, or its kinase domain to the formation site
and generate an excess of PI3Ps. If the only function of the PI3K complex is to provide PI3Ps and PI3P
concentration is the only regulatory signal, this should inhibit or enhance autophagosome formation,
respectively.
Interestingly, we also observed that Beclin1 and Atg14L or UVRAG are required to maintain Vps34s ki-
nase activity, which has not been reported before. It would be of interest to determine whether the
Vps34-p150 heterodimer is sufficient to generate PI3Ps at the autophagosome formation site or if the
whole PI3K complex needs to be assembled. This would give some insight on the functional and tempo-
ral relationship between the individual proteins within the complex. If assembly and translocalization of
the Vps34-p150 heterodimer are sufficient to generate PI3Ps and induce autophagosome formation, the
Beclin1-Atg14L heterodimer would merely serve as localization signal and to maintain complex stabil-
ity. However, given that Beclin1 is a binding platform interacting with a number of regulatory proteins,
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this option appears unlikely.
In order to completely understand the signaling events leading to autophagosome formation, the knock
off/on strategy could be extended to other protein complexes, like mTORC1 or the ULK1 complex.
mTORC1 is a master regulator involved in various processes, so that mislocalization of mTORC1 or its
components would probably affect cellular events globally. Yet, it would be possible to target upstream
nutrient-sensing proteins or complexes like RagA/B or Rheb. This may also be an option to artificially
create specific stress or starvation signals. To dissect the nature and dynamics of ULK1 and PI3K com-
plex interaction, the SLF’-TMP dimerization system could be combined with another dimerization ap-
proach to recruit the complexes sequentially to potential autophagosome formation sites.
Another yet unresolved aspect of autophagosome formation is the spatial organization of the process.
We observed that autophagosomes are primarily formed at the ER, but also at the ERGIC, Golgi and
mitochondria. Considering that omegasomes are mostly ER-localized, this raises the question how
and under which conditions autophagosomes are generated at the other compartments. To investi-
gate this further, the experimental conditions could be varied to explore if certain stress stimuli induce
autophagosome biogenesis from different localizations, maybe even in a tissue- or cell-specific fashion.
Further, one could attempt to re-create an omegasome-like platform at the ERGIC, Golgi or mitochon-
dria by targeting Vps34 or other kinases and phosphatases to the compartments and modulating the
lipid composition on the membrane. In line with this, inducible chemical dimerization could be em-
ployed to determine the minimally required autophagosome formation machinery at a specific cellular
localization. To this end, the SLF’-TMP system could be used in combination with other dimerization
systems to progressively recruit different complexes or even single proteins to the different compart-
ments. Another option would be to mislocalize several autophagy complexes to the plasma membrane
and then gradually release them.
Employing the knock off/on approach, we also gained valuable insights on UVRAGs autophagy-related
function. Based on our observations, we propose a model in which UVRAG is first involved in genera-
tion, transport and fusion of Atg9 vesicles to support autophagosome formation and later coordinates
trafficking and lysosomal fusion of the closed autophagosome. Here, we analyzed the effect of UVRAG
mislocalization on autophagy using common autophagy markers. However, one could dissect UVRAGs
function further by studying the effect on potential interaction partners like mTORC1, Bif-1, Rubicon,
HOPS or Atg9 vesicles. Again, it might also be conclusive to monitor the lipid synthesis at the omega-
some or the autophagosome, since UVRAG features a lipid-binding domain 10 and may be regulated by
changes in the lipid composition of autophagosomal membranes.
Taken together, the results presented in this study show that the knock off and on approach is a versatile
new strategy to modulate and study the spatiotemporal interaction of proteins or protein complexes
in autophagy. In the future, we hope to apply and expand the strategy further to explore the details of
autophagosome formation and maturation. However, it also remains worth mentioning, that the knock
off and on system is by far not limited to autophagy and can be applied to any cellular process of choice.
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Appendices

A Methods and Materials
A.1 ImageJ Macros
A.1.1 EGFP Puncta Count
macro "EGFP Puncta Count [F5]" {
run("Bio-Formats");
dir = getDirectory("Choose an output directory");
path = dir;
MergeDir = path + "Merge" + File.separator;
File.makeDirectory(MergeDir);
setBatchMode(true);
ids=newArray(nImages);
for (i=0;i<nImages;i++) {
selectImage(i+1);
title = getImageID;
ids[i]=getImageID;
saveAs("tif", MergeDir+title);
path = dir;
ROIDir = path + "ROI" + File.separator;
File.makeDirectory(ROIDir);
path = dir;
ResultsDir = path + "Results" + File.separator;
File.makeDirectory(ResultsDir);}
setBatchMode(false);
imgArray = newArray(nImages);
for (i=0; i<nImages; i++) {
selectImage(i+1);
imgArray[i] = getImageID();}
for (i=0; i< imgArray.length; i++) {
selectImage(imgArray[i]);
myImageID = getImageID();
setTool("freehand");
waitForUser("Selection", "Select ROI, then click OK.");
selectImage(myImageID);
run("Make Inverse");
run("Set...", "value=NaN");
getNumber("How many cells?", 0);
newDir = ROIDir;
selectImage(myImageID);
title = getTitle;
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saveAs("tif", newDir+title);
run("Close");}
setBatchMode(true);
path = ROIDir
filename = getFileList(path);
for (i=0; i<filename.length; i++) {
if(endsWith(filename[i], ".tif")) {
open(path+filename[i]);
run("Split Channels");}}
path = dir
newDir = path + "Split" + File.separator;
File.makeDirectory(newDir);
ids=newArray(nImages);
for (i=0;i<nImages;i++) {
selectImage(i+1);
title = getTitle;
saveAs("tif", newDir+title);}
run("Close All");
setBatchMode(false);
list=getFileList(newDir);
for(i=0;i<list.length;i++){
showProgress(i+1, list.length);
filename = newDir + list[i];
if(endsWith(list[i],".tif")&&indexOf(list[i],"C2")>=0){
open(filename);}}
imgArray = newArray(nImages);
for (i=0; i<nImages; i++) {
selectImage(i+1);
imgArray[i] = getImageID();}
for (i=0; i< imgArray.length; i++) {
selectImage(imgArray[i]);
myImageID = getImageID();
run("Threshold...");
waitForUser("Threshold", "Set threshold to select CELL AREA, then click OK.");
selectImage(myImageID);
rename("Cell Area");
run("Analyze Particles...", "size=300-Infinity pixel circularity=0.00-1.00
show=[Overlay Outlines] display summarize");
selectImage(myImageID);}
dir = ResultsDir;
selectWindow("Summary");
saveAs("Text", dir +"Cell Area.txt");
selectWindow("Cell Area.txt");
run("Close All");
list=getFileList(newDir);
for(i=0;i<list.length;i++){
showProgress(i+1, list.length);
filename = newDir + list[i];
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if(endsWith(list[i],".tif")&&indexOf(list[i],"C2")>=0){
open(filename);}}
imgArray = newArray(nImages);
for (i=0; i<nImages; i++) {
selectImage(i+1);
imgArray[i] = getImageID();}
for (i=0; i< imgArray.length; i++) {
selectImage(imgArray[i]);
myImageID = getImageID();
run("Threshold...");
waitForUser("Threshold", "Set threshold to select GREEN PUNCTA AREA, then
click OK.");
selectImage(myImageID);
name = getTitle;
rename("Green Puncta Area");
run("Analyze Particles...", "size=3-Infinity pixel circularity=0.00-1.00
show=[Overlay Outlines] display summarize");}
dir = ResultsDir;
selectWindow("Summary");
saveAs("Text", dir +"Green Puncta Area.txt");
selectWindow("Green Puncta Area.txt");
selectWindow("Results");
run("Close");
run("Close All");
selectWindow("Log");
saveAs("Text", dir +"Cell Number.txt")}
A.1.2 mCherry-EGFP Puncta Count
macro "mCherry-EGFP Puncta Count [F6]"{
run("Bio-Formats");
dir = getDirectory("Choose an output directory");
path = dir;
MergeDir = path + "Merge" + File.separator;
File.makeDirectory(MergeDir);
setBatchMode(true);
ids=newArray(nImages);
for (i=0;i<nImages;i++) {
selectImage(i+1);
title = getImageID;
ids[i]=getImageID;
saveAs("tif", MergeDir+title);
path = dir;
MaskGreenDir = path + "MaskGreen" + File.separator;
File.makeDirectory(MaskGreenDir);
path = dir;
ROIDir = path + "ROI" + File.separator;
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File.makeDirectory(ROIDir);
path = dir;
AlignedDir = path + "Aligned" + File.separator;
File.makeDirectory(AlignedDir);
path = dir;
ResultsDir = path + "Results" + File.separator;
File.makeDirectory(ResultsDir);
path = dir;
Masks2Dir = path + "Masks2" + File.separator;
File.makeDirectory(Masks2Dir);}
setBatchMode(false);
imgArray = newArray(nImages);
for (i=0; i<nImages; i++) {
selectImage(i+1);
imgArray[i] = getImageID();}
for (i=0; i< imgArray.length; i++) {
selectImage(imgArray[i]);
myImageID = getImageID();
setTool("freehand");
waitForUser("Selection", "Select ROI, then click OK.");
selectImage(myImageID);
run("Make Inverse");
run("Set...", "value=NaN");
getNumber("How many cells?", 0);
newDir = ROIDir;
selectImage(myImageID);
title = getTitle;
saveAs("tif", newDir+title);
run("Close");}
dir1 = ROIDir;
list = getFileList(dir1);
for (i=0; i<list.length; i++) {
showProgress(i+1, list.length);
filename = dir1 + list[i];
if (endsWith(filename, "tif")) {
run("Bio-Formats", "open=filename autoscale color_mode=Default view=Hyperstack
stack_order=XYCZT");}}
imgArray = newArray(nImages);
for (i=0; i<nImages; i++) {
selectImage(i+1);
imgArray[i] = getImageID();}
for (i=0; i< imgArray.length; i++) {
selectImage(imgArray[i]);
myImageID = getImageID();
run("StackReg ", "transformation=[Rigid Body]");
newDir = AlignedDir;
selectImage(myImageID);
title = getTitle;
113
APPENDIX A
saveAs("tif", newDir+title);
run("Close");}
setBatchMode(true);
path = AlignedDir
filename = getFileList(path);
for (i=0; i<filename.length; i++) {
if(endsWith(filename[i], ".tif")) {
open(path+filename[i]);
run("Split Channels");}}
path = dir
newDir = path + "Split" + File.separator;
File.makeDirectory(newDir);
ids=newArray(nImages);
for (i=0;i<nImages;i++) {
selectImage(i+1);
title = getTitle;
saveAs("tif", newDir+title);}
run("Close All");
setBatchMode(false);
list=getFileList(newDir);
for(i=0;i<list.length;i++){
showProgress(i+1, list.length);
filename = newDir + list[i];
if(endsWith(list[i],".tif")&&indexOf(list[i],"C2")>=0){
open(filename);}}
imgArray = newArray(nImages);
for (i=0; i<nImages; i++) {
selectImage(i+1);
imgArray[i] = getImageID();}
for (i=0; i< imgArray.length; i++) {
selectImage(imgArray[i]);
myImageID = getImageID();
run("Threshold...");
waitForUser("Threshold", "Set threshold to select CELL AREA, then click OK.");
selectImage(myImageID);
rename("Cell Area");
run("Analyze Particles...", "size=300-Infinity pixel circularity=0.00-1.00
show=[Overlay Outlines] display summarize");
selectImage(myImageID);}
dir = ResultsDir;
selectWindow("Summary");
saveAs("Text", dir +"Cell Area.txt");
selectWindow("Cell Area.txt");
run("Close");
run("Close All");
list=getFileList(newDir);
for(i=0;i<list.length;i++){
showProgress(i+1, list.length);
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filename = newDir + list[i];
if(endsWith(list[i],".tif")&&indexOf(list[i],"C2")>=0){
open(filename);}}
imgArray = newArray(nImages);
for (i=0; i<nImages; i++) {
selectImage(i+1);
imgArray[i] = getImageID();}
for (i=0; i< imgArray.length; i++) {
selectImage(imgArray[i]);
myImageID = getImageID();
run("Threshold...");
waitForUser("Threshold", "Set threshold to select GREEN PUNCTA AREA, then
click OK.");
selectImage(myImageID);
name = getTitle;
rename("Green Puncta Area");
run("Analyze Particles...", "size=3-Infinity pixel circularity=0.00-1.00
show=[Overlay Outlines] display summarize");
run("Convert to Mask");
rename(name);}
// get image IDs of all open images
dir = Masks2Dir;
ids=newArray(nImages);
for (i=0;i<nImages;i++) {
selectImage(i+1);
name = getTitle;
ids[i]=getImageID;
saveAs("tiff", dir + name);}
run("Close All");
list=getFileList(newDir);
for(i=0;i<list.length;i++){
showProgress(i+1, list.length);
filename = newDir + list[i];
if(endsWith(list[i],".tif")&&indexOf(list[i],"C1")>=0){
open(filename);}}
// get image IDs of all open images
dir = Masks2Dir;
ids=newArray(nImages);
for (i=0;i<nImages;i++) {
selectImage(i+1);
name = getTitle;
ids[i]=getImageID;
saveAs("tiff", dir + name);}
dir = ResultsDir;
selectWindow("Summary");
saveAs("Text", dir +"Green Puncta Area.txt");
selectWindow("Green Puncta Area.txt");
run("Close");
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run("Close All");
nucleiName = "C1";
cytoplasmName = "C2";
inputFolder = Masks2Dir;
var allImages;
allImages = getFileList(inputFolder);
var numberOfImages = 0;
numberOfImages = countNucleiImages();
nucleiImages = getImagesContaining(nucleiName);
function countNucleiImages() {
count = 0;
for(i=0; i<allImages.length; i++) {
if (indexOf(allImages[i], nucleiName) !=-1 )
count++;}
return count;}
function getImagesContaining(text) {
result = newArray(numberOfImages);
index = 0;
for (i=0; i<allImages.length; i++) {
if (indexOf(allImages[i], text) != -1) {
result[index] = allImages[i];
index++;}}
return result;}
for (i=0; i<nucleiImages.length;i++) {
inputPath = inputFolder + nucleiImages[i];
open(inputPath);
rename("Red");
run("8-bit");
open(inputFolder + replace(nucleiImages[i], nucleiName, cytoplasmName));
rename("Green");
run("8-bit");
imageCalculator("Subtract create", "Red","Green");
selectWindow("Green");
run("Close");
selectWindow("Red");
run("Close");}
// get image IDs of all open images
dir = MaskGreenDir;
ids=newArray(nImages);
for (i=0;i<nImages;i++) {
selectImage(i+1);
name = getImageID;
ids[i]=getImageID;
saveAs("tiff", dir + name);}
run("Close All");
list=getFileList(MaskGreenDir);
for(i=0;i<list.length;i++){
showProgress(i+1, list.length);
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filename = MaskGreenDir + list[i];
if(endsWith(list[i],".tif")>=0){
open(filename);}}
imgArray = newArray(nImages);
for (i=0; i<nImages; i++) {
selectImage(i+1);
imgArray[i] = getImageID();}
for (i=0; i< imgArray.length; i++) {
selectImage(imgArray[i]);
myImageID = getImageID();
run("Threshold...");
waitForUser("Threshold", "Set threshold to select RED PUNCTA AREA, then click
OK.");
selectImage(myImageID);
name = getTitle;
rename("Red Puncta Area");
run("Analyze Particles...", "size=2-Infinity pixel circularity=0.00-1.00
show=[Overlay Outlines] display summarize");
selectImage(myImageID);}
run("Close All");
path= ResultsDir;
list=getFileList(path);
for(i=0;i<list.length;i++){
open(path+list[i]);}
dir = ResultsDir;
selectWindow("Results");
run("Close");
selectWindow("Summary");
saveAs("Text", dir +"Red Puncta Area.txt");
dir = ResultsDir;
selectWindow("Log");
saveAs("Text", dir +"Cell Number.txt")}
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B Results and Discussion
B.1 Establishing the Knock Off and On Strategy
Figure B.1: Co-localization of exogenous autophagy proteins at the plasma membrane of MCF7 cells after 2 hours
starvation in EBSS and 30 minutes treatment with SLF’-TMP. Scale bar: 10µm. A FKBP’-Beclin1 attracts Atg14L
to the plasma membrane, but not Vps34. B FKBP’-Beclin1 and UVRAG co-localize at the plasma membrane, but
Vps34 remains cytoplasmic. C FKBP’-Beclin1 attracts UVRAG to the plasma membrane, but not p150. D Beclin1 is
mislocalized to the plasma membrane through interaction with FKBP’-Atg14L, but Vps34 is not attracted. E FKBP’-
Vps34 cannot serve as a bait for Atg14L or Beclin1.
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Figure B.2: Co-localization of overexpressed and endogenous PI3K complex proteins at the plasma membrane of
HEK293T cells after 1 hour starvation in EBSS. Scale bar: 10µm. A Co-localisation of exogenous and endogenous
Beclin1. B Co-localisation of exogenous and endogenous UVRAG. C Co-localisation of exogenous and endogenous
Atg14L. D Co-localisation of exogenous and endogenous Vps34.
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Figure B.3: Co-localization of overexpressed and endogenous PI3K complex proteins at the plasma membrane of
HEK293T cells after 1 hour starvation in EBSS and treatment with SLF’-TMP.. Scale bar: 10µm. A Co-localisation of
exogenous and endogenous Beclin1. B Co-localisation of exogenous and endogenous UVRAG. C Co-localisation of
exogenous and endogenous Atg14L. D Co-localisation of exogenous and endogenous Vps34.
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Figure B.4: Cellular localization of overexpressed FKBP’-Beclin1 and immunostained endogenous UVRAG. Cells
were starved in EBSS for 1 hour in presence or abscence of SLF’-TMP. Scale bar: 10µm. A FKBP’-Beclin1 attracts
endogenous UVRAG to the plasma membrane of HEK293T cells. B In HeLa cells, immunostained UVRAG appears
to localize to the plasma membrane regardless of SLF’-TMP treatment. C In MCF7 cells immunostained UVRAG
displays a similar phenotype as in HeLa cells.
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Figure B.5: Cellular distribution of overexpressed FKBP’-Beclin1 and immunostained endogenous Atg14L. Cells
were starved in EBSS for 1 hour in presence or abscence of SLF’-TMP. Scale bar: 10µm. A In HEK293T cells, im-
munostaining for Atg14L shows punctate structures close to the plasma membrane, but no co-localization of FKBP’-
Beclin1 and Atg14L. B FKBP’-Beclin1 attracts endogenous Atg14L to the plasma membrane of HeLa cells. C In MCF7
cells, immunostained Atg14L displays a similar phenotype as in HEK293T cells and appears to localize to punctacte
structures.
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Figure B.6: Cellular distribution of overexpressed FKBP’-UVRAG and immunostained endogenous Beclin1. Cells
were starved in EBSS for 1 hour in presence or abscence of SLF’-TMP. Scale bar: 10µm. A In HEK293T cells, im-
munostaining for Beclin1 shows diffused punctate structures and indicates no co-localization of FKBP’-UVRAG
and Beclin1. B In HeLa cells, immunostaining for Beclin1 shows more definded punctate structures, but no co-
localization of FKBP’-UVRAG and Beclin1 could be detected. C In MCF7 cells, immunostaining for Beclin1 indicates
diffuse cytoplasmic localization and punctate structures, but no co-localization of FKBP’-UVRAG and Beclin1.
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B.2 Modulation of Autophagosome Formation with Knock Off and
On
Figure B.7: Knock off of Beclin1 perturbs autophagosome formation in EGFP-LC3-MCF7 cells. A MCF7 expressing
the control construct mCherry-FKBP’ show no reaction to dimerizer addition and autophagosome formation is not
affected. B Autophagosome formation is inhibited after dimerizer addition in MCF7 cells transfected with mCherry-
FKBP’-Beclin1.
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Figure B.8: Knock off of FKBP’-Beclin1 perturbs autophagy flux. mCherry-EGFP-LC3-MCF7 cells were starved
in EBSS for 2 hours and simultaneously treated with SLF’-TMP, TMP or BafilomycinA1. AP = Autophagosomes,
AL = Autolysosomes. Error bars: weighted mean ± SEM (n≥ 40); *** = p≤ 0.001; statistical significance was deter-
mined by student’s t-test against the starvation condition; data was normalized against the fed condition. A Mis-
localization of FKBP’ alone has no effect on autophagosome formation or maturation. BafilomycinA1 treatment
causes an increase autophagsomes, but a decrease in autolysosomes indicating blockage of autophagosome mat-
uration. B FKBP’-Beclin1 knock off causes a significant reduction of yellow and red puncta suggesting that overall
autophagy flux is impaired. The effect can be reversed by addition of TMP. BafilomycinA1 treatment produces the
same phenotype as in the control cells expressing only FKBP’.
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B.3 UVRAGs Function in Autophagy
Figure B.9: Interaction of Beclin1-U and Atg14L or UVRAG in MCF7 cells after 2 hours starvation in EBSS and
30 minutes treatment with SLF’-TMP. Scale bar: 10µm. A FKBP’-Beclin1-U cannot mislocalize Atg14L to the
plasma membrane suggesting that the construct is deficient in Atg14L binding. FKBP’-Beclin1-U attracts UVRAG
to the plasma membrane indicating that UVRAG binding is maintained regardless of the truncation. B FKBP’-
Beclin1∆CCD cannot attract Atg14L or UVRAG to the plasma membrane.
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Figure B.10: Mislocalization of enodgenous UVRAG does not affect early autophagosome formation, but mod-
ulates autophagosome maturation. Error bars: weighted mean ± SEM (n≥ 20 for WIPI assay, n≥ 40 for EGFP-
mCherry-LC3 assay); ** = p≤ 0.01, *** = p≤ 0.001; statistical significance was determined by student’s t-test against
the starvation condition; data was normalized against the fed condition. A Knock off of Beclin1-U has no impact on
WIPI2b puncta formation. B FKBP’-Beclin1-U knock off causes a significant reduction of autophagosomes (AP)
and autolysosmes (AL) suggesting that overall autophagy flux is impaired. The effect can be reversed by addi-
tion of TMP. BafilomycinA1 treatment produces the same phenotype as in the control cells expressing only FKBP’.
mCherry-EGFP-LC3-MCF7 cells were starved in EBSS for 2 hours and simultaneously treated with SLF’-TMP, TMP
or BafilomycinA1.
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B.4 Spatial Organization of Autophagosome Biogenesis
Figure B.11: Bait proteins co-localizing with specific organelle markers. Scale bar: 10µm. A mKate-Cb5 was used
to label the ER and co-localizes with TagBFP-eDHFR-Cb5. B TagBFP-eDHFR was targeted to the ERGIC using ER-
GIC53. C mKate-Giantin was employed to visualize the Golgi and TagBFP-eDHFR-Giantin served as cellular Golgi
anchor. D Mitochondria were labeled with mCherry-ActA and co-lolcalizes with TagBFP-eDHFR-ActA.
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